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Prostaglandin (PG) F2a is the uterine luteolytic hormone in the guinea-pig
(Horton and Poyser, 1976). Oestradiol acting on a progesterone-primed uterus
appears to be the physiological stimulus for increased PGF2ot production by the
guinea-pig uterus (particularly by the endometrium) towards the end of the cycle
(Blatchley and Poyser, 1974; Poyser, 1983b; Poyser, 1993). Arachidonic acid (AA) is
the precursor of PGs. Phospholipids appear to be the source of AA for PG synthesis
in the guinea-pig uterus (Leaver and Poyser, 1981). A specific stimulation of the
mechanisms involved in the uptake of AA into guinea-pig endometrium (particularly
into phospholipids) has been demonstrated to occur towards the end of the oestrous
cycle (Ning, Leaver and Poyser, 1983). The three enzymes acyl-CoA synthetase
(ACS), acyl-CoA:lysophospholipid acyltransferase (ACLS) and phospholipase (PL)
A2 control AA turnover via reacylation and deacylation of glycerophospholipids and,
consequently, may play an important role in controlling the amount of free AA
available for conversion to PGF2a. If an increase in the activities of ACS and ACLS
were to occur towards the end of the oestrous cycle in the guinea-pig endometrium,
this could explain the increased incorporation of AA into endometrial phospholipids
observed on day 15 of the cycle. Although an increase in the rate of AA uptake may
be beneficial in providing a faster turnover of AA for PG synthesis, such an increase
may actually limit PG synthesis, since, following its release by PLA2, free AA would
be reacylated at a faster rate. Indeed, this could be of importance during early
pregnancy, when uterine PGF2a output must remain low so that luteal function is
maintained. Thus, PG release may not only be controlled by PLA2, but also by the
reacylating enzymes ACS and ACLS in stimulated tissues. Therefore, the role of
ACS, ACLS and PLA2 in relation to PG production in the non-pregnant and pregnant
guinea-pig uterus has been investigated.
ACS, ACLS and PLA2 activities were detected in guinea-pig endometrium on
both day 7 (day of low PGF2a output) and day 15 (day of high PGF2a output) of the
oestrous cycle and in the endometrium of ovariectomized guinea-pigs treated with
oestradiol and/or progesterone.
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Treatment with aristolochic acid (ARA) and quinacrine (QUIN) (PLA2
inhibitors) significantly (P < 0.05) reduced PGF2ct output from both day 7 and day 15
endometrium cultured for 24 h, demonstrating the crucial role that PLA2 plays in the
regulation of AA release for PGF2a synthesis in the guinea-pig. Unexpectedly,
treatment with p-hydroxymercuribenzoic acid (HMB) and thimerosal (THM) (ACS
and ACLS inhibitors) also significantly (P < 0.05) decreased PGF2a output. However,
during long term inhibition of ACS and ACLS, since the rate of uptake of AA into
lysophospholipids will be reduced, the amount of AA appropriately placed in the sn-2
position of appropriate phospholipids for the action of PLA2 will also be reduced.
Therefore, PLA2 may be indirectly inhibited by a lack of substrate.
ACS, ACLS and PLA2 activities were detected in the endometrium and
conceptus of early pregnant (day 15) guinea-pigs. All three enzymes were also
detected in the endometrium, subplacenta, chorio-allantoic placenta, chorion and
amnion of day 29 and 36 pregnant guinea-pigs. Treatment with THM and ARA of day
22, 29 and 36 pregnant guinea-pig endometrial and fetal tissues during 24 h culture
suggested that the control of AA uptake is important in the subplacenta, chorio¬
allantoic placenta, chorion and amnion, and that PLA2 appears to have an essential
role in the control of PG synthesis from the endometrium, chorion and amnion of
pregnant guinea-pigs.
Treatment of day 7 non-pregnant superfused guinea-pig uterus iti vitro with
HMB, THM and, surprisingly, ARA all increased PGF2a, PGE2 and 6-keto-PGFia
outputs. HMB and THM treatment also prevented the A23187-stimulated increase in
PG output. In contrast, HMB and THM treatment decreased, whilst ARA treatment
increased, PGF2a output from day 7 guinea-pig uterine homogenates incubated for 1 h
in the presence of 2 pg/ml AA.
In summary, ACS, ACLS and PLA2 activities were all detected in the
endometrium of non-pregnant, and in the endometrium and fetal tissues of pregnant,
guinea-pigs. The stimulus responsible for increased PLA2 activity towards the end of
the cycle remains obscure. The anti-luteolytic factor produced by the guinea-pig
conceptus does not appear to influence the rate of AA uptake in the endometrium or
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conceptus. However, the control of AA uptake in the placenta and fetal membranes
seems to have a role in the tightly regulated control ofPG synthesis during pregnancy.
CHAPTER 1 : GENERAL INTRODUCTION
Introduction to Prostaglandins
1:1 History of prostaglandins
Prostaglandins were first discovered over sixty years ago by gynaecologist
Raphael Kurzrok and pharmacologist Charles Lieb in 1930 who were conducting
research into methods of artificial insemination. They observed that human semen
caused uterine contractions in some women and relaxation in others. Experiments
carried out in vitro on isolated human uterine strips resulted in similar findings and led
to the confusing observation that a single uterine tissue sample could either contract
or relax when treated with different semen samples. Two independent workers later
described the presence in human seminal plasma of a vasodepressor and smooth
muscle contracting substance which was lipid-soluble and acidic in nature (Goldblatt,
1933, 1935). It was also detected in extracts of seminal plasma in monkey, goat and
sheep (von Euler, 1935, 1936). The name "prostaglandin" (PG) was established by
von Euler in 1935 to describe this unknown substance which appeared to originate
from the prostate gland. However in 1959, Eliasson determined that the seminal
vesicles, not the prostate gland, were the source of PGs in the seminal plasma, but the
name prostaglandin remained. By 1939, von Euler had concluded that PG was a lipid-
soluble fatty acid most probably containing a double bond and a hydroxyl group. Due
to inadequate purification and analytical techniques and the fact that PGs are present
in very low concentrations in tissues, research on PGs was delayed considerably. In
1949, Bergstrom confirmed von Euler's findings that biological activity was due to a
group of highly active lipid-soluble unsaturated fatty acids. Bergstrom and Sjovall
(1957) went on to isolate one prostaglandin "factor" (PGF) in crystalline form using
techniques such as paper and gas-liquid chromatography and countercurrent
distribution. By 1960, using the technique of X-ray crystalography, they had
proposed structures for PGF and PGE (Bergstrom and Sjovall, 1960a, b). The
structures were confirmed as PGF]a and PGE], respectively, using mass
spectrometry (Bergstrom, Ryhage, Samuelsson and Sjovall, 1963).
1:2 Chemistry and nomenclature of prostaglandins
The PGs consist of a family of structurally related compounds with a wide
diversity of biological actions. They are all based on the structure of "prostanoic acid"
and can be generally described as 20-carbon, oxygenated, unsaturated fatty acids.
They are made up of a cyclopentane ring with an upper (a) and lower (co) side chain
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consisting of 7 and 8 carbon atoms, respectively. There are numerous structure
variations which are classified into 9 different types (PGA to PGI). The letter
designated to a specific PG describes differences occurring in the cyclopentane ring
(with the exception of PGG2 and PGH2 which both have the same ring structure).
Thromboxanes possess an additional oxygen atom enclosed within the ring. The PGs
are also divided into 3 different "series" according to the number of double bonds in
the side chains and these are represented by a subscript numeral. This degree of
unsaturation of the PG is dependent on the fatty acid precursor. The fatty acid
precursors of PGs of the "1", "2" and "3" series are cis-8,11,14-eicosatrienoic acid,
cis-5,8,11,14-eicosatetraenoic acid and cis-5,8,11,14,17-eicosapentaenoic acid,
respectively. The resulting PGs of the "1" series have a double bond in the trans
13,14 position. PGs of the "2" series have an additional double bond in the cis 5,6
position and those of the "3" series have a third double bond at the trans 17,18
position. PGs of the F group also have an additional subscript which denotes whether
the carbon-9 hydroxyl group is above ((3) or below (a) the plane of the cyclopentane
ring i.e. it describes its isomeric form. PGs have an hydroxyl group at carbon-15, and
either a hydroxyl or ketone group at carbon-9 and (apart from A, B and C forms) at
carbon-11. PGs of the "2" series are the major PGs found in biological systems, with
the exception of primate seminal fluid where both "1" and "2" series PGs are found
(Kelly, 1978). PGI2 is cyclised between carbon-6 and the oxygen moiety at carbon-9.
Figure 1 illustrates the chemical structures of the fatty acids used for eicosanoid
synthesis, and of the PGs and thromboxanes synthesized from arachidonic acid
1:3 Synthesis and metabolism of prostaglandins
PGs are not stored in tissues and therefore any increase in their tissue levels or
output must be preceded by their immediate synthesis (Piper and Vane, 1971). One
exception to this does exist in primate seminal fluid where PGs are synthesized by the
seminal vesicles and stored in the seminal plasma (Kelly, Taylor, Hearn, Short, Martin
and Marston, 1976). All cell types are capable of synthesizing PGs from fatty acids
with the exception of red blood cells and sperm (Granstrom, 1981) and therefore PG
biosynthesis can occur anywhere in the body. All naturally occurring PGs and
thromboxanes are synthesized from 3 essential unsaturated fatty acids (Van Dorp,
Beerthius, Ningteren and Vonkeman, 1964; Bergstrom, Danielsson and Samuelsson,
1964). Arachidonic acid (5,8,11,14-cis-eicosatetraenoic acid) is the most important of
these fatty acids as it is the precursor of PGs of the "2" series. Formation of PGs
requires that arachidonic acid be in the non-esterified form. The concentration of free
arachidonic acid is very low in tissues, and therefore the release of arachidonic acid
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Figure I. The chemical structures of (lie fatty acids used for cicosanoid
synthesis, and of the prostaglandins and thromboxanes synthesized from
arachidonic acid.





from some bound source is considered to be the rate-limiting step in PG synthesis.
During PG synthesis, free arachidonic acid is firstly converted into the unstable (but
biologically active) cyclic endoperoxide intermediates PGG2 and PGH2 (Hamberg,
Svensson, Wakabayashi and Samuelsson, 1974) by the action of the enzyme
prostaglandin endoperoxide (PGH) synthase. PGH synthase has two activities, namely
a fatty acid cyclo-oxygenase which converts arachidonic acid to the cyclic
endoperoxide, 15-hydroxyperoxide compound (PGG2) by the insertion of two O2
molecules at carbons 11 and 15, and a prostaglandin hydroperoxidase which then
rapidly converts the PGG2 into its 15-hydroxy analogue, PGH2. Five other enzymes
with isomerase or reductase activities convert PGH2 into the specific PGs and
thromboxanes (Figure 2). Which of these compounds is formed depends upon the
tissue and the enzymes it possesses (Samuelsson, Goldyne, Granstrom, Hamberg,
Hammarstrom and Malmsten, 1978). For example, in platelets (Hamberg, Svensson
and Samuelsson, 1975) thromboxane (TX) A2 is the major compound formed, but in
aortic tissue (Gryglewski, Bunting, Moncada, Flower and Vane, 1976) PGH is the
major product. The half-life of PGG2 and PGH2 in aqueous medium at 37°C is
approximately 5 min (Hamberg el al., 1974) and the two endoperoxides may be
converted to PGE2, PGD2, PGF2a, PGH and TXA2. Action of an isomerase enzyme
on PGH2 results in PGE2, whilst a reduction step would yield PGF2a. In acidic
conditions PGE2 dehydrates to form PGA2 which can then be isomerised
enzymatically into PGC2 and then PGB2 (Jones, Cammock and Horton, 1972). 19-
Hydroxylated derivatives of PGE2, PGF2a, PGA2 and PGB2 have also been
detected. PGI2 synthase converts PGH2 to the labile but biologically active PGH
The TXA2 synthase enzyme catalyses the conversion of PGH2 to TXA2
(Hammarstrom and Falardeau, 1977). Both PGI2 (half-life 3-5 min) and TXA2 (half-
life 30 s) are unstable in body fluids and rapidly form 6-keto-PGFja and TXB2
respectively, with a subsequent large loss in biological activity. PGD2, an isomer of
PGE2 (Granstrom, Lands and Samuelsson, 1968) is also formed from PGH2.
PGs are metabolised at carbon-15 by oxidation of the secondary alcohol group
into a ketone, which requires NAD+ as a co-factor. These 15-keto-prostaglandin
metabolites (especially those of the F series) retain most of the biological activity of
the parent compound. However subsequent reduction of the 13,14-double bond
results in a much greater loss of activity, and these 13,14-dihydro-15-keto-
prostaglandin compounds formed are the main circulating metabolites of PGE2 and
PGF2a in the plasma. They are often present in a 20-fold greater concentration than
the parent compound. Most tissues are capable of metabolising PGs, but this is often
at quite a low rate. However some tissues, such as the lungs, have a very high PG
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metabolic activity (Lands, 1979; Samuelsson, Granstrom, Green, Hamberg and
Hammarstrom, 1975). Between 95-99% of PGF2a and PGE2 present in the
circulation is metabolised by a single passage through the lungs (Ferriera and Vane,
1967). The inactivation of PGs is considered as a "two-stage" mechanism, involving
an initial uptake step followed by intracellular metabolism by an NAD+-dependent 15-
hydroxyprostaglandin dehydrogenase. Bito, Baroody and Reitz (1977) suggested that
the delay in the transit time of both PGF2a and PGE2 through the pulmonary
circulation was due to intracellular internalisation prior to metabolism. PGA2 escapes
metabolism when passing through the lungs even though it is a good substrate for the
metabolising enzymes (Horton and Jones, 1969) indicating that PGA2 is not a good
substrate for the uptake process (Bito et al., 1977). Since PGI2 and PGD2 are also
poor substrates for this uptake mechanism, they can act as circulating hormones,
whilst PGF2a and PGE2 (that are both readily internalised) can only act locally.
Further metabolism of the main circulating metabolites of PGs to dinor and tetranor
compounds by P-oxidation, followed by co-oxidation to the 20-alcohols or carboxylic
acids occurs in the liver. Hydroxylation at the 19-position can also occur, and PGE
compounds can be converted to PGF derivatives. For these reasons, a number of
urinary metabolites may be derived from any one PG, the main metabolite produced
being dependent upon the species (Horton, 1972; Samuelsson el al., 1975).
The Roles of Prostaglandins in Reproductive Processes
1:4 Luteolysis in the non-pregnant animal
Luteolysis (luteal regression), defined as the loss of luteal function consists of
two stages; first, there is a decreased secretion of progesterone (functional luteolysis)
followed by a loss of luteal tissue (structural luteolysis) (Niswender, Juengel,
McGuire, Belfiore and Wiltbank, 1994). The influence of the uterus in controlling the
process of luteolysis was first reported by Loeb in 1923 when he found that
hysterectomy in the guinea-pig resulted in the maintenance of corpora luteal function
prolonging the oestrous cycle from 15-17 to 60-120 days. In later studies, Loeb
(1927) observed that the maturation of follicles was not dependent on the presence of
the uterus. However, removal of unregressed corpora lutea lead to a new ovulation
suggesting that cyclic changes occurring in the hysterectomized guinea-pig were due
to the persistence of the corpora lutea. Loeb proposed that the guinea-pig uterus, in
particular the mucosa, produced an internal secretion which acted specifically on the
corpus luteum leading to its regression; he named this secretion "uterine luteolytic
factor". Subsequently, removal of the uterus resulting in the prolongation of luteal
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function was demonstrated in other species, including the cow and sheep (Wiltbank
and Casida, 1956; Anderson, Neal and Melampy, 1962), pig (Spies, Zimmerman, Self
and Casida, 1958), horse (Ginther and First, 1971) and the pseudo-pregnant rat
(Bradbury, 1937), rabbit (Asdell and Hammond, 1933), mouse (Critser, Rutledge and
French, 1980) and hamster (Caldwell, Mazer and Wright, 1967). However, ovarian
cyclicity remained unaffected by hysterectomy in the dog (Cheval, 1934), ferret
(Deanesly and Parkes, 1933) and the monkey (Burford and Diddle, 1936). In the
human, hysterectomy or the congenital absence of the uterus, fallopian tubes or
vagina has no effect on cyclic luteal function (Whitelaw, 1958; Doyle, Barclay,
Duncan and Kirkton, 1971; Fraser, Baird, Hobson, Michie and Hunter, 1973).
Specific destruction of the endometrial layer of the uterus was demonstrated to be
responsible for prolongation of the oestrous cycle in the pig (Anderson, Butcher and
Melampy, 1961) and guinea-pig (Butcher, Chu and Melampy, 1962) which
strengthened the original proposal of Loeb (1927) that a luteolytic factor originated
from the uterus and controlled luteal function and therefore oestrous cycle length.
However this mechanism did not apply to all species.
1:5 Local nature of action of uterine luteolytic factor
The local nature of action of the luteolytic factor was demonstrated in the
guinea-pig when unilateral hysterectomy resulted in normal corpora luteal regression
on the unoperated side of the uterus but luteal maintenance on the operated side
(Fischer, 1965; Bland and Donovan, 1966). This effect has also been shown in the
sheep (Moor and Rowson, 1966a). In both intact and unilaterally hysterectomized
heifers (where the retained uterine horn was next to the ovary containing the corpora
lutea), oxytocin treatment from days 3-8 shortened the oestrous cycles. However,
cycles were lengthened where the retained uterine horn was contralateral to the ovary
(Ginther, Woody, Mahajan, Janakiraman and Casida, 1967). The evidence suggests
that the action of the luteolytic factor is limited to the ovary ipsilateral to the uterine
horn from which it originates.
1:6 Evidence indicating PGF2a is the uterine luteolytic hormone
In 1968, Ducharme, Weeks and Montgomery demonstrated that PGF2a was a
potent venoconstrictor. A short time later, it was proposed that luteolysis could be
due to a reduction in ovarian blood flow and that the luteolytic factor was possibly a
venoconstricting substance produced by the uterus. When infused into rats on days 5
and 6 of pseudopregnancy, PGF2a caused both structural and functional luteal
regression compared to saline-treated animals (Pharriss and Wyndgarden, 1969).
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Numerous studies that followed demonstrated that PGF2a administration shortened
the lifespan of the corpus luteum in the guinea-pig (Blatchley and Donovan, 1969),
rabbit (Gutknecht, Cornette and Pharriss, 1969; Gutknecht, Duncan and Wyndgarden,
1972), sheep (McCracken, Glew and Scaramuzzi, 1970; Chamley, Buckmaster, Cain,
Cerini, Cerini, Cumming and Goding, 1972), monkey (Kirton, Pharriss and Forbes,
1970), cow (Louis, Hafs and Morrow, 1972; Lauderdale, 1972; Rowson, Tervit and
Brand, 1972), horse (Douglas and Ginther, 1972; Noden, Oxender and Hafs, 1974),
pig (Gleeson, 1974; Guthrie and Polge, 1976; Lindloff, Holtz, Elsaesser,
Kreikenbaum and Smidt, 1976; Moeljono, Bazer and Thatcher, 1976), goat (Ott,
Nelson and Hixon, 1980), hamster (Labhsetwar, 1971), mouse (Labhsetwar, 1972)
and rat (Chatterjee, 1973). In order to clarify that PGF2a was the uterine luteolytic
factor, it was necessary to show that it was present in the uterine venous blood prior
to luteal regression. Increasing concentrations of PGF2a were observed in sheep
uterine venous blood on days 14, 15 and 16 of the oestrous cycle (Bland, Horton and
Poyser, 1971) and were in the same range as those which had been previously
demonstrated to be capable of decreasing progesterone levels (McCracken el al.,
1970). This observation was confirmed by McCracken, Carlson, Glew, Goding, Baird,
Green and Samuelsson (1972), Thorburn, Cox, Currie, Restall and Schneider (1972),
and Fitzpatrick and Sharma (1973) when increasing PGF2a concentrations were
measured in the uterine venous blood of sheep just prior to the occurrence of
luteolysis. PGF2a was also detected in the utero-ovarian vein of the guinea-pig in
higher concentrations from day 11 of the oestrous cycle, with a peak occurring on day
15 concurrent with a sharp decline in progesterone levels (Blatchley, Donovan,
Horton and Poyser, 1972; Earthy, Bishop and Flack, 1975). An increase in the release
of PGF2a from the uterus at the time of progesterone decline has also been
demonstrated in the pig (Gleeson and Thorburn, 1973; Gleeson, Thorburn and Cox,
1974; Moeljono, Thatcher, Bazer, Frank, Owens and Wilcox, 1977; Hunter and
Poyser, 1982), goat (Homeida and Cooke, 1982) and cow (Nancarrow, Buckmaster,
Chamley, Cox, Cumming, Cummins, Drinan, Findlay, Goding, Restall, Schneider and
Thorburn, 1973; Shemesh and Hansel, 1975). In pseudopregnant rabbits, a rapid
decline in progesterone was found to be directly related to an increase in the PGF2a
concentrations in the uterine venous plasma (Lytton and Poyser, 1982).
The introduction of glass beads into the guinea-pig uterus caused a shortening
of the oestrous cycle (Donovan and Traczyk, 1962; Bland and Donovan, 1966).
Poyser, Horton, Thompson and Los (1971) demonstrated that such a distension of the
uterine horns resulted in a large release of PGF2a. These observations suggested that
PGF2a was released due to the distension of the uterus, and then had a luteolytic
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effect on the ovary. Bland and Donovan (1965) demonstrated that if only one uterine
horn was distended in the guinea-pig, then only the corpora lutea of the ipsilateral
ovary regressed prematurely. Similarly, in sheep where only one uterine horn had been
distended with an intra-uterine device, only the corpora lutea of the ipsilateral ovary
regressed prematurely. At autopsy, these corpora lutea were found to be smaller than
normal, confirming that luteolysis had occurred (Ginther, Pope and Casida, 1966).
Spilman and Duby (1972) demonstrated increased levels of endometrial PGF2a in
close proximity to an intra-uterine insert in sheep, and peripheral plasma levels of PGF
were also elevated in rats and hamsters possessing such a device (Saksena, Lau and
Castracane, 1973). Blatchley, Donovan and Poyser (1976) recorded that in animals
fitted with intra-uterine beads, an increased PGF2a concentration was evident in the
utero-ovarian venous plasma.
In particular cases the corpus luteum is not always maintained for its normal
duration. Such short luteal phases have been studied in the cow, occurring at puberty
(Gonzales-Padilla, Niswender and Wiltbank, 1975) and during the transition from
postpartum anoestrus to cyclicity (Odde, Wood, Kiracofe, McKee and Kittock,
1980). Evidence suggests that premature luteolysis occurs as a result of an early
release of uterine PGF2a (Zollers, Garverick, Youngquist, Ottobre, Silcox, Copelin
and Smith, 1991)
Further evidence demonstrating that PGF2a is the uterine luteolytic hormone
in numerous species includes active immunization against PGF2aj and also the
administration of indomethacin:-
i. Effect of immunization against PGFgq on luteolysis
Following immunization against PGF2a, antibodies are produced that neutralise the
activity of endogenous PGF2a present in the circulation. Active immunization against
PGF2a lengthened the oestrous cycle of the sheep (Scaramuzzi, Baird, Wheeler and
Land, 1973) and the guinea-pig (Horton and Poyser, 1974; Hildebrandt-Stark,
Marcus, Yoshinaga, Behrman and Greep, 1975). A good correlation was found
between the extent to which the oestrous cycle was extended and the titre of the
PGF2a antibody present in individual guinea-pigs (Horton and Poyser, 1974).
Measurement of plasma progesterone concentrations indicated that, following
immunization against PGF2a, the corpora lutea were maintained in a functional
secretory state (Poyser and Horton, 1975). Similar results were found in the cow and
sheep (Fairclough, Smith and McGowan, 1981). Also, in post-partum cows
immunization procedures against PGF2a resulted in luteal maintenance of greater
than 39 days (Copelin, Smith, Keisler and Garverick, 1989).
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ii. Effect of indomethacin administration on luteolvsis
Indomethacin is a potent inhibitor of PG synthesis by blocking the cyclo-oxygenase
component of the PGH synthase complex (Vane, 1971), and has been shown to inhibit
PG production by guinea-pig uterine homogenates (Poyser, 1972). Therefore,
administration of indomethacin to a species where PGF2a is the uterine luteolytic
hormone, such as the guinea-pig, should result in the inhibition of PG synthesis and
therefore prolong luteal function. Yet, when indomethacin was administered to
guinea-pigs orally or subcutaneously, oestrous cycles were not prolonged for more
than 3-4 days (Marley, 1972; Horton and Poyser, 1973). However, the administration
of indomethacin in the form of a slow-release preparation within the lumen of the
guinea-pig uterus did greatly prolong luteal function (Horton and Poyser, 1973) and
maintained high progesterone levels (Poyser and Horton, 1975). Concerning other
species, subcutaneous administration of indomethacin resulted in extended length of
pseudopregnancy comparable to that due to hysterectomy in the pseudopregnant
rabbit (O'Grady, Caldwell, Auletta and Speroff, 1972). Similar results have been
reported in the pseudopregnant mouse (Critser, Rutledge and French, 1981), rat and
hamster (Lau, Saksena and Chang, 1975). Subcutaneously administered indomethacin
was demonstrated to delay the pulsatile appearance of PGF2a metabolite (13,14-
dihydro-15-keto-PGF2a) and luteolysis in the goat (Cooke and Homeida, 1985), and
also to prolong luteal maintenance in the pig. However, in hysterectomized gilts,
luteal function was unaffected by indomethacin treatment indicating that the source of
luteolytic PGF2a in the pig is the uterus (Kraeling, Rampacek and Kiser, 1981). In
the sheep and cow, intra-uterine infusions of indomethacin prolonged luteal function
(Lewis and Warren, 1975, 1977a) and also inhibited oestrogen-induced luteolysis
(Lewis and Warren, 1974, 1977b). There is controversy whether indomethacin is able
to act systemically or needs to be given locally to block uterine PGF2a synthesis in
sheep. Oral or parenteral administration of various PGH synthase inhibitors failed to
prolong the oestrous cycle in one study (Mellin and Busch, 1976), but subcutaneous
indomethacin treatment from day 7 of the cycle onwards did prevent loss of luteal
function, as detected in maintained high plasma progesterone levels, in 3 out of 5
ewes. Following slaughter on day 23, normal corpora lutea were observed suggesting
that indomethacin administered systemically is able to prevent luteolysis (Kann and
Lacroix, 1982). This idea is strengthened by previous work by Spilman and Duby
(1972) who demonstrated that subcutaneous administration of indomethacin abolished
previously observed increases in PGF2a concentrations in the uterine vein of ewes
fitted with an intra-uterine device. In normally cycling Rhesus monkeys, indomethacin
blocked oestradiol-induced luteolysis and was associated with a significant increase in
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peripheral plasma progesterone concentration (Auletta, Caldwell and Speroff, 1976,
1978, Auletta, Agins and Scommegna, 1978) suggesting that PGs may play an
important role in luteal function in the monkey. In women, PGF2a infused
intravenously on day 21 of the oestrous cycle did result in a sharp drop in
progesterone concentrations (Lehmann, Peters, Breckwoldt and Bettendorf, 1972).
However, other studies found that such treatment did not affect the length of the
luteal phase or the pattern of steroid secretion in normally cycling women (LeMaire
and Shapiro, 1972; Jewelewicz, Cantor, Dryenfurth, Warren and Van de Wiele, 1972)
or in pregnant women prior to abortion (Speroff Caldwell, Brock, Anderson and
Hobbins, 1972), thus it is unlikely that PGF2a has a luteolytic function in women.
1:7 Mechanism by which PGF2a causes luteal regression
The evidence presented has clearly shown that PGF2a is the uterine luteolytic
hormone in several species. At the onset of luteal regression, serum progesterone
concentrations decrease (Diekman, O'Callaghan, Nett and Niswender, 1978a; Baird,
1984) followed by a loss of luteal weight (Diekman et a/., 1978b; Braden, Gamboni
and Niswender, 1988). Structural changes in the corpus luteum include accumulation
of lipid droplets in the cytoplasm of luteal cells, degeneration of capillaries and an
increase in the number of primary lysosomes (Nett, McClellan and Niswender, 1976).
As luteolysis progresses there is an eventual reduction in the number of steroidogenic
luteal cells (Farin, Moeller, Sawyer, Gamboni and Niswender, 1986: Braden et «/.,
1988). Evidently, the process of luteal regression comprises complex changes within
the corpus luteum, so how exactly does PGF2a cause luteolysis?
1:7:1 PGF2a and ovarian blood flow
DuCharme et al. (1968) demonstrated that PGF2a possessed potent
vasoconstrictor properties leading to the hypothesis that PGF2a could cause a
reduction in blood flow to the ovary, perhaps even to the corpora lutea specifically,
resulting in luteal regression due to anoxia (Pharriss and Wyndgarden, 1969; Pharriss,
Cornette and Gutnecht, 1970). Indeed, the corpus luteum is a highly vascularized
gland receiving over 80 % of the ovarian blood supply (Nett et a/., 1976) Several
studies followed to investigate changes in ovarian blood flow during the oestrous
cycle. Sheep luteal tissue was shown to possess a high blood flow rate particularly at
times when functional corpora lutea were present (Thorburn and Hales, 1972) and the
administration of PGF2a caused a rapid decrease in luteal blood flow (Nett et rr/.,
1976). Niswender, Moor, Akbar, Nett and Diekman (1975) demonstrated that luteal
and ovarian blood flow rates decreased around the time of luteal regression leading to
the proposition that blood flow to the ovary, particularly to the corpora lutea, played
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an important role in the control of luteolysis (Niswender, Reimers, Diekman and Nett,
1976). This hypothesis was further supported by work on the guinea-pig using
labelled microspheres which reported high luteal and ovarian blood flow rates only up
until day 12 of the oestrous cycle (Hossain, Lee, Clarke and O'Shea, 1979). However,
measurement of the ovarian blood flow in sheep failed to show a decrease in blood
flow prior to the decline in progesterone levels associated with luteal regression
(McCracken et a/., 1970; Baird, 1974). Later, Einer-Jensen and McCracken (1977)
reported that the decrease in progesterone secretion from the corpora lutea at the time
of luteolysis in the sheep occurred before a decrease in ovarian blood flow was
observed, supporting the idea that vasoconstriction due to PGF2a was not the initial
stimulus, but a consequence, of luteal regression. O'Shea, Nightingale and Chamley,
(1977) suggested that the decline in ovarian blood flow observed during luteal
regression was possibly due to small capillaries in the ovary becoming narrow by
being blocked by cell debris from the regressing corpora lutea.
1:7:2 PGF2a receptors in corpora lutea
Specific PGF2a receptors have been shown to be present in the luteal cell
membrane in the sheep (Powell, Hammerstrom and Samuelsson, 1974), cow (Rao,
Carman and Gorman, 1978), rat (Wright, Luborskymoore and Behrman, 1979), mare
(Kimball and Wyndgarden, 1977) and human (Powell, Hammarstrom, Samuelsson
and Sjoberg, 1974). Presumably, PGF2a must bind with its luteal cell membrane
receptor to induce luteolysis, and the variation in PGF2a receptor number and affinity
during the oestrous cycle may be a mechanism of controlling the timing of luteolysis
Indeed, in the cow, an increase in the affinity of receptors in the corpus luteum results
in an elevation of PGF2a binding, with maximum receptor affinity occurring at the
time of actual luteal regression (Rao, Estergreen, Carman and Moss, 1979). In the
pseudopregnant rat, PGF2a binding to the corpora lutea increases up to a maximum
on day 7, and this is followed by a gradual decline after day 9 preceding luteolysis
(Brambaifa and Schillinger, 1984). However, in the mare, variation in PGF2a
receptor numbers was apparent but no relation between receptor number and the state
of the oestrous cycle was observed (Kimball and Wyndgarden, 1977).
1:7:3 Role of oestradiol in luteolysis
It has been proposed that oestradiol is required for the luteolytic action of
PGF2a to be realized, since PGF2a-induced luteolysis is prevented in
hysterectomized ewes where the oestrogen-producing ovarian follicles have been
previously destroyed by X-irradiation (Hixon, Gengenbach and Hansel, 1975). This is
further supported by the observation that luteolysis does occur in hysterectomized
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ewes treated with PGF2a, in doses below the threshold for inducing luteolysis, in
conjunction with oestradiol treatment (Gengenbach, Hixon and Hansel, 1977).
1:7:4 Relevance of presence oflarge and small luteal cells
In several species such as the sheep (Fitz, Mayan, Sawyer and Niswender,
1982), cow (Urseley and Leymarie, 1979) and pig (Lemon and Moir, 1977), two
morphologically and functionally distinct steroidogenic cell types exist within the
corpus luteum, namely small (12-22 pm diameter) and large (>22 pm diameter) luteal
cells. Both cell types secrete progesterone although unstimulated secretion of
progesterone is 5-10 times greater in the large than in the small luteal cells (Fitz el a/.,
1982; Rodgers, O'Shea and Findlay, 1983a). However, there is a greater proportion
of small cells present so that each group secretes an equivalent amount of
progesterone (Rodgers, O'Shea and Findlay, 1983a).
Progesterone secretion is dependent on luteinizing hormone (LH) and cyclic
adenosine 5'-monophosphate (cAMP) in small luteal cells since treatment with
adenylate cyclase-activating agents, such as forskolin or cholera toxin, stimulates
progesterone secretion (Hoyer, Fitz and Niswender, 1984). This is not so in large
luteal cells (Niswender, Schall, Fitz, Farin and Sawyer, 1985), as treatment with
forskolin or cholera toxin does not result in enhanced progesterone production even
though these agents increase the occupancy of cAMP-dependent protein kinase by
cAMP (Niswender and Hoyer, 1985). These findings indicate that progesterone
production is probably not controlled by cAMP in large luteal cells.
The majority of PGF2a receptors are found in large luteal cells (Fitz et al..
1982) and it was suggested that an increase in the numbers of the large type of cell
towards the end of the oestrous cycle could explain the increase in sensitivity of the
corpora lutea to PGF2a (Fitz and Sawyer, 1982). Niswender and Hoyer (1985) added
the proposition that LH could achieve this increase in large luteal cells by stimulating
the differentiation of small to large cell types. However, no such differentiation
occurred as the number oflarge ovine luteal cells was not found to change during the
oestrous cycle (O'Shea, Rodgers and Wright, 1986). These studies supported the
previous suggestion that, during the cycle, large luteal cells increase in size (not in
number), and by possessing a greater number of receptors than the small cells, are
more susceptible to the action of PGF2a The inhibition of secretion of progesterone
by PGF2a has been demonstrated in large but not small ovine luteal cells (Wegner,
Martinez-Zaguilan, Wise, Gillies and Hoyer, 1990). High-affinity receptors for
PGF2a have also only been detected in large ovine luteal cells providing further
evidence that the luteolytic signal initiated by PGF2a is mediated by the large, not
small, luteal cells (Wiltbank, Guthrie, Mattson, Kater and Niswender, 1989).
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1:7:5 Inhibition of progesterone secretion by PGF2a
i Synthesis of progesterone.
The substrate for the synthesis of progesterone is cholesterol. Free cholesterol
is either used for steroid synthesis or is converted into cholesterol esters and stored as
lipid droplets (Jefcoate, McNamara, Artemenko and Yamazaki, 1992). The enzyme,
cholesterol esterase, releases cholesterol from cholesterol esters. Activity of the
enzyme is regulated by the phosphorylation of two serine residues. Phosphorylation of
one serine residue by cAMP-dependent protein kinase (PK) A activates the enzyme,
whereas phosphorylation of the other residue by Ca2^ /calmodulin-dependent protein
kinase prevents activation of the enzyme (Jefcoate et a/., 1992). The conversion of
cholesterol to pregnenolone involves three proteins, adrenodoxin, adrenodoxin
reductase and cytochrome P450scc. Pregnenolone is converted to progesterone by the
action of 3P-hydroxysteroid dehydrogenase-5,4-isomerase (3P-HSD) (Labrie, Simard,
Luu-The, Belanger and Pelletier, 1992).
ii. Actions ofPGF2a
Within 15 min of PGF9a administration in the corpus luteum, the LH-induced
increase in cAMP is prevented in the rat (Lahav, Freud and Lindner, 1976) and in the
sheep (Fletcher and Niswender, 1982). LH binding to its receptor activates adenylate
cyclase causing an increase in cAMP which then stimulates luteal progesterone
synthesis and release. This inhibitory effect of PGF2a on LF[-stimulated adenylate
cyclase is unlikely to be directly mediated by a G-protein (McCann and Flint, 1993).
It was proposed that a reduction in cAMP levels leads to the
dephosphorylation of cholesterol esterase to its inactive form therefore inhibiting
progesterone synthesis (Henderson and McNatty, 1975). Following PGF2a
administration, cholesterol esterase activity was seen to decline in the rat ovary;
however, a greater effect was seen on the activity of cholesterol esterase synthetase
(Behrman, MacDonald and Greep, 1971). Other studies on the corpora lutea of rat
(Jordon, 1981) and cow (Pate and Condon, 1984) also reported inhibition by PGF2a
of cAMP-induced progesterone production by inhibiting cholesterol esterase and
cholesterol ester synthetase (Torday, Jefcoate and First, 1980). Also in
hysterectomized guinea-pig, PGF2a treatment resulted in a 50 % reduction in the
conversion of pregnenolone to progesterone by inhibiting the activity of cholesterol
esterase (although not cholesterol ester synthetase) and 3P-HSD (Dwyer and Church,
1979a, b). In the ovary, PGE2~induced progesterone production is neither inhibited in
vivo or in vitro by PGF2a (McNatty, Henderson and Sawers, 1975; Henderson,
Scaramuzzi and Baird, 1977) indicating that PGF2a specifically antagonises LH,
presumably at a point inhibiting cAMP production.
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After binding to its receptor, PGF2a through a direct or indirect action must
prevent the LH receptor from stimulating adenylate cyclase (Henderson and McNatty,
1975). This is further exemplified by the finding that administration of cAMP to rat
luteal cells cultured in vitro overcomes the inhibition in progesterone secretion due to
the action of PGF2a (Thomas, Dorflinger and Behrman, 1978). One possible
mechanism by which PGF2a may prevent LH-induced cAMP production was
proposed by Luborsky, Slater and Behrman (1984) whereby PGF2a prevents LH
receptor movement and LH receptor up-regulation. Once LH binds to its receptor,
LH-receptor complexes move and bind together forming "aggregates" which appear
to be necessary for the activation of adenylate cyclase and therefore cAMP
production. In the rat ovary, microfilaments are involved in LH-induced adenylate
cyclase activity, so that PGF2a may have a luteolytic action directed towards the
microfilaments preventing receptor mobility and redistribution (Zor, Strulovici and
Lindner, 1978).
On receiving a pulse of LH, binding of LH to luteal cells increases within 2h
suggesting that an up-regulation of available LH membrane receptors occurs. It is
therefore also possible that PGF2a prevents LH binding to its receptor by simply
inhibiting the availability of LH receptors in luteal cell membranes so that during luteal
regression LH receptor number and LH binding steadily decrease along with a
resulting decline in progesterone levels. LH binding to its receptor is reduced by
PGF2a in the rat (Behrman, Grinwich, Hichens and MacDonald, 1978), sheep
(Diekman el a/., 1978b) and pig (Barb, Kraeling, Rampacek and Pinkert, 1984). It has
been proposed that this prevention in the appearance ofLH receptors, LH binding and
movement of LH-receptor complexes is due to the phosphorylation of membrane
proteins by a calcium-dependent, calmodulin-mediated mechanism resulting in
membrane rigidification (Riley and Carlson, 1985). In the rat, administration of
PGF2oc decreases plasma membrane fluidity and increases superoxide radical
formation (Carlson, Buhr and Riley, 1989; Sawada and Carlson, 1991). Even though
the number of LH receptors has been shown to decrease following PGF2a treatment
both in rats (Hichens, Grinwich and Behrman, 1974) and sheep (Diekman et al.,
1978b), in the latter study the decrease in receptor numbers was not evident until after
a significant decrease in progesterone concentrations had already occurred, suggesting
that the initial luteolytic signal is mediated via some other mechanism.
The main antisteroidogenic effect of PGF2a appears to be mediated through
the protein kinase C (PKC) second messenger system. PGF2a has been shown to
activate phospholipase (PL) C via a pertussis toxin-sensitive G-protein in the sheep
corpus luteum (McCann and Flint, 1993). This results in the hydrolysis of membrane
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phosphatidylinositol-4,5-bisphosphate (PIP2) to inositol-1,4,5-triphosphate (IP3) and
1,2-diacylglycerol (DAG) (Berridge, 1987). DAG increases the affinity of PKC for
calcium and IP3 releases calcium from intracellular stores resulting in a rise in free
intracellular calcium ([Ca2];) concentrations and the activation of PKC. The
administration of PGF2a resulted in activation of PKC in ovine large luteal cells
(Wiltbank, Diskin and Niswender, 1991) and in an increase in PIP2 hydrolysis in luteal
cells from Rhesus monkey (Houmard, Guan, Stokes and Ottobre, 1992).
Pharmacological activation of PKC has also been shown to reduce progesterone
production from ovine large luteal cells (Wiltbank et a/., 1991; Conley and Ford,
1989; Hoyer and Marion, 1989) and isolated rat luteal cells (Baum and Rosberg,
1987). The antisteroidogenic effects of PKC do not appear to act directly on
steroidogenic enzymes, but do inhibit the transport of cholesterol to cytochrome
P450scc (Witlbank, Belfiore and Niswender, 1993). However, PGF2a has also been
shown to decrease steady-state levels of mRNA encoding 3(3-HSD (Hawkins,
Belfiore, Kile and Niswender, 1993).
The pharmacological activation of PKC has no detrimental effects on cell
viability in the sheep (Wiltbank et al., 1991; Hoyer and Marion, 1989). There is now
accumulating evidence that the second messenger system actually mediating the
luteolytic effects of PGF2a is free [Ca2 ];. In most tissues maintenance of calcium
homeostasis is important for basic cellular function and optimal responsiveness to
hormonal stimulation. PGF2a has been shown to induce both an initial and sustained
post transient increase in free [Ca2+]; in ovine (Wegner et a/., 1990), bovine (Alila.
Corradino and Hansel, 1989) and monkey (Houmard et a/., 1992) luteal cells. Large
sustained increases in free [Ca2 ]; in myocardial cells (Buja, Hagler and Willerson.
1988) and hepatocytes (Starke, Hoek and Farber, 1986) have been shown to decrease
cellular function and ultimately lead to cell death. Ovine large luteal cells cultured in
the presence of A23187 died in culture since they are unable to equilibrate large
increases in free [Ca2 ]; (Hoyer and Marion, 1989). Since the end result of luteal
regression is demise of the corpus luteum, the sustained increase in free [Ca2 ],
initiated by PGF2a in large luteal cells may be one mechanism responsible for
decreased secretion of progesterone and cell degeneration associated with luteolysis.
More recent studies have demonstrated that ovine large and small luteal cells
differ in their regulation of intracellular calcium homeostasis. Treatments that increase
free [Ca" ], result in a decrease in progesterone secretion in large cells, but have no
effect in small cells (Martinez-Zaguilan, Wegner, Gillies and Hoyer, 1994). Therefore,
luteal regression at the cellular level appears to be associated with a PGF2a-induced
increase and sustained elevation in free [Ca2 ];, which is observed in large, but not
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small, luteal cells (Horion and Marion, 1989; Wiltbank et a/., 1989; Wegner et a/.,
1990, 1991). Further work has shown that PGF2a releases calcium from a
thapsigargin-sensitive intracellular calcium pool in ovine large luteal cells (Wegner,
Martinez-Zaguilan, Gillies and Floyer, 1994). Thapsigargin, a sesquiterpene lactone
tumor promoter, specifically inhibits a Ca2+-ATPase associated with the endoplasmic
reticulum. By contrast, the calcium ionophore A23187 causes an increase in free
[Ca2']i, by promoting influx of Ca2' in most cell types. Inhibition of secretion of
progesterone by thapsigargin has been demonstrated in mixed suspensions of rat luteal
cells (Pepperell and Behrman, 1990) and by A23187 in ovine large (but not small)
luteal cells (Hoyer and Marion, 1989) suggesting that extracellular, as well as
intracellular, calcium contributes to the PGF2a-induced increase in cytosolic free
calcium concentrations in large luteal cells. However, in ovine large luteal cells,
progesterone secretion was found to be inhibited by either a sustained increase or
decrease in free [Ca2']j, providing evidence that optimal secretion of progesterone is
dependent upon a specific range of free [Ca2 ]; within these cells (Wegner et a/.,
1991). It is possible that key enzymes responsible for progesterone synthesis are not
adequately stimulated at reduced [Ca2 ]j concentrations, whereas sustained elevations
in [Ca2 ]; may inhibit secretion of progesterone due to cytotoxic effects of calcium on
a variety of cellular reactions.
In summary, a reduced capacity of ovine large luteal cells to regulate [Ca2 ]j
may facilitate the induction of luteal regression in these cells by PGF2a (Martinez-
Zaguilan el a/., 1994). Furthermore, whereas an adequate concentration of [Ca2 ]j is
required to support progesterone production in both large and small luteal cells,
optimal progesterone production in large cells depends upon an appropriate window
of [Ca2 ]i (Wegner et a/., 1991).
It has also been reported that ovine luteal cells appear to undergo apoptosis
during PGF2a-indiiced luteolysis (Sawyer, Niswender, Braden and Niswender, 1990).
It is therefore possible that the antisteroidogenic actions of PGF2a are mediated by
the activation of the PKC pathway while the luteolytic actions of PGF2a may result
from the process of apoptosis, with the increase in concentrations of free [Ca2 ]; being
the signal for induction of this process (Niswender et ci/., 1994).
1:8 Transfer of the uterine luteolytic factor from the uterus to the ovary
Studies involving ligation of the vascular tissue in the area surrounding the
uterus and ovary in the guinea-pig, resulted in maintenance of the corpora lutea.
However, when ligation of the oviduct was carried out, no effect on luteal regression
was observed indicating that uterine PGF2a was transferred to the ovary by some
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mechanism via the vasculature (Bland and Donovan, 1969a; Fisher, 1967; Oxenreider
and Day, 1967). Similar findings were observed in the rat (Clemens, Minaguchi and
Meites, 1968; Butcher, Barley and Inskeep, 1969) and in the hamster (Orsini, 1968).
In the sheep, bilateral ligation of the middle uterine arteries and veins resulted in luteal
maintenance, although this was not observed when ligation of the arteries alone was
performed (Kiracofe, Menzies, Grier and Spies, 1966; Kiracofe, Spies and Grier,
1973) indicating that an intact uterine vein was essential for luteal regression to occur.
Separation of the ovarian artery from the utero-ovarian vein in the sheep was also
seen to prevent luteal regression (Barrett, Blockey, Brown, Cumming, Goding, Mole
and Obst, 1971) and a counter-current mechanism of transfer of PGF2a from the
uterine vein to the ovarian artery was proposed. Del Campo and Ginther (1972) had
previously reported that the ovarian arteries were always in close proximity and
association, and frequently coiled around the uterine veins in the guinea-pig, rat and
hamster. In the sheep and cow, Del Campo and Ginther (1973) observed that the
ovarian artery appeared to follow a "torturous" path over the utero-ovarian vein, and
suggested that the ovarian artery was the means by which PGF2a reached the ovary.
Estimated amounts of labelled PGF2a transferred via a counter-current mechanism
from the uterine vein to the ovarian artery in the sheep have been found to be 2 %
(McCracken et a/., 1972), 0.1-0.56 % (Land, Baird and Scaramuzzi, 1976) and 0.3 %
(Heap, Fleet and Hamon, 1985). This efficiency of transfer would seem very low,
although, it must be noted that if the efficiency of transfer were much greater, PGF2a
levels would increase and remain high due to the inability of the local tissues to
metabolise prostaglandins. If the transfer process were 100% efficient and the
metabolism nil, PGF2a would pass through the ovary ad infinitum (Horton and
Poyser, 1976). Consequently, any PGF2a not transferred to the ovarian artery will
pass into the systemic circulation and be metabolised in the lungs (Ferriera and Vane,
1967). Hixon and Hansel (1974) have also demonstrated this counter-current
mechanism to occur in the cow. Alawachi, Bland and Poyser (1981) also proposed
the existence of an additional pathway for PGF2a transfer to the ovary via the venous
drainage passing alongside the oviduct, as PGF2a levels are higher in the oviducal
vein than in the peripheral venous plasma between days 12 and 16 of the sheep
oestrous cycle. A counter-current transfer of PGF2a between the oviductal vein and
ovarian artery could also occur
Lamond and Drost (1973) demonstrated that the interruption of the section of
ovarian artery distal to the region where counter-current transfer had been reported to
occur, did not disrupt the oestrous cycle in the ewe, and suggested that another
mechanism of PGF2a transfer to the ovary from the uterus must exist. Furthermore,
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the uterine and ovarian vasculature are independent in both the rabbit (Hunter and
Casida, 1967) and horse (Del Campo and Ginther, 1973) supporting the view that
another mechanism of transfer exists, as a counter-current mechanism cannot justify
the transfer ofPGFga from the uterine vein to the ovarian artery in these two species.
Unusual findings were reported in the pig when it was observed that hemi-
hysterectomy still maintained bilateral luteal regression. Removal of one ovary and
autotransplantation of the remaining ovary to the vacant site also had no effect on
luteolysis. Since no common utero-ovarian vessels were present, and the uterine vein
and ovarian artery were separated by a distance of at least 5 cm, no counter-current
mechanism could occur (Harrison and Heap, 1972). A possible explanation for these
findings was that PGFga was acting systemically since, unlike most species, in the pig
the majority of PGFga passes through the lungs unchanged (Davies, Fleet, Harrison
and Maule Walker, 1980). However, infusion of PGFga into the jugular vein of the
sow did not cause luteal regression (Kotwica, 1980) which contradicted a systemic
transfer of PGF2a, and it was therefore proposed that the lymph system provided a
mechanism of transport of PGFga in view of the rich lymphatic vascularization
present in the sow uterus. A counter-current transfer of PGFga between the lymph
vessels and the ovarian artery was also suggested to exist in the sheep (Staples, Fleet
and Heap, 1982). Increased amounts of PGFga were detected in the uterine lymph of
non-pregnant sheep onwards from day 10 of the oestrous cycle (Abdel Rahim, Bland
and Poyser, 1983; 1984a). Abdel Rahim and Bland (1985) proposed that the close
association between the uterine lymphatic vessels and the ovarian artery close to the
utero-ovarian vein could provide a counter-current transfer mechanism from the
uterine lymph to the ovarian artery. Evidence for this theory was soon provided by
Heap el a/., (1985) who administered [^Hj-PGFga into the uterine lumen of non¬
pregnant sheep 7-15 days following oestrus. A peak of radioactivity was recorded in
the uterine lymph vessels within 50 min. The estimated efficiency of PGFga transfer
from a lymphatic vessel to the ovarian artery was found to be 0.4 %; a value similar to
that of the transfer from uterine vein to ovarian artery (0.3 %). Infusion of pH]-
PGF2a mto the lymphatic vessels themselves resulted in a higher concentration of
radioactivity in the plasma from adjacent utero-ovarian veins and ovarian veins than in
the peripheral plasma. The local nature of this transfer was clearly observed by the
higher concentrations of [^H]-PGF2a present in the ovary and corpora lutea adjacent
to the site of intra-lymphatic infusion in comparison with those tissues opposite
Abdel Rahim, Bland and Poyser (1984b) demonstrated the need for this counter-
current mechanism in the sheep by insertion of a glass canula into the uterine branch
of the utero-ovarian vein, followed by disconnection of all other tissue between the
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uterus and ovary. Luteal regression did not take place suggesting that uterine venous
blood alone is not able to supply enough PGF2a from the uterus to the ipsilateral
ovary for luteal regression to occur. This alternative method of transfer of PGF2a via
the lymphatic system could explain how luteal regression by PGF2a occurs in species
such as the horse (Del Campo and Ginther, 1973) where anatomical differences do
not appear to allow a counter-current mechanism to operate within the vascular
system alone. The collected evidence suggests that transfer of uterine PGF2a to the
ovary for the purpose of luteal regression may be mediated by a combination of two
counter-current mechanisms involving both uterine venous blood and uterine lymph,
the relative importance of each being species dependent.
1:9 Stimulus responsible for PGF2a synthesis and release by the uterus
The cyclical pattern of release of PGF2a indicated that some form of
hormonal control was probably involved in the physiological stimulus for PGF2a
synthesis and release by the uterus. Numerous studies followed to investigate the role
of the ovarian steroids on uterine PGF2a synthesis and release.
Subcutaneous administration of oestradiol to day 7 guinea-pigs was found to
result in premature luteal regression and shortening of the oestrous cycle (Choudary
and Greenwald, 1968; Bland and Donovan, 1968). This effect was abolished in
hysterectomized animals showing that the uterus was involved in mediating the
luteolytic action of oestradiol (Bland and Donovan, 1970). Injection of oestradiol on
day 10 and 11 of the oestrous cycle of the ewe also caused early luteal regression but
failed to do so in hysterectomized ewes (Stormshak, Kelley and Hawk, 1969). Bolt
and Hawk (1972) failed to induce luteal regression in hysterectomized ewes in any
trial with exogenous oestradiol supporting the theory that oestradiol-induced luteal
regression in the guinea-pig and sheep requires the presence of the uterus. Similar
findings were also reported in the cow (Eley, Thatcher and Bazer, 1979). Corpora
luteal mass was reduced in cycling, pregnant and hysterectomized cows following
oestradiol treatment, although progesterone levels remained high in the
hysterectomized cows indicating the necessity of the uterus for the complete luteolytic
effect of oestradiol to be realized (Kaltenbach, Niswender, Zimmerman and Wiltbank,
1964). An increase in oestradiol concentrations was found to occur at the time of
follicular growth in the sheep (Smeaton and Robertson, 1971), and destruction of the
ovarian follicles mechanically (Ginther, 1970) or by X-ray irradiation (Karsch,
Noveroske, Roche, Norton and Nalbandov, 1970) prevented luteal regression in both
the sheep and cow (Villa-Godoy, Ireland, Wortman, Ames, Hughes and Fogwell,
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1985). The collected evidence clearly indicated that oestradiol was causing luteal
regression via a response mediated by the uterus.
Blatchley et al. (1972) observed that oestradiol treatment of guinea-pigs on
days 4 to 6 of the oestrous cycle resulted in a premature increase in the concentration
of PGF2a in the utero-ovarian plasma on day 7. This effect was not seen in
hysterectomized animals indicating that PGF2a originated from the uterus. In the
sheep uterus autotransplanted to the neck and infused with oestradiol in vivo, PGF2a
output was stimulated after 60 to 90 min (Barcikowski, Carlson, Wilson and
McCracken, 1974). It was proposed that endogenous oestradiol released from the
developing ovarian follicles was the physiological stimulus for uterine PGF2a
synthesis and release. Subsequently, the oestradiol concentration present in the
guinea-pig ovarian venous plasma was shown to begin to increase on days 9 to 10 of
the oestrous cycle (Joshi, Watson and Labhsetwar, 1973) preceding the increase in
PGF2a concentration which begins on day 11 of the cycle (Blatchley el a/., 1972;
Earthy ei a/., 1975). Similar observations were reported in the sheep (Cox, Thorburn,
Currie and Restall, 1974; Thorburn, Cox, Currie, Restall and Schneider, 1973), cow
(Shemesh, Ayalon and Lindner, 1972; Nancarrow et a/., 1973), pig (Henricks,
Guthrie and Handlin, 1972; Gleeson and Thorburn, 1973; Gleeson et al., 1974),
pseudopregnant rat (Welschen, Osman, Dullaart, de Greef, Ulienbroek and de Jong,
1975) and pseudopregnant hamster (Shaikh, Birchall and Saksena, 1973).
A controversy arose over the exact role of ovarian oestradiol in the stimulus
for uterine PGF2a output from the uterus in sheep when no relationship was found
between oestradiol concentrations in the plasma and the initial increase in PGF2a
release (Baird, Land, Scaramuzzi and Wheeler, 1976; Ottobre, Lewis. Thayne and
Inskeep, 1980). Destruction of sheep ovarian follicles, to remove the major source of
oestradiol, only delayed luteal regression (Warren, Hawk and Bolt, 1973), and passive
immunization against endogenous oestradiol prevented oestrus and ovulation but not
luteal regression (Fairclough, Smith and Peterson, 1976), suggesting that a rise in
plasma oestradiol concentrations was not the only factor required for normal
luteolysis in the sheep. Other studies in ovariectomized sheep reported that the output
of PGF2a from the uterus was increased by oestradiol treatment following several
days of exogenous or endogenous progesterone treatment (Scaramuzzi. Baird, Boyle,
Land and Wheeler, 1977; Barcikowski et al., 1974). In the ovariectomized sheep
treated with progesterone for 7 days, a significant increase in PGF2a concentration in
the uterine venous plasma was observed, although progesterone treatment for a
further 7 days caused a decrease in PGF2a output from the uterus (Scaramuzzi et al.,
1977). Ottobre et al. (1980) subsequently demonstrated that early treatment of sheep
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with progesterone on days 0 and 1 of the oestrous cycle advanced the occurrence of
the initial increase in uterine PGF2a output to day 8 compared to day 12 in control
untreated animals. Also, infusion of progesterone to ewes for 10 days (immediately
following oestrus) resulted in a stimulation of PGF2a output from the uterus which
peaked on days 9-10 (McCracken, 1980). These findings suggested that a period of
progesterone secretion was also necessary for increased uterine PGF2a output and
that the timing of this increase was dependent upon when plasma progesterone
concentrations increased.
Blatchley and Poyser (1974) treated ovariectomized guinea-pigs with
oestradiol and /or progesterone, and measured the subsequent PGF2a concentrations
in the utero-ovarian venous plasma. Progesterone and oestradiol treatment alone
resulted in PGF2a concentrations similar to those normally found on days 3 and 10 of
the cycle, respectively. However, only 2 of the 6 animals treated with oestradiol
exhibited PGF2a concentrations higher than those treated with progesterone alone. In
animals treated with a progesterone implant for 7 days followed by 3 days
simultaneous progesterone and oestradiol treatment, PGF2a concentrations were
greatly elevated in all guinea-pigs. PGF2a concentrations in the uterine tissue of
ovariectomized mice significantly increased after 3 days of progesterone followed by
3 days of oestradiol treatment when compared to mice treated with either steroid
alone (Saksena and Lau, 1973). PGF2a levels in the peripheral plasma of
ovariectomized ewes were also reported to rise after treatment with oestradiol
following a series of progesterone injections (Caldwell, Tilson, Brock and Speroff,
1972). The evidence pointed to the theory that oestradiol acting on a progesterone-
primed uterus was the physiological stimulus responsible for the output of luteolytic
PGFga from the uterus. However, whether a specific stimulation of PGFga was
occurring was not known until Antonini, Turner and Pauerstein (1976) demonstrated
that PGFga output from the guinea-pig uterus in vivo increased without any change
in PGEg output Further work by Poyser (1983b) investigating the effect of oestradiol
and progesterone treatment on the outputs of PGF2a, PGE2 and 6-keto-PGF]a (the
stable metabolite ofPGb) in ovariectomized guinea-pigs found that the outputs of all
three PGs were low from untreated ovariectomized guinea-pig uteri and progesterone
treatment had no significant effect on any of the PG outputs. However, oestradiol
treatment significantly stimulated the outputs ofPGFgc^ PGE2 and 6-keto-PGF|a 7-
fold, 1.7-fold and 2.9-fold, respectively. When the uteri were primed with
progesterone prior to oestradiol treatment, a further 2-fold increase in PGF2a output
was observed, but no significant increases occurred in PGE2 or 6-keto-PGFia
outputs when compared to PG outputs from oestradiol-only treated uteri. Oestradiol
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may have a dual action in increasing uterine PG synthesizing capacity and directing
synthesis toward PGF2a. The essential role of the ovarian steroids in luteolysis in the
guinea-pig was demonstrated when the administration of onapristone (a progesterone
antagonist) and ICI 182780 (an oestrogen antagonist) on days 11-14 of the oestrous
cycle significantly decreased uterine PGF2a output from the day 15 guinea-pig uterus.
Plasma progesterone levels remained elevated confirming that luteal regression had
been prevented (Poyser, 1993a). Thus it appears that oestradiol acting on a
progesterone primed uterus is the physiological stimulus for the increase in PGF2a
synthesis and release from the guinea-pig uterus at the time of luteolysis.
The passive immunization of sheep against either oestradiol or progesterone
failed to prevent complete luteolysis in either animals (Fairclough et a/., 1976;
Fairclough, Smith, Peterson and McGowan, 1976) suggesting that oestrogen and
progesterone may not be the only factors involved in the control of uterine PGF2a
output in the sheep. However, a later study demonstrated that adequate progesterone
exposure during the early to mid-luteal phase of the oestrous cycle is essential for the
initiation of ovarian-uterine mechanisms that lead to luteolysis in ewes (Morgan,
Geisert, McCann, Bazer, Ott, Mirando and Stewart, 1993).
1:10 Role of oxytocin in uterine PGF2a production
The potent spasmogenic action of oxytocin was first demonstrated by Dale in
1906 when he showed that intravenously administered extracts of pituitary gland
resulted in strong uterine contractions in the pregnant cat. Oxytocin was later shown
to shorten the oestrous cycle in cyclic heifers when administered during the first week
following oestrus (Auletta, Currie and Black, 1972; Anderson and Bowerman, 1963).
This effect was shown to occur only in animals with an intact uterus (Armstrong and
Hansel, 1959; Anderson, Bowerman and Melampy, 1965) indicating that oxytocin
was acting via some mechanism mediated by the uterus. In unilaterally
hysterectomized heifers, oxytocin treatment resulted in shortened cycles only in those
animals where the remaining uterine horn was adjacent, not contralateral, to the ovary
containing a corpus luteum, thus indicating a local utero-ovarian mechanism (Ginther
el a/., 1967). The proposition then arose that oxytocin was involved in the stimulation
of luteolytic uterine PGF2a synthesis and release.
Following oxytocin treatment of heifers during the early part of the oestrous
cycle, an increase in uterine PGF2a output and decrease in jugular venous
progesterone levels was observed (Newcomb, Booth and Rowson, 1977; Milvae and
Hansel, 1980). Earlier studies had demonstrated that, in the sheep, the stimulation of
PGF2a output from the uterus by an oxytocin infusion into the uterine arterial supply
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was greatest after day 14 of the cycle i.e. during the luteal phase of the oestrous cycle
(Roberts, Barcikowski, Wilson, Skarnes and McCracken, 1975; Wilson, Roberts and
McCracken, 1974) and was unrelated to myometrial activity (Roberts and
McCracken, 1976). Oxytocin was also found to stimulate PGF2a release from the
uterus in the rat (Campos, Liggins and Seamark, 1980), rabbit (Small, Gavagan and
Roberts, 1978), goat (Cooke and Homeida, 1982, 1985) and cow (Wathes, Swann,
Birkett, Porter and Pickering, 1983).
The administration of oxytocin stimulates the release ofPGF2a from the ovine
uterus in vivo (Sharma and Fitzpatrick, 1974; Roberts et a/., 1975) and from ovine
endometrial explants in vitro (Roberts, McCracken, Gavagan and Soloff, 1976; Silvia
and Homanics, 1988). Immunization against oxytocin has also been found to delay
luteal regression in the sheep (Flint, Mitchell and Sheldrick, 1979; Sheldrick, Mitchell
and Flint, 1980; Schams, Prokoff and Barth, 1983) and goat (Cooke and Homeida,
1985). In sheep, PGF2a can also stimulate luteal secretion of oxytocin (Flint and
Sheldrick, 1982b; Watkins and Moore, 1987; Lamsa, Kot, Eldring, Nay and
McCracken, 1989). Therefore, luteal oxytocin and uterine PGF2a appear to exist in a
positive feedback loop that may contribute to the endogenous secretion of PGF2a
during luteal regression. Flint, Sheldrick, Theodosis and Wooding (1986) proposed
that endogenous oxytocin, of luteal origin, plays an essential role in regulating uterine
secretion of PGF2a in the sheep.
In contrast to the sheep, goat and cow, oxytocin does not appear to be
involved in the release of PGF2a from the uterus of the guinea-pig. Donovan (1961)
found that oxytocin treatment had no effect on cycle length when administered to
guinea-pigs. This was further confirmed when oxytocin was shown to have no effect
on prostaglandin production from either day 7 or 15 superfused guinea-pig uterus in
vitro (Poyser and Brydon, 1983) or from cultured endometrial tissue (Riley and
Poyser, 1987b). However, the latter study is in contradiction to a study by Leaver and
Seawright (1982). A more recent study has demonstrated that oxytocin binding sites
are present in the guinea-pig ovary and are regulated by steroid hormones so that
oxytocin may play a role in follicular steroidogenesis, maturation or ovulation rather
than in luteal function. Oxytocin binding sites were present in the guinea-pig uterus,
but their numbers only varied very slightly during the oestrous cycle (Zhang, Dreifuss,
Dubois-Dauphin and Tribollet, 1991).
1:10:1 Oxytocin and ovarian steroids
Oxytocin was found to increase greatly PGF2a levels in the posterior vena
cava of anoestrous sheep only if they had been previously oestradiol-primed. This
suggested that the stimulation of uterine PGF2a release by oxytocin may depend
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upon the presence of oestradiol (Sharma and Fitzpatrick, 1974). Oestradiol-priming
was also shown to increase greatly uterine PGF2a release following oxytocin
treatment in ovariectomized rats (Campos et a/., 1980) and ovariectomized rabbits
(Small et al., 1978). Previous workers had shown that the sensitivity of the rat uterus
to oxytocin increased towards the end of the cycle (Chan, O'Connell and Pomeroy,
1963) and following oestrogen treatment (Follet and Bentley, 1964). Soloff and
Swartz (1974) demonstrated that the rat uterus bound oxytocin with high affinity and
that oestradiol treatment increased the number of oxytocin binding sites present in the
ovariectomized rat uterus after only 6h (Solofft 1975). It was then shown that the
quantity of high affinity oxytocin receptors in sheep uterus increased after day 14 of
the oestrous cycle, reaching a peak at oestrus. The endometrium was found to have a
binding capacity twice that of the myometrium (Roberts et al., 1976). This led to the
proposition that oestradiol levels could regulate endometrial PGFga release by
controlling the availability of oxytocin receptors (McCracken, 1980). However, the
sheep endometrium only became responsive to oxytocin after plasma progesterone
levels had begun to decline so that progesterone appears to inhibit the rise in oxytocin
receptors induced by oestrogen (Sheldrick and Flint, 1985; Roberts et al., 1976).
Therefore in the sheep, oestrogen acting on a progesterone-primed uterus appears to
be the initial stimulus for increased endometrial PGF2a release and once progesterone
levels have started to decrease the endometrium becomes responsive to oxytocin
which may play an important role in the maintenance of uterine PGF2a output during
luteolysis in the sheep. Several studies have proposed that the oxytocin-induced
stimulation of ovine endometrial PG synthesis may be mediated through its ability to
stimulate a rapid increase in the activity of PLC (Flint, Leat, Sheldrick and Stewart.
1986a; Silvia and Homanics, 1988).
1:10:2 Oxytocin and phospholipase (PL) C
Activation of PLC results in the hydrolysis of phosphoinosites, releasing
diacylglycerol (DAG) and inositol phosphates (IP3) (Berridge, 1987). DAG can act as
a second messenger through the activation of PKC which may phosphorylate, and
therefore activate, enzymes involved in liberating free arachidonic acid from storage
pools to serve as a substrate for PG synthesis. The involvement of PLC was
confirmed when agonists that mimic the effects of DAG and IP3 enhanced PGF2a
release from ovine (Silvia and Homanics, 1988; Silvia, Lee, Trammell, Hayes,
Lowberger and Brockman, 1994) and bovine (Lafrance and Gofff 1990) endometrial
tissue. Alternatively, it was proposed that arachidonic acid may be cleaved directly
from DAG by DAG and monoacylglycerol lipases (Flint et a/., 1986a). However,
recent work has demonstrated that it is difficult to establish a definitive association
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between the level of PLC activity and the amount of PGF2a released in vitro in the
ewe (Silvia et al., 1994). Considerable PGF2a release can occur from ovine and
bovine endometrial tissue with little or no detectable increase in PLC (Raw and Silvia,
1991; Mirando, Becker and Whiteaker, 1993; Silvia and Raw, 1993).
1:10:3 Oxytocin and phospholipase (PL) A2
AlFf is a potent stimulator of PGF2a release from ovine endometrial tissue
(Silvia et a/., 1994) which appears to induce cellular responses by increasing the
activity of G-proteins (Gilman, 1987). G-proteins can interact with several enzymes
that could contribute to the regulation of endometrial PGF2a synthesis, such as
adenylate cyclase, PLC and PLA2 (Gilman, 1987; Fain, Wallace and Wojcikiewicz,
1988). However, oxytocin did not induce an accumulation of cAMP in ovine
endometrial tissue (Vallet and Bazer, 1989) and cAMP had no stimulatory effect on
the release of PGF2a by bovine (Lafrance and Goff 1990) or guinea-pig (Poyser,
1987a) endometrial tissue iti vitro. Therefore, adenylate cyclase does not appear to be
involved in the stimulation ofPGF2a synthesis by oxytocin in the endometrium.
Previous work has demonstrated that the synthesis of PGs is associated with
an increase in the activity of PLA2 in numerous cell types (Irvine, 1982). This increase
in activity could be induced by an increase in PLC (and associated second
messengers) or through direct activation from the ligand-bound receptor through a G-
protein (Fain et al., 1988). Studies on ovine endometrial tissue using melittin (a
stimulator of PLA2) and aristolochic acid (an inhibitor of PLA2) have demonstrated
that the stimulatory effect of oxytocin on endometrial PGF2a release is mediated
through PLA2 (Lee and Silvia, 1994). However, the precise point at which PLA2 fits
in the regulatory cascade triggered by oxytocin remains to be determined
1:11 Pulsatile release of PGF2a
The output of PGF2a from the uterus has been shown to occur in a pulsatile,
not continuous, manner in the sheep (Thorburn, Cox, Currie, Restall and Schneider.
1972; McCracken et al., 1972), cow (Nancarrow et al., 1973), pig (Gleeson and
Thorburn, 1973; Gleeson et al., 1974) and goat (Homeida and Cooke, 1982). In the
sheep at the time of luteolysis, PGF2a output was found to occur as a series of high
amplitude, short duration pulses (Thorburn el al., 1973; Barcikowski et al., 1974;
Baird et a!., 1976; Fairclough, Moore, McGowan, Peterson, Smith, Tervit and
Watkins, 1980; Flint and Sheldrick, 1983; Zarco, Stabenfeldt, Quirke, Kindahl and
Bradford, 1988a).
The minimal effective luteolytic dose of PGF2a when administered as a
continuous infusion into the arterial supply of sheep ovary was found to be in the
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range of 2 pg/h (Coding, Baird, Cumming and McCracken, 1971). When PGF2a was
infused as pulses into the autotransplanted sheep ovary (at a frequency calculated to
mimic physiological exposure of the in situ ovary to PGF2a during naturally
occurring luteolysis), it was found that 4 pulses of 1 h each (0.04 - 0.08 pg/ml) in a 19
h period caused permanent luteal regression in 25 % of animals. However, when 5
pulses were given in a total period of 25 h, permanent luteal regression occurred in all
animals (Schramm, Bovaird, Glew, Schramm and McCracken, 1983). The average
total effective dose of PGF2a required to induce luteal regression when administered
as 5 x 1 h pulses was equal to l/40th of the regarded effective dose when
administered as a continuous infusion into the ovarian artery. These low
concentrations of PGF2a were proposed to be comparable to quantitative estimates
of PGFga concentrations exchanged by the counter-current mechanisms in the utero-
ovarian vein in the sheep (McCracken, Schramm and Okulicz, 1984b). A pulsatile
infusion administering 1 pulse per day over 4 days failed to induce permanent
regression indicating that a relatively short pulse frequency over a minimal period of
around 24 h is the probable stimulus for physiological luteal regression in the sheep
(Schramm et a/., 1983).
1:12 Control of pulsatile PGF2a release
The pulsatile release ofPGF2a during luteal regression was originally thought
to be linked to oxytocin secretion from the posterior pituitary (Roberts and
McCracken, 1976; Fairclough el al., 1980). Oxytocin itself is released in a pulsatile
manner in the sheep (Mitchell, Kramer, Brennecke and Webb, 1982) and goat
(Homeida and Cooke, 1983). However, several studies demonstrated that it was
doubtful that an increase in oxytocin concentrations at the time of luteolysis
stimulated uterine PGFga release in cycling sheep since oxytocin and progesterone
levels decreased simultaneously at the time of oestrus (Webb, Mitchell, Falconer and
Robinson, 1981; Sheldrick and Flint, 1981; Schams, Lahlou-Kassi and Glatzel, 1982).
This close association between oxytocin and progesterone levels led to the
proposition that the ovary was possibly responsible for oxytocin secretion. Indeed,
high oxytocin concentrations were then reported in both ovine and bovine corpora
lutea (Wathes and Swann, 1982; Fields, Eldridge, Fuchs, Roberts and Fields, 1983)
and a later study demonstrated that the large luteal cells were responsible for oxytocin
synthesis and secretion (Rodgers, O'Shea, Findlay, Flint and Sheldrick, 1983b).
Cloprostenol (a PGF2a analogue) administration stimulated oxytocin secretion into
the ovarian vein in the sheep. Oxytocin concentrations decreased at oestrus, but
frequent sampling revealed that the majority of pulses of uterine PGF2a were
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accompanied by rises in peripheral plasma oxytocin concentrations (Flint and
Sheldrick, 1982a, b) which suggested that PGF2a and oxytocin secretion may be
linked by a positive feedback mechanism (Flint and Sheldrick, 1983). This was further
supported by the observation that following hysterectomy in the sheep, oxytocin
secretion decreased from the corpora lutea indicating that oxytocin requires the
presence of endogenous uterine PGF2a for its secretion (Sheldrick and Flint, 1983).
However, although cloprostenol administration did not increase oxytocin
concentrations in ovarian and jugular venous plasma in hysterectomized sheep, luteal
regression was not delayed so that oxytocin secreted from the corpora lutea does not
appear to be involved in ovarian events mediating PGF2a-induced luteolysis in the
sheep.
Similar findings have been reported in the goat. Decreasing peripheral levels of
oxytocin from day 12 are characterised by frequent pulses of oxytocin (Homeida and
Cooke, 1983). Indomethacin treatment on days 11 and 16 of the cycle delayed
luteolysis, prevented the decrease in oxytocin concentrations and suppressed the
pulsatile appearance of both oxytocin and PGF2a metabolite in the peripheral
circulation (Cooke and Homeida, 1984). No effect on peripheral oxytocin or PGF2a
metabolite concentrations was observed in ovariectomized goats following PGF2a
administration (Homeida and Cooke, 1985), suggesting that uterine PGF2a may
induce the pulsatile release of ovarian oxytocin during luteolysis.
In the sheep, pulses of PGF2a occur concurrently with pulses of oxytocin (or
its associated neurophysin) during luteal regression (Fairclough el al., 1980; Webb el
al., 1981; Flint and Sheldrick, 1983). Further work revealed that the majority of this
oxytocin is secreted by the corpus luteum (Hooper, Watkins and Thorburn, 1986;
Moore, Choy, Elliot and Watkins, 1986). Uterine PGF2a and luteal oxytocin appear
to comprise a positive feedback loop (Flint and Sheldrick, 1983). Indeed, oxytocin
can stimulate uterine secretion of PGF2a (Sharma and Fitzpatrick, 1974; Roberts el
al., 1975; Roberts and McCracken, 1976) and PGF2a can stimulate secretion of
oxytocin from the corpus luteum (Flint and Sheldrick, 1982b; Watkins and Moore,
1987; Heap, Fleet, Davies, Goode, Hamon, Walters and Flint, 1989; Lamsa el a/.,
1989). Flint el al. (1986) proposed that the high concentrations of both PGF2a and
oxytocin were achieved through activation of this positive feedback loop. At the time
of luteolysis, concentrations of PGF2a increase in the utero-ovarian venous effluent
before any detectable increase in oxytocin (Moore el al., 1986) implying that the
activation of the feedback loop begins on the uterine side of the loop. The actual
stimulus that initiates PGF2a secretion is still unclear. In sheep, pulses of PGF2a are
frequently associated with increases in both neurohypophyseal and luteal secretion of
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oxytocin (Hooper et al., 1986). McCracken, Smith, Lamsa and Robinson (1991)
suggested that neurohypophyseal oxytocin, released in a pulsatile fashion, could serve
as a pulse generator signal initiating uterine secretion ofPGF2a.
Ovarian steroid hormones may also contribute to the regulation of the
secretion of pulsatile PGF2a. Pulsatile secretion of uterine PGF2a is greatly reduced
in the absence of ovarian steroids (Silvia and Raw, 1993b). Changes in the uterine
responsiveness to oxytocin appear to be regulated by oestradiol and progesterone
(Sharma and Fitzpatrick, 1974; McCracken, 1980; Homanics and Silvia, 1988; Vallet,
Lamming and Batten, 1990a). Oestradiol and progesterone may also influence the
"pulse generator" since infusion of oestradiol into ovariectomized ewes resulted in the
secretion of a pulsatile pattern of neurohypophyseal oxytocin similar to that observed
in intact ewes during the follicular phase (McCracken, Schramm, Manning and
Robinson, 1984a; McCracken et al., 1984b). A more recent study has demonstrated
that progesterone plays an important role in regulating the number and magnitude of
secreted pulses of PGF2a from the ovine uterus (Silvia and Raw, 1993b). The
administration of progesterone to ovariectomized ewes completely restored the
frequency, and partially restored the magnitude, of uterine PGF2a pulses, suggesting
that ovarian secretory products other than progesterone (such as luteal oxytocin) are
not required to initiate pulsatile secretion of PGF2a, but may be necessary to achieve
full pulse magnitude. A role of oestradiol in regulating pulsatile secretion of PGF2a
was not evident (Silvia and Raw, 1993b).
The mechanism by which the eventual termination of both oxytocin and
PGF2a secretion is achieved was proposed to be due to the down-regulation of
oxytocin receptors by oxytocin (Flint and Sheldrick, 1985), since a continuous
intravenous infusion of oxytocin between days 13 and 21 after oestrus in the sheep
delays the return to oestrus and prevents the increase in uterine oxytocin receptors
that normally precedes oestrus. However, in a later study, Sheldrick and Flint (1986)
treated steroid-primed ovariectomized sheep with oxytocin at 1, 2, 4 or 6 h intervals.
All initial doses elicited large increases in circulating PGF2a metabolite. The
subsequent doses failed to result in such high increases, although the response was
higher when the time period between doses was greater. This suggested that a period
of uterine refractoriness existed following administration of oxytocin in steroid-primed
ovariectomized sheep. Since uterine oxytocin receptor numbers remained unchanged
after 2 h of oxytocin treatment, this indicated that uterine refractoriness to oxytocin
was not due to down-regulation of oxytocin receptors (Sheldrick and Flint, 1986).
The timing of the period of uterine refractoriness following oxytocin treatment was
consistent with the frequency of uterine PGF2a Pulses secreted at luteolysis, which
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have been reported to occur at intervals of greater than 6 h (Sheldrick and Flint,
1986). This was also consistent with the frequency with which PGF2a must be
administered to obtain enhanced luteolytic potency (Schramm et al., 1983).
The outputs of PGF2a, PGE2 and 6-keto-PGF]a from the guinea-pig uterus
superfused in vitro were shown to increase following treatment with phospholipase
(PL) A2, the calcium ionophore A23187 and arachidonic acid (Poyser and Brydon,
1983; Poyser, 1987). When the same treatment was applied 1 h after termination of
the first treatment, PLA2 failed to increase uterine prostaglandin output, A23187
caused a smaller increase, but arachidonic acid treatment produced the same large
increase in uterine PG output. Therefore, the uterus demonstrated complete
refractoriness to PLA2, partial refractoriness to A23187 and no refractoriness to
arachidonic acid with respect to the stimulation of uterine PG output. However, this
refractoriness only lasts for 3-5 h (Poyser, 1991). Since there is no failure with time in
the mechanisms that convert exogenous arachidonic acid into PGs, the refractoriness
of uterine PG production seems to occur at the level of endogenous arachidonic acid
release. This would indicate that there are one or several pools of bound arachidonic
acid which are readily releasable but which take 3-5 h to refill, and this may explain, in
part, the pulsatile nature of uterine PGF2a release.
1:13 Hormonal control of uterine receptors
Progesterone treatment has been shown to inhibit the replenishment of uterine
oestrogen receptors in the immature, oestradiol-treated rat (Hsueh, Peck and Clark,
1976), human (Tseng and Gurpide, 1975), ovariectomized oestradiol-treated monkey
(Brenner, Resko and West, 1974), and rat (West, Verhage and Brenner, 1976). In
ovine endometrium, progesterone prevented the increase in oxytocin receptors
normally stimulated by oestradiol (Koligian and Stormshak, 1977a), and when
circulating progesterone concentrations were maximal, during the mid-luteal phase,
oestrogen receptor concentrations were found to be at their lowest (Koligian and
Stormshak, 1977b). Progesterone has also been shown to rapidly and selectively
down-regulate oestrogen receptors in the hamster (Evans and Leavitt, 1980) and rat
uterus (Okulicz, Evans and Leavitt, 1981). Ovariectomized guinea-pigs treated with
oestradiol exhibited an increase in the concentration of uterine progesterone
receptors, this increase being prevented by pretreatment with protein synthesis or
RNA synthesis inhibitors. However, when progesterone was administered following
pretreatment with oestradiol, a marked decrease in progesterone receptor
concentration resulted. This was unaffected by protein synthesis inhibitors, indicating
enhanced receptor inactivation as a possible mechanism, such as induction of
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translocation of receptors to the cytosol (Vu Hai, Logeat, Warembourg and Milgrom,
1977). Therefore, the down-regulation of progesterone receptors could explain the
loss of the inhibitory action of progesterone on oestradiol seen towards the end of the
oestrous cycle in the sheep uterus (McCracken et al, 1984a).
There is considerable evidence that the concentration of uterine oxytocin
receptors is regulated principally by the circulating steroid hormones (McCracken et
a/., 1984b; Sheldrick and Flint, 1985), with oestradiol tending to induce receptor
formation and progesterone having an initial inhibitory effect which switches to an
enhancement after 10-12 days (Vallet et al., 1990; Zhang, Weston and Hixon, 1992).
Uterine oxytocin receptors have been shown to be present in ovariectomized ewes
(Vallet et al., 1990; Zhang et al., 1992). However, these receptors are functionally
inactive as oxytocin administration is unable to stimulate PGF2a release, presumably
because other essential elements in the signalling pathway are steroid-dependent (Flint
et al., 1986; Hixon and Flint, 1987). Initial treatment of ovariectomized ewes with
progesterone down-regulates the oxytocin receptor, but this effect is lost with time,
so that receptors reappear after about 12 days of continuous progesterone treatment
(Homanics and Silvia, 1988; Vallet et al., 1990). It was proposed that maximal
responses in terms of both oxytocin receptor concentration and PGF2a release in the
ewe can be achieved by a period of progesterone treatment, followed by oestradiol
administration during progesterone withdrawal (Vallet et al., 1990; Zhang et al.,
1992). This hypothesis was supported by a previous study by Homanics and Silvia
(1988) which demonstrated that oxytocin administration on days 5 or 10 of steroid
treatment did not result in any change in PGF2a metabolite (PGFM) concentration in
the jugular venous blood of ovariectomized ewes treated with either oestradiol,
progesterone or both steroids. When oxytocin was administered on day 15 of
progesterone treatment, circulating PGFM levels did increase. However, a greater
increase in PGFM levels was observed in animals that had been treated with both
progesterone and oestradiol. A later study in 1990 by Ayad, McGogg and Wathes
also provided evidence that progesterone and oestradiol treatment together resulted in
maximal oxytocin binding. They found that oxytocin binding to oviductal membranes
in prepubertal, anoestrous and pregnant ewes was very low. However, in anoestrous
ewes treated with both steroids, binding was similar to that measured in normal ewes
at oestrus. Therefore in the ewe, it appears that the hormonal stimuli that maximally
induce uterine PGF2a release towards the end of the cycle, also induce maximum
oxytocin binding to reproductive tissues thereby further stimulating uterine PGF2a
release and maintaining the process of luteolysis. Progesterone appears to have the
dominant role in the control of luteolysis in the ewe since long-term progesterone
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treatment alone was found to be sufficient to induce both endometrial oxytocin
receptors and uterine PGF2a release in response to oxytocin administration.
Oestrogen may simply mediate the time course of PGF2a release in response to
oxytocin, maintaining luteolysis as progesterone levels decrease in response to PGF2a
(Vallet et al., 1990).
A recent study has also suggested that local paracrine factors, as well as
circulating steroid hormone concentrations, are likely to be involved in the regulation
of oxytocin receptors during the oestrous cycle of the ewe (Wathes and Hamon,
1993). Clearly, the mechanisms by which oxytocin receptor number and function are
regulated, have yet to be fully elucidated.
To summarise, the main evidence supporting the theory that PGF2a is the
uterine luteolytic hormone in many species: -
i. Administration of PGF2a mimics the action of the "uterine luteolytic factor"
resulting in luteolysis.
ii. PGF2a has been detected in the uterine vein prior to and during luteolysis.
iii. The insertion of intrauterine devices or beads which induce premature luteolysis
stimulate an early release ofPGF2a from the uterus.
iv. Indomethacin administration which inhibits PGF2a synthesis prolongs luteal
function.
v. Active or passive immunization against PGF2a results in luteal maintenance.
vi. PGF2a has been shown to have a luteolytic effect on luteal cells.
vii. PGF2a has been shown to be transferred from the uterus to the ovary.
1:14 PGF2a in the early pregnant animal
Implantation in the guinea-pig is completed during a period of 6-8 hours on
the sixth day following fertilization (Blandau, 1949). The terms "superficial" and
"interstitial" describe different implantation mechanisms, and separate those in which
the blastocyst remains in the uterine lumen and those in which it penetrates the luminal
epithelium and embeds itself in the uterine wall. The guinea-pig blastocyst was first
classed as one demonstrating a true type of interstitial implantation by Spee in 1883.
Both man and the guinea-pig have a "discoid haemochorial placenta" in which
maternal blood circulates through trophoblastic channels. In the guinea-pig, this
discoid haemochorial placenta (chorio-allantoic placenta) rests on a base called the
subplacenta (Egund and Carter, 1974), or yolk sac or vitelline placenta (Schroder,
Schoch, Elwers and Leichtweiss, 1991). During implantation in guinea-pigs (and rat,
rabbit, hamster and mouse) the yolk sac membrane gains contact with the endometrial
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epithelium forming the yolk sac placenta (Schroder et at., 1991). In guinea-pigs, the
resorptive (luminal) microvillous side of the yolk sac epithelium forms extensive
interdigitations with the apical microvilli of the endometrial epithelium (Kaufmann and
Davidoff, 1977) through a process termed "yolk sac inversion". The cells that
constitute the subplacenta are derived from fetal endodermal cells (Schroder et a/.,
1991).
Ovarian progesterone is necessary for the maintenance of pregnancy, so it is
essential that the regression of the corpus luteum is prevented after a successful
mating. Consequently, in those animals that secrete a uterine luteolytic hormone, the
luteolytic influence of the uterus must be abolished in some way following conception.
Pregnant guinea-pigs, ovariectomized on day 21 of gestation, aborted unless treated
with progesterone. However, if ovariectomy was carried out on day 30 of gestation,
none of the animals aborted (Heap and Deanesly, 1966; Csapo, Puri and Tarro, 1981).
Therefore, in the guinea-pig, ovarian progesterone is necessary to maintain pregnancy
until about day 25, in a 67-day gestation. The corpora lutea of the guinea-pig are
actually maintained until days 58-67, but are not essential for the maintenance of
pregnancy beyond day 25 (Bland and Donovan, 1969b). Around day 25, the "luteo-
placental shift" occurs when the placenta takes over progesterone production.
However, the corpora lutea remain fully functional until about day 40 after which
progesterone secretion gradually declines (Heap and Deansesly, 1966). A similar
situation exists in the sheep. In some other species, such as the cow, pig and goat,
ovarian progesterone is essential throughout gestation. In pregnant guinea-pigs, the
usual increase in PGFga output from the non-pregnant uterus after day 11 is
prevented by the presence of the conceptuses (Blatchley, Maule Walker and Poyser,
1975a, b; Antonini et'a/., 1976). Conceptuses from pregnant guinea-pigs grafted on to
the spleen of non-pregnant animals maintained corpora lutea in the recipient guinea-
pigs beyond their normal life-span (Bland and Donovan, 1969b). The low
concentrations of PGF2a present in the utero-ovarian vein of pregnant guinea-pigs
were not due to increased metabolism of prostaglandins, lack of substrate or the
redirection of synthesis towards PGE2 (Maule Walker and Poyser, 1978). Therefore,
it was suggested that the conceptus secretes an anti-luteolytic factor which may
suppress uterine PGF2a output by inhibiting the stimulatory effect of oestradiol on
endometrial PGF2a synthesis and release (Poyser, 1984a). This anti-luteolytic factor
was previously shown to act both locally and systemically since both uterine horns
from day 15 unilaterally pregnant guinea-pigs produced significantly less PGFgo. u>
vitro than horns from day 15 non-pregnant animals. However the local anti-luteolytic
action is stronger than the systemic action since the non-pregnant horns of the
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unilateral pregnancies produced significantly more PGF2a than the pregnant horns
(Maule Walker and Poyser, 1974).
During early pregnancy, luteal maintenance is associated with the production
of antiluteolytic proteins by the embryonic trophoblast between days 13-21 in the ewe
(Godkin, Bazer, Moffatt, Sessions and Roberts, 1982), cow (Bartol, Roberts, Bazer,
Lewis, Godkin and Thatcher, 1984) and goat (Gnatek, Smith, Duby and Godkin,
1989). In the sheep, the embryo secretes a protein called ovine trophoblast protein-1
(oTP-1) which has been shown to inhibit oestradiol- and oxytocin-induced stimulation
of endometrial PGF2a synthesis in vivo (Vallet, Bazer, Fliss and Thatcher, 1988).
oTP-1 has a molecular weight of 20 kDa and has approximately 70 % homology with
the a-interferons (Imakawa, Anthony, Kayemi, Marotti, Polites and Roberts, 1987;
Stewart, McCann, Barker, Lee, Lamming, Flint, 1987; Charpigny, Reinaud, Huet,
Guillomot, Charlier, Pernollet and Martal, 1988). a-Interferon also strongly inhibits
PGF2a syndesis by sheep endometrial cells (Salamonsen, Manikhot, Healy and
Findlay, 1989; Salamonsen, Stuchberg, O'Grady, Godkin and Findlay, 1988). During
the oestrous cycle and early pregnancy oTP-1 binding sites are present in the sheep
endometrium (Knickerbocker and Niswender, 1989) and interferon-a will also bind to
these sites (Stewart el a!., 1987). A similar protein, called bovine trophoblast protein
(bTP-1) (Mr 21 kDa), is secreted by bovine embryos. bTP-1 shows considerable
homology with oTP-1 and also inhibits endometrial PGF2a synthesis (Gross, Plante,
Thatcher, Hansen, Helmer and Putney, 1988c; Lifsey, Braumbach and Godkin, 1989).
Intra-uterine and systemic administration of recombinant bovine interferon-cti at the
time of maternal recognition of pregnancy to cyclic ewes can also act as a
antiluteolysin, apparently acting in a similar way to oTP-1 (Parkinson, Lamming, Flint
and Jenner, 1992). In cattle, bTP-1 appears to inhibit both basal, and oxytocin- and
oestradiol-stimulated uterine PGF2a secretion (Thatcher, Danet-Desnoyers and
Wetzels, 1992), whereas in sheep oTP-1 may inhibit the pulsatile secretion of PGF2a
although this is accompanied by an increase in basal PGF2a secretion (Inskeep and
Murdoch, 1980). In order to distinguish trophoblast protein-1 from other types of
interferon, these trophoblast proteins have been recently renamed interferon-! (see
Poyser, 1995). Another study has proposed that embryo-derived platelet-activating
factor may play a role in suppressing uterine PGF2a secretion in the sheep (Battye,
O'Neill and Evans, 1991).
The conceptus of the pig has also been demonstrated to secrete an interferon-
like protein during early pregnancy (Cross and Roberts, 1989). However, proteins
secreted by the conceptus do not inhibit uterine PGF2a release in the pig in vivo
(Harney and Bazer, 1989). The secretion of oestradiol by the pig embryo appears to
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induce an alteration in PGF2a secretion, whereby PGF2a is secreted into the uterine
lumen (where it is sequestered) rather than into the uterine venous drainage (Bazer
and Thatcher, 1977; Bazer, Mirando, Ott, Harney, Dubois, Schalue, Pontzer,
Hostetler, Johnson and Ogle, 1992). Therefore, the corpora lutea remain protected
from the luteolytic influence of PGF2a Oestradiol-induced calcium cycling and
synergistic effects of prolactin may be involved in this redirection of PGF2a secretion
(Bazer el a/., 1992).
Administration of PGF2a induced luteolysis in nonpregnant but not in
pregnant sheep (Nancarrow, Evison and Connell, 1982; Silvia and Niswender, 1986)
even though the number of PGF2a receptors was similar in both at the time of
maternal recognition of pregnancy (Wiepz, Wiltbank, Nett, Niswender and Sawyer,
1992). In addition, the responsiveness of large luteal cells to PGF2a was not different
between pregnant and nonpregnant animals (Wiltbank, Wiepz, Knickerbocker,
Braden, Sawyer, Mayan and Niswender, 1992a). Therefore, inhibition of the action
of PGF2a may occur at the level of the luteal cell. It has been proposed that the
pregnant uterus secretes a factor, possibly PGE2, that reduces the luteolytic effects of
PGF2a. PGE2 treatment lengthened the lifespan of the corpus luteum in sheep
(Inskeep, Smutny, Butcher and Pexton, 1975), cattle (Gimenez and Henricks, 1983),
primates (Zelinski-Wooten and Stouffer, 1990) and stimulated progesterone
production by ovine large luteal cells (Fitz, Hoyer and Niswender, 1984).
Other factors that may be involved during maternal recognition of pregnancy
are luteal protective proteins secreted by the early ovine embryo (Wiltbank, Wiepz,
Knickerbocker, Belfiore and Niswender, 1992b). These conceptus proteins did not
directly stimulate progesterone production, but appeared to block the action of
PGF2a on large luteal cells. Since there was no change in binding of PGF2a to its
receptor at the same doses of conceptus protein that completely inhibited the
antisteroidogenic action of PGF2a, secreted conceptus proteins appear to act after
activation of free calcium / PKC intracellular effector pathways and may have general
cellular protective actions. oTP-1 failed to exhibit such anti-PGF2a activity, but
conceptus proteins devoid of oTP-1 did prevent the antisteroidogenic effects of
PGF2a Therefore, secreted conceptus proteins may be important in maintaining the
corpus luteum during early pregnancy in the sheep (Wiltbank el a/., 1992b).
In the guinea-pig, interferon-a does not inhibit PGF2a or PGE2 production by
day 15, non-pregnant endometrium in culture (Leckie and Poyser, 1990a). Proteins
related to interferon-a appear to act as anti-luteolytic factors during early pregnancy
by inhibiting endometrial PGF2a synthesis in some species (sheep and cow) but not in
others such as the pig and guinea-pig.
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In the human and other primates the luteotrophic stimulus is provided by a
placental protein hormone chorionic gonadotrophin (CG) (Hobson, 1971). In the
guinea-pig, hypophysectomy 3-6 days after mating (Heap, Perry and Rowlands, 1967)
or ovariectomy 3-4 weeks post coitum (Herrick, 1928) does not result in abortion.
Therefore, corpora lutea of pregnancy and the production of progesterone must be
maintained by an extra-pituitary source of luteotrophin. Bland and Donovan (1969)
demonstrated that the transfer of conceptuses to, and their subsequent removal from,
the uterus of guinea-pigs resulted in first the prevention and secondly the recurrence
of oestrus. They concluded that a placental hormone, whose nature was unknown,
was responsible for continued luteal function and the absence of oestrus during
pregnancy in the guinea-pig. In an earlier study by Davies, Dempsey and Amoroso
(1961) investigating the development of the guinea-pig subplacenta throughout
pregnancy, it was concluded that this tissue may be the source of a gonadotrophin. A
later study successfully extracted a gonadotrophic substance from placentae and
subplacentae of days 10-63 pregnant guinea-pigs (Humphreys, Hobson and Wide,
1982). A subsequent study demonstrated that the guinea-pig placenta produces a CG,
which on purification has physiochemical, biological and immunological properties
similar to those of human CG (hCG) (Bambra, Lynch, Foxcroft, Robinson and
Amoroso, 1984). The concentration ofCG in the guinea-pig placenta plus subplacenta
is approximately 1/100th of that found in the human placenta, however, if the CG
would reach the ovary via a local veno-arterial pathway such a low concentration may
be sufficient to maintain the corpus luteum (Humphreys et a/., 1982).
Biologically active gonadotrophins with gonadotrophin profiles similar to hCG
and its subunits have been shown to be present in the placentae of rat, mouse and
hamster (Wide and Hobson, 1978), and implanting mouse blastocysts synthesize and
release a glycoprotein allied to CG (Fishel and Surani, 1980). The administration of
hCG reduced the luteolytic effect of PGF2a in the ewe (Bolt, 1979). The luteotrophic
function of CG has been well described for several primate species, including man (see
Hearn, Webley and Gidley-Baird, 1991). Passive immunization against hCG between
days 20 and 25 after ovulation of 10 pregnant marmoset monkeys resulted in all
pregnancies being terminated within 2-6 days. When marmoset embryos were cultured
individually with added anti-hCGp antiserum, attachment and trophoblastic outgrowth
was prevented These effects were not observed in embryos incubated with
nonimmune IgG or in normal marmoset culture. These studies suggest that the
neutralization of CG during embryo attachment in vivo and in vitro prevents
implantation and terminates early pregnancy in the marmoset monkey (see Hearn et
a!., 1991). Also, the direct perfusion of hCG into the corpora lutea of marmoset
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monkeys produced an immediate stimulus resulting in a significant increase in
progesterone production within 10-20 min (see Hearn el a!., 1991) strengthening the
evidence that CG has luteotrophic action The first external secretion of CG by the
human embryo is most probably in the late blastocyst stages (Fishel, Edwards and
Evans, 1984).
The identity of the anti-luteolytic factor in the guinea-pig remains unconfirmed
as yet. A 38.2 kDa protein secreted by the day 15 conceptus which inhibits
endometrial PGF2a synthesis has been isolated (Leckie and Poyser, 1992). There is a
strong similarity between hCG and CG extracted from the guinea-pig placenta, which
therefore may have a luteotrophic function similar to that of hCG (Humphreys et a/.,
1982). Whether the 38.2 kDa protein previously isolated from the guinea-pig
conceptus is secreted particularly by the placenta, and whether it is related to hCG
(37.6 kDa) is as yet unknown, and requires further study.
The Control of Prostaglandin Synthesis
1:15 Mechanism by which ovarian hormones control PGF2a synthesis
The concentrations of PGF2a present in uterine tissues are very low and
definitely inadequate to account for the large increase in PGF2a released from the
uterus towards the end of the cycle in the guinea-pig (Poyser, 1972) and sheep
(Wilson, Cenedella, Butcher and Inskeep, 1972). Since PGs are not stored in the
uterus, they must be immediately synthesized prior to their release. The mechanisms
by which the ovarian steroids control this synthesis are discussed in this section.
1:15:1 Steroid binding and protein synthesis
In order to elicit a response, steroids must initially bind to their appropriate
receptor. Steroid receptors were originally thought to exist as soluble constituents of
the cytosol. However, studies with fluorescent antibody labelling (King and Greene.
1984) demonstrated that the receptor protein is bound to the nuclear chromatin.
Steroid molecules cross the cell membrane readily since they are lipid soluble and bind
to the receptor. The steroid-receptor complex is believed to bind to both the DNA
and chromatin protein, the latter binding increasing the affinity of the interaction with
the DNA. The receptor determines the specificity for a particular DNA sequence and
thus regulates the formation of particular messenger RNAs, thereby directing the
synthesis of specific proteins. A subsequent increase in general protein levels and an
accumulation of phospholipids are observed following steroid administration (Mueller,
Gorski and Aizawa, 1961). Intrauterine administration of actinomycin D (an inhibitor
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of DNA-dependent RNA synthesis) on day 11 of the oestrous cycle prevented luteal
regression in the sheep (French and Casida, 1973). This led to the suggestion that,
towards the end of the cycle, oestradiol acted on a progesterone-primed uterus to
stimulate DNA-dependent RNA synthesis resulting in a rise in the enzymes involved
in PGF2a synthesis. Indeed, in the guinea-pig actinomycin D treatment prevented the
normal rise in "uterine prostaglandin synthase enzymes" observed just prior to the
time of luteal regression (Poyser, 1979). Later studies revealed that progesterone
concentrations remained high during lengthened cycles and that PGF2a production by
uterine homogenates in vitro on day 15 was reduced by 80-85 % in guinea-pigs which
had received intrauterine actinomycin D on day 10 compared to control animals. None
of the effects could be reversed by oestradiol treatment (Poyser and Riley, 1987).
Actinomycin D, cycloheximide (which inhibits the elongation step of protein
transcription) and puromycin (which releases nascent polypeptide chains prior to their
complete synthesis) all reduced PGF2a output from both day 7 and 15 guinea-pig
endometrium cultured for 24 h (Riley and Poyser, 1989). However, this effect was not
observed when the inhibitors were superfused in vitro over the tissues for a 20 min
period, indicating that these compounds do not have a rapid inhibitory effect on
endometrial PG synthesis. Intrauterine administration of actinomycin D on day 10
reduced the synthesis of both secreted and cellular proteins by day 15 cultured
endometrium suggesting that the increased endometrial synthesis of PGs, particularly
PGF2a towards the end of the cycle, appears to be dependent upon increased
endometrial protein synthesis.
1:15:2 Influence of ovarian steroids on PGH synthase activity
PGH synthase exhibits self-catalysed breakdown so that as PGs are formed,
the enzyme catalysing the reaction is inactivated (Lands, LeTellier, Rome and
Vanderhoek, 1972; Lands, 1979). Thus, the total amount of PGs synthesized by
endometrial homogenates is indicative of the concentration of PGH synthase present,
especially as the metabolism of PGs in the absence of exogenous NAD by the guinea-
pig uterus is negligible (< 5%) (Poyser, 1979). Increases in the amounts of PGF2a
synthesized by homogenates of guinea-pig uterus towards the end of the cycle
(Poyser, 1972) are parallelled by increases in PGF2a concentrations in the utero-
ovarian vein (Blatchley el al., 1972). This led to the proposition that increasing PG
levels formed by the uterus may reflect an increase in the amount of PGH synthase
present in the uterus (Poyser, 1973). Indeed, estimation of the amounts of [^H]-
arachidonic acid converted into PGs by guinea-pig uterine microsomes confirmed that
an increase in PG synthesizing activity did occur towards the end of the cycle
(Wlodawer, Kindahl and Hamberg, 1976).
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Various studies demonstrated that oestradiol treatment influenced the ratio of
PG products synthesized by the uterus. Ovariectomy in the rat induced a 10-fold and
3-fold increase in uterine PGE and PGF release respectively. However, oestradiol
treatment caused a decrease in PGE levels parallelled by an increase in PGF levels
(Ham, Cirillo, Zanetti and Kuehl, 1975). Oestradiol was found to stimulate an
increase in endometrial PGH synthase in the guinea-pig (Naylor and Poyser, 1975;
Wlodawer et al., 1976; Thaler-Dao, Ramonatxo, Saintot, Chaintreuil and Crastes de
Paulet, 1982) and sheep (Raw, Curry and Silvia, 1988) uterus. Oestradiol treatment of
ovariectomized guinea-pigs stimulated an increase in endometrial PG synthesizing
capacity and increased the PGF2a to PGE2 ratio whereas progesterone treatment had
no effect on endometrial PG synthesizing capacity when administered alone.
However, when both steroids were administered progesterone attenuated the
stimulatory action of oestradiol in endometrial PG synthesizing capacity (Poyser,
1983a). A preferential stimulation of PGF2a synthesizing capacity in guinea-pig
endometrium has been shown to occur after day 11 of the cycle (Poyser, 1983a),
coupled with an increase in the amount of oestradiol released from the guinea-pig
ovary after day 11 up to oestrus (Joshi et al., 1973). This increase in ovarian
oestradiol output would satisfactorily provide the stimulus for the increase in
endometrial PGH synthase concentrations which occurs during the same period.
However, for maximal PGF2a release to occur from the guinea-pig uterus superfused
in vitro, a period of progesterone-priming must precede oestradiol treatment (Poyser,
1983b). The enzymatic capacity of the guinea-pig uterus to synthesize PGF201 appears
to be stimulated by oestradiol and inhibited by progesterone, whereas the maximal
synthesis and release of PGF2a seems to be dependent upon oestradiol acting on a
progesterone-primed uterus.
Progesterone treatment increased the concentration of PGH synthase in
uterine epithelial cells of ovariectomized sheep (Raw et al., 1988) and rats (Ohta,
1985). Treatment of intact ewes with progesterone early in the oestrous cycle was
also shown to induce a premature increase in the concentration of mRNA coding for
PGH synthase in uterine tissue as well as premature luteolysis (Eggleston, Wilken,
VanKirk, Slaughter and Murdoch, 1990). Therefore, progesterone appears to
stimulate the synthesis of PGH synthase and this may explain the period of
"progesterone-priming" required for maximal prostaglandin output.
However, changes in endometrial PGH synthase levels do not appear to be the
only factor controlling endometrial PGF2a release at the time of luteolysis. PGF2a
output from superfused guinea-pig uterus in vitro, increases 21.9-fold between days 7
and 15 of the cycle (Poyser and Brydon, 1983) whereas there is only a 2- to 3-fold
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variation in the activity of PG synthesizing enzymes during the cycle (Poyser, 1972;
Wlodawer et «/., 1976; Poyser, 1983a). It would therefore seem likely that an increase
in the supply of free precursor arachidonic acid is a more probable stimulus for the
increase in PGF2a synthesis by the endometrium at the time of luteolysis rather than
an increase in PGH synthase activity.
1:15:3 Influence of ovarian steroids on phospholipase A2 activity
In the guinea-pig, free arachidonic acid available for PG synthesis only makes
up 0.1 % of the total arachidonic acid present in the uterus (Leaver and Poyser,
1981). However, arachidonic acid esterified into membrane phospholipids is found in
much greater quantities (1 mg/g uterine tissue). Progesterone has been shown to
induce an accumulation of lipid droplets in ovine uterine epithelial cells (Brinsfield and
Hawk, 1973) and an accumulation of phospholipids and triglycerides in rat
endometrial tissue (Boshier and Holloway, 1973; Boshier, Holloway and Millener,
1981; Manimekalai, Umapathy and Govindarajulu, 1979) all being potential precursor
pools for PGF2a synthesis. In the rat uterus, oestradiol treatment increased the rate of
arachidonic acid turnover in both phospholipid and triglyceride storage pools (Toth
and Hertelendy, 1986) and reduced the cytoplasmic area occupied by lipid droplets
(Boshier and Holloway, 1973; Williams and Rogers, 1980). Therefore, the steroid
hormones may influence the mobilization and turnover of arachidonic acid from "lipid
stores" and play a key role in the control of PG production from the guinea-pig
uterus.
Studies have shown that uterine phospholipase (PL) A2 is stimulated by
administration of steroid hormones in the hypophysectomized (Dey, Hoversland and
Johnson, 1982) and ovariectomized rat (Pakrasi, Cheng and Dey, 1983). In the human
endometrium, the pre-ovulatory surge of oestradiol was proposed to be the stimulus
for a rapid increase in concentration of the calcium-dependent form of PLA2, which
subsequently decreased as progesterone concentrations increased (Bonney, 1985;
Bonney, Qizalbash and Franks, 1987). This rise in PLA2 activity was shown to occur
prior to maximum PG production by the endometrium at the end of the cycle
(Downie, Poyser and Wunderlich, 1974; Singh, Baccarini and Zuspan, 1975).
PLA2 activity has been demonstrated to increase only 1.5-fold between days 7
and 16 of the guinea-pig oestrous cycle (Downing and Poyser, 1983). Thus, an
increase in PLA2 activity may not be solely responsible for the 22-fold increase in
uterine PGF2a production by the guinea-pig uterus which occurs between days 7 and
15 of the cycle. It has been proposed that activation of PLA2, by increasing free
intracellular calcium concentrations, is probably of greater importance than the
absolute activity of PLA2 in controlling the supply of free arachidonic acid for PGF2a
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synthesis by the guinea-pig endometrium during the oestrous cycle (Downing and
Poyser, 1983).
1:16 PGH synthase and the control of prostaglandin synthesis
The enzymes that contribute to the "PG synthase complex" are present in
almost all cells, and PGs have been detected in a great variety of different tissues
(Bergstrom, 1966; Karim, Sandler and Williams, 1967). The concentrations of
intracellular free fatty acids, in particular arachidonic acid, are always kept very low
(Marcus, Ullman and Safier, 1969; Haye and Jacquemin, 1977) so that accumulation
of PGs in tissues does not occur (Jouvenez, Nugteren, Beerthius and Van Dorp,
1970). It was demonstrated (Lands and Samuelsson, 1968; Vonkeman and Van Dorp,
1968) that fatty acids esterified in lipids were not substrates for oxidative cyclisation
to PGs. Thus, a prior hydrolysis of esterified fatty acids to their non-esterified form
must occur for PG synthesis to proceed. Eliasson (1959), Pace-Asciak and Wolfe
(1968) and Vogt, Meyer, Kunze, Lufft and Babilli (1969) all demonstrated that PGs
are quickly released when tissues are removed and allowed to stand prior to
extraction, indicating that PG release and action are closely associated with PG
biosynthesis in physiological conditions. It was later found that arachidonic acid itself
was rapidly released from guinea-pig spleen and rat cerebral cortex after killing of the
animal and manipulation of the tissue (Flower and Blackwell, 1976, Marion, Pappius
and Wolfe, 1979). From the evidence, it is clear that the availability of the appropriate
free fatty acid precursor to PGH synthase is of major importance in the control of PG
synthesis. Previous studies on the cyclooxygenase oxygenation process in PG
synthesis revealed an unusual kinetic pattern (Smith and Lands, 1972). Arachidonic
acid administration to the enzyme accelerated the enzyme's activity to maximum
velocity after which it gradually decreased to zero velocity. Addition of fresh enzyme
resulted in further synthesis of PGs, suggesting that the enzyme was "self-limiting" or
"suicidal" in behaviour. Addition of glutathione peroxidase was also shown to inhibit
the cyclooxygenase activity. A prosthetic group (haem) was shown to be present
within the enzyme and destroyed at a much slower rate than the enzyme (Hemler and
Lands, 1980), so that the inactivation of the enzyme seemed to be due to a direct
action on the enzyme and not on the haem group. Together, the evidence implies that
PGG2 (a hydroperoxy acid) acts as a co-factor in its own biosynthesis.
PGH synthase (PGHS-1) was originally purified from bovine (Miyamoto,
Ogino, Yamamoto and Hayaishi, 1976) and ovine (Hemler, Lands and Smith, 1976;
Van der Ouderaa, Buytenhek, Nugieren and Van Dorp, 1977) seminal vesicles
(Samuelsson el a/., 1978). Cloning of human (Yokoyama and Tanabe, 1989), ovine
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(DeWitt and Smith, 1989; Merlie, Fagan, Mudd and Needleman, 1987) and murine
(DeWitt, El-Harith, Kraemer, Andrews, Yao and Armstrong, 1990) complementary
DNA (cDNA) for PGHS-1 revealed that this protein is encoded by a 2.8-kb
messenger RNA (mRNA) transcript. Recently, a novel isoform of PGHS, (PGHS-2)
encoded by a distinct mRNA has been identified. An increase in PGHS activity in
epithelial cells isolated from trachael mucosa was shown to be associated with an
increase in a previously undescribed 4.0-kb mRNA that hybridized to PGHS cDNA
(Rosen, Birkenmeier, Raz and Holtzman, 1989) and chicken embryo fibroblasts,
induced by Rous sarcoma virus, expressed a 4.1 kb mRNA encoding a 603-amino
acid PGHS-like protein (Xie, Chipman, Robertson, Erikson and Simmons, 1991). A
rapid induction of a 4.4-kb mRNA encoding a novel PGHS isoform has also been
demonstrated in rat preovulatory follicles before ovulation (Sirois and Richards, 1992;
Sirois, Simmons and Richards, 1992). The two isozymes of PGHS are denoted as
PGHS-1 (Mr 69 kDa) and PGHS-2 (Mr 72 kDa), the former being a constitutive
enzyme and the latter being an inducible form (Wong and Richards, 1991; Sirois and
Richards, 1992).
The synthesis of PGHS-2 has been shown to be stimulated by a variety of
factors including cell activation and serum (Xie et a/., 1991), phorbol esters (Xie et
al., 1991; Kujubu, Fletcher, Varnum, Lim and Herschman, 1991), chorionic
gonadotrophin (CG) (Sirois and Richards, 1992; Sirois, Simmons and Richards,
1992), lipopolysaccharide (O'Sullivan, Huggins, Meade, DeWitt and McCall, 1992)
and interleukin-ip (IL-1P) (O'Banion, Winn and Young, 1992). The expression of
PGHS-2 has also been shown to be selectively inhibited by dexamethasone (Kujubu
and Herschman, 1992). It is possible that the inducible nature of PGHS-2 is consistent
with its involvement in physiological processes. For example, the increase in PGHS
that occurs in ovine fetal cotyledonary tissue at term, has been shown to be
predominantly PGHS-2 (Wimsatt, Nathanielsz and Sirois, 1993).
Immunohistochemical studies have also demonstrated that PGHS-2 is localized to
implantation sites in newly differentiating murine uterine stromal cells at the time of
blastocyst attachment, indicating a potential physiological role for PGHS-2 in the
early stages of mouse implantation. This study also demonstrated that increased PG
secretion by uterine stromal cells in response to interleukin-la occurs as a result of
the selective expression of PGHS-2 (Jacobs, Hwang, Julian and Carson, 1994).
These studies raise the question as to whether the increase in PGF2a
production by the guinea-pig uterus at the end of the oestrous cycle occurs as a result
of a specific increase in PGHS-2. However, in a recent study (Naderali and Poyser, in
press), Western blotting analyses demonstrated that PGHS-2 was present in the
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soluble extracts of guinea-pig endometrium obtained on both days 6 and 17 of the
oestrous cycle. Therefore, increased PGF2a output at the end of the cycle does not
appear to depend upon the "inducible" form of PGHS (ie PGHS-2) being synthesized
specifically towards the end of the cycle in the guinea-pig.
1:17 The physiological role of arachidonic acid
Arachidonic acid is an essential fatty acid i.e. it is necessary for growth and
reproduction in biological systems (Burr and Burr, 1930). It is usually present in the
meat and fish components of the diet, although it can also be derived from linoleic
acid via chain elongation and desaturation steps (Gurr and James, 1971). PG
production can be regulated by altering the distribution of arachidonic acid within the
cell so that it is unavailable for release from phospholipids (Laposanta, Kaiser and
Capriotti, 1988). Therefore, changes in the availability of arachidonic acid induced by
diet can lead to alterations in PG synthesis. A study by Olsen, Hansen and Sorensen
(1986) demonstrated that a diet rich in marine fats, which have a high content of n-3
polyunsaturated fatty acids, leads to a decrease in the synthesis of PGs of the 2-series.
Women from the Faroe Islands, who have such a diet, had a longer period of
gestation compared with an equivalent group of women from Denmark. Suppression
of endometrial PGE2 and PGF2a synthesis following such supplementation can be
explained as direct competition between these fatty acids and arachidonic acid for
incorporation into membrane phospholipids. The amount of arachidonic acid available
for 2-series PG synthesis will therefore be reduced. However, perinatal mortality has
been shown to be higher in the Faroes than in Denmark; during 1972 - 1982, the late
fetal death rates were 11.5 and 6.2 / 1000 live births and early neonatal death rates
were 7.6 and 6.2 / 1000 live births, respectively (see Olsen, Hansen and Sorensen,
1986). Causes of the higher perinatal mortality in the Faroes are not clear, but may be
caused by factors that are independent of birthweight and gestational age. One
possibility proposed is that the increased perinatal mortality is due to side-effects of
the n-3 polyunsaturated fatty acids, similar to those following obstetric use of PG
synthetase inhibitors; closure of ductus arteriosus in utero, followed by neonatal
pulmonary hypertension (Kierse 1981). A later study demonstrated that fish oil
supplementation in the third trimester prolonged pregnancy without detrimental
effects (Olsen, Hansen and Jensen, 1990).
Guinea-pig uterine cells have been shown to contain only approximately 1 |_tg
free arachidonic acid/g uterine tissue, but as much as lmg arachidonic acid/g uterine
tissue esterified in lipids (Leaver and Poyser, 1981). Therefore, arachidonic acid
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esterified in lipids can be considered as "stored arachidonic acid". Arachidonic acid
can be stored in both the neutral lipids and phospholipids.
1:18 Source of arachidonic acid for prostaglandin synthesis
The neutral lipids are comprised of long chain fatty acids esterified to either
glycerol or cholesterol, forming glycerides and cholesterol esters respectively. The
triglycerides and cholesterol esters, when acted on by lipase and esterase enzymes
respectively, are a potential source for supplying free arachidonic acid for the purpose
of PG synthesis. In some tissues, such as the adrenal cortex or adipose tissue, where
the mass of neutral lipids is equal to or greater than that of phospholipids it is possible
that a large proportion of free arachidonate originates from the neutral lipids (Christ
and Nugteren, 1970; Vahouny, Chamberbhan, Hodges and Treadwell, 1978).
However, much evidence supports the theory that phospholipids represent the primary
source of arachidonic acid for the purpose of PG synthesis. For example, Flower and
Blackwell (1976) demonstrated the uptake of labelled arachidonic acid into cellular
lipids on incubation with guinea-pig platelets and spleen slices. Mechanical agitation
or immunological challenge of the platelets or spleen resulted in a loss of radioactivity
from the phospholipid pool only, followed by an increase in the concentrations of free
labelled arachidonic acid and labelled PG formation. Other studies have supported this
hypothesis (Kunze and Vogt, 1971; Samuelsson, 1972; Hong and Levine, 1976; Vogt,
1978; Blackwell and Flower, 1979; Lands, 1979).
1:19 The phospholipids
Using the steriospecific numbering (sti) system with the structure of glycerol
represented in the Fischer projection with the C-2 hydroxyl group projecting to the
left, the carbon atoms are numbered 1, 2 and 3. The phospholipids are all derived
from glycerol and therefore, all have a 3 carbon backbone. The phospholipids include,
amongst others, phosphatidylcholine (PC), phosphatidylethanolamine (PE),
phosphatidylserine (PS), phosphatidylinositol (PI) and sphingomyelin (Sph)
Glycerophospholipids contain a .w-glycerol 3-phosphate moiety along with two fatty
acids esterified at carbons 1 and 2 (since the two primary alcohol groups of glycerol
are not steriochemically identical, and in the case of phospholipids, it is usually the
same hydroxyl group that is esterified to the phosphate residue). The phosphate group
is joined by an ester linkage to inositol or a nitrogenous base (a phosphodiester
bridge), such as choline, serine or ethanolamine from which the name of the
phospholipid is derived. Figure 3 illustrates the structures of several common
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phospholipids. At physiological pH, PC and PE have no net charge and exist as
dipolar zwitterions, whereas PS has a net charge of -1, causing it to be an acidic
phospholipid. PE is related to PC in that trimethylation of PE produces PC. Most
phospholipids contain more than one kind of fatty acid per molecule, so that a given
class of phospholipids from any tissue actually represents a family of molecular types.
Unsaturated fatty acids such as arachidonic acid are preferentially esterified at carbon
2 (Lands and Merk, 1963). PC and PE are synthesized by activation of the
nitrogenous base, whereas PI and PS synthesis involves activation of diglyceride.
With relevance to uterine PG production PC, PE and PI will be considered in more
detail.
1:19:1 Synthesis of phosphatidylcholine (PC)
The major pathway for the biosynthesis of PC (lechithin) involves the
sequential conversion of choline to phosphocholine, cytidine diphosphatecholine
(CDP-choline) and PC. In this pathway, the phosphocholine polar head is activated
using cytidine-5'-triphosphate (CTP). Free choline (a dietary requirement for most
mammals) is initially phosphorylated by adenosine triphosphate (ATP), a reaction
catalysed by the enzyme choline kinase, resulting in the formation of phosphocholine
and adenosine diphosphate (ADP) (Wittenberg and Kornberg, 1953). The
phosphocholine is then "activated" by reacting with CTP and CDP-choline and
pyrophosphate (PPi), the reaction being catalysed by phosphocholine
cytidyltransferase which is completely specific for cytidine nucleotides (Kennedy and
Weiss, 1956). The phosphocholine moiety of CDP-choline is then transferred to the
vacant primary hyroxyl group of a diglyceride (a neutral lipid), by the action of
phosphocholine glyceride transferase (Weiss, Smith and Kennedy, 1958) and PC is
formed and cytidine monophosphate (CMP) is released as a by-product.
PC can also be synthesized by repeated methylation of PE, by the action of
phosphatidylethanolamine N-methyltransferase. The stepwise methylation of PE, with
3 moles of S-adenosylmethionine as the methyl donor, results in PC (Bremer and
Greenberg, 1961). This reaction occurs in the liver in the human.
1:19:2 Synthesis of phosphatidylethanolamine (PE)
The synthesis ofPE is essentially analogous to that of PC. CDP-ethanolamine
and PPi are formed by the action of ethanolamine kinase and phosphoethanolamine
cytidyltransferase, which is followed by the transferral of the phosphoethanolamine
moiety of CDP-ethanolamine to a diglyceride resulting in the formation of PE
(Kennedy and Weiss, 1956). PE can also be generated by the decarboxylation of
phosphatidylserine; however, this is thought to represent only a minor pathway in PE
synthesis.
1:19:3 Synthesis of phosphatidylinositol (PI)
Unlike PC and PE, PI synthesis involves the activation of the diglyceride, not
the nitrogenous base. The initial step, catalysed by CTP-phosphatidate
cytidyltransferase, involves the reaction of phosphatidic acid with CTP to form CDP-
diglyceride, and PPi as a by-product. The enzyme CMP-phosphatidate:inositol
phosphatidate transferase then catalyses the addition of a free inositol to the CDP-
diglyceride resulting in the formation ofPI (Possmayer and Strickland, 1967).
1:20 The phospholipases
A group of enzymes known as the phospholipases are responsible for the
release of fatty acids, such as arachidonic acid, from stored phospholipids. There are a
number of different phospholipase (PL) enzymes including PLAj, PLA2 and PLC,
each acting at a specific ester bond present in phospholipids. PLAj and PLA2 cleave
the acyl ester bond at the i??-l and sn-2 position respectively, whilst PLC acts at the
phosphodiester bond (Dennis, 1983). Cellular phospholipases are found in almost
every type of cell and have a wide variety of functions (Waite, 1985).
1:20:1 Phospholipase Aj
Hydrolysis of fatty acids at the .S77-1 position by PLAj releases 2-acyl
lysophosphatides which are rapidly metabolised by lysophospholipases or reacylated
to phosphatides (Lands and Merck, 1963). Since arachidonic acid is usually esterifed
at the sn-2 position the activity of PLAj is of no relevance in the release of free
arachidonic acid for PG synthesis.
1:20:2 Phospholipase A2
PLA2 was the first phospholipase to be discovered following the observation
that both pancreatic juice and cobra venom were able to hydrolyse PC (Witcoff,
1951). Using mixed preparations of PC and PE, in which sn-\ and sn-2 position fatty
acids had been specified, de Haas, Daemen and Van Deenen (1962) demonstrated that
PLA2 activity at the sn-2 position resulted in the formation of a 1-acyl
lysophosphatide. It was later determined that three points of attachment were
necessary for hydrolysis of a fatty acid ester bond, namely at the sn-2 fatty acid ester
linkage, oxygen alkyl group at sn-\ and at the hydroxyl function of the phosphoryl
moiety (where Ca^+ ions may act as a linkage between the phospholipase enzyme and
the substrate).
Most arachidonate in mammalian cells is esterified almost exclusively in the 2-
acyl position in the fatty acyl chains of glycerophospholipids and it was therefore
suggested that the enzyme that was most likely to release arachidonic acid from
phospholipids was phospholipase (PL) A2. The treatment of guinea-pig spleen slices
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with mepacrine (an antimalarial drug which blocks PLA2 activity) inhibited the release
of arachidonic acid (Flower and Blackwell, 1976) indicating that PLA2 was involved
in the release of arachidonic acid from phospholipids. Intracellular PLA2 activities
have been found in almost all cells examined (Van den Bosch, 1980). PLA2 perfused
into guinea-pig lung (Babilli and Vogt, 1965; Vogt et al., 1969) and frog intestine
(Bartels, Vogt and Wille, 1968; Bartels, Kunze, Vogt and Wille, 1970) resulted in the
appearance of increased amounts of PGs in the collected perfusates. Sykes, Williams
and Rogers (1975) demonstrated that PLA2 stimulated the synthesis of prostaglandins
in homogenates of human pregnant myometrium. The administration of exogenous
arachidonic acid to frog intestine (Kunze, 1970) and pregnant human myometrium
(Sykes et al., 1975) also resulted in a stimulation of PG synthesis suggesting that
PLA2 was releasing arachidonic acid from some source for PG synthesis. PLA2 in
plasma membranes and microsomes is totally Ca^4" dependent (Newkirk and Waite,
1973) whereas other lipolytic enzymes do not require Ca^+ and are therefore not
inhibited by EDTA (ethylene diamine tetra-acetic acid) (McMurray and Magee,
1972). PG synthesis in homogenates of bovine seminal vesicles is markedly increased
by Ca^+ and inhibited by EDTA (Kunze, Bohn and Vogt, 1974) providing further
evidence for a role ofPLA2 in PG synthesis.
More recent studies have demonstrated that the release of arachidonic acid
from membrane phospholipids occurs via receptor activation ofPLA2 by a G-protein
In various tissues, including neutrophils, fibroblasts and sensory neurones, PLA2 is
activated by a G-protein which is inhibited by pertussis toxin (ADP-ribosylates G-
proteins) (Burch, Luini and Axelrod, 1986; Burgoyne, Cheek and O'Sullivan, 1987;
Axelrod, Burch and Jelsema, 1988; Wang, Kester and Dumm, 1988; Nakashima,
Nagata, Ueeda and Nozawa, 1988). Fluoride (an activator of G-proteins) stimulates
PGI2 synthesis by the rat aorta (Jeremy and Dandona, 1988). Many receptors that are
known to activate PLA2 are also coupled to PLC. Since the products of PLC
activation may in theory stimulate PLA2, various studies were performed to clarity
whether sequential activation, as opposed to parallel activation of the two lipases, was
occurring. Pertussis toxin was shown to selectively inhibit PLA2 activation without
impairing PLC activation and neomycin (a PLC inhibitor) selectively inhibited PLC
without inhibiting PLA2 (Burch et al., 1986) supporting parallel activation of the two
lipases.
Cockcroft, Nielson and Stutchfield (1991) proposed that PLA2 activation is
under dual regulation in human neutrophils; a G-protein-dependent pathway and a
Ca2' / PKC-regulated pathway. Lipocortins are Ca2+ / lipid-binding proteins that block
the access of PLA2 to the phospholipid substrate. Touqui, Rothut, Shaw, Fradin,
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Vargaftig and Russo-Marie (1986) proposed a model of PLA2 activation in human
platelets whereby phosphorylation of lipocortin removes the inhibitory constraint from
the PLA2, thus allowing activation. Lipocortins have also been shown to be substrates
for PKC in human neutrophils (Stoehr, Smolen and Suchard, 1990). Glucocorticoid
hormones stimulate the production of lipocortin in many tissues, therefore inhibiting
PLA2 activity and resulting in decreased PG synthesis and release (Flower, 1986). In
the guinea-pig, endometrial PLA2 activity does not appear to be restrained by a PKC-
inactivated lipocortin, since glucocorticoids had no effect on PG synthesis from the
guinea-pig endometrium in culture (Riley and Poyser, 1987b)
In the guinea-pig endometrium, PGF2a synthesis is not regulated by a toxin-
sensitive G-protein, but may be regulated by a fluoride-sensitive G-protein (Leckie
and Poyser, 1990a). This fluoride-mediated stimulation of prostaglandin output from
the guinea-pig uterus may be due to the activation of a G-protein resulting in the
mobilization of intracellular calcium (by a mechanism which does not involve the
activation of PLC or calmodulin) which in turn, activates PLA2 (Leckie and Poyser,
1990b).
PLA2 enzymes are found both extracellularly and intracellularly. The different
kinds of mammalian PLA2 (from Mukherjee, Miele and Pattabiraman, 1994) enzymes
are listed below:-
Type I - Low molecular weight (14 kDa) PLA2s
Group I - (secretory and cytosolic): pancreas, lung, spleen, gastric mucosa, sperm, serum.
Group II - (secretory and membrane-associated): synovial fluid, placenta, platelets,
neutrophils, mesangium, astrocytes, hepatocytes, seminal fluid, peritoneal fluid, serum.
Type II - Ca2+-independent PLA2s
40 kDa (microsomal): plasmalogen-selective; myocardium.
58 kDa (cytosolic): dimeric. PE-selective; platelets.
Type III - cPLA2
85 kDa (cytosolic) regulated by Ca2+, G-proteins and phosphorylation: neutrophils,
platelets, macrophage-like cells, liver, brain.
Type IV- Lysosomal PLA2s
Acidic pH optima; ubiquitous
The most-thoroughly characterized PLA2s have been small molecular weight (14 kDa)
enzymes, present in many tissues and extracellular fluids, referred to as "Type I" or
"secretory" PLA2s. These have a high disulphide bond content, require millimolar
concentrations of Ca2+ for catalysis and exhibit little or no fatty acyl specificity. Two
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groups of Type I PLA2s have been isolated (see Mukherjee et a/., 1994). Group I are
secreted as zymogens by the pancreas, but have also been isolated from other organs
including the lung, spleen and gastric mucosa. In the latter two organs, the enzyme is
intracellular. A non-pancreatic, Group I PLA2 is also present in human spermatozoa,
distinct from the seminal fluid Group II enzyme (Cordella-Miele, Miele and
Mukherjee, 1993). Group II PLA2 has been isolated from human synovial fluid, and is
also present in the plasma where it is significantly elevated in numerous pathologic
disorders (see Rosenthal, Rzigalinski, Blackmore and Franson, 1995). It has also been
shown to be present in several tissues as secretory and cell surface associated enzymes
(eg. placenta, platelets, neutrophils and peritoneum). In platelets and mast cells,
Group II PLA2 appears to be associated with intracellular granules and secreted
during cellular degranulation (Kudo, Murakami, Hara and Inoue, 1993). In humans, it
appears that there is a single gene for Group II PLA2 (Mayer and Marshall, 1993). An
ischemia-induced myocardial 40 kDa, Ca2 -independent, microsomal PLA2, that
preferentially hydrolyzes sn-2 arachidonyl plasmalogen substrates has also been
descibed (Hazen, Stuppy and Gross, 1990; Hazen, Ford and Gross, 1991). The
isolation of a dimeric 58 kDa Ca2 -independent PLA2 from sheep platelets and cloning
of its cDNA have also been reported (Zupan, Steffens, Berry, Landt and Gross,
1992). This enzyme (also referred to as "14-3-3 protein") is found in the cytosol and
selectively hydrolyzes 2-arachidonyl PE (Zupan et al., 1992).
In addition to the well known Type I or secretory PLA2s (sPLA2) with a low
molecular weight (14 kDa), a new form of PLA2 ("cytosolic" or "cPLA2 ) has been
demonstrated (also referred to as "Type III PLA2"). This PLA2 has a high molecular
weight (85 kDa), can translocate from cytosol to cell membrane in the persence of
micromolar concentrations of Ca2+, and is linked to membrane receptors (Clark, Lin,
Kriz, Ramesha, Sultzman, Lin, Milona and Knopf, 1991). cPLA2 lacks disulphide
bonds and shows no significant sequence similarity with any other PLA2. The enzyme
exhibits a marked specificity for sn-2 arachidonyl phospholipids (Mayer and Marshall,
1993). Other PLA2 activities have been demonstrated in lysosomes having low pH
optima and which are Ca2+-independent (see Mukherjee et a/., 1994).
Both cytosolic 85 kDa PLA2 (cPLA2) and secretory non-pancreatic Group II
14 kDa PLA2 (sPLA2) may contribute to arachidonate mobilization and therefore PG
synthesis. One difficulty in distinguishing the relative contributions of different PLA2s
in cellular systems is the lack of selective, membrane permeant PLA2 inhibitors. For
example, PLA2 inhibitors such as PGBx, PX-52 and aristolochic acid have been
shown to have similar IC5oS in vitro for both 85 and 14 kDa PLA2s (Franson and
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Rosenthal, 1994). Further studies are required to fully elucidate the mechanisms
which regulate activation of cellular phospholipases and subsequent synthesis.
1:20:3 Phospholipase C
The action of PLC on PI also provides a mechanism by which arachidonic acid
is released, and this mechanism has been mainly studied in thrombin- or collagen-
stimulated platelets. PLC releases 1,2-diacylglycerol (DAG) (Rittenhouse-Simmons,
1979) from which arachidonic acid may be cleaved directly by the action of DAG and
monoacylglycerol lipases (Flint et al., 1986a). It is doubtful that PLC activity is
related to uterine PG release in the guinea-pig since PI contains less than 10 % of the
total arachidonic acid present in the guinea-pig uterus (Leaver and Poyser, 1981) and
no change in PI turnover was reported during the oestrous cycle (Ning and Poyser,
1984). Phorbol 12-myristate 13-acetate (PMA, a PKC activator) had no effect on PG
output from cultured guinea-pig endometrial tissue (Riley and Poyser, 1987a) or from
superfused uterus in vitro (Poyser, 1987a) on either day 7 or 15 of the oestrous cycle.
Both PLC and PLA2 stimulated PG outputs from day 7 and 15 superfused guinea-pig
uterus in vitro. However, PLA2 released a pattern of PGs similar to those released by
calcium (mainly PGF2a at the time of luteolysis), whereas PLC released a
significantly greater amount of PGE2 (Poyser, 1987a). It was therefore concluded
that stimulation of endogenous PLA2 by calcium rather than stimulation of
endogenous PLC was involved in the release of uterine arachidonic acid for the
purpose of PGF2a synthesis in the guinea-pig at the time of luteolysis (Poyser,
1987a).
Agonists that mimic the effects ofDAG and IP3 (second messengers generated
by PLC) have been shown to stimulate the release of PGF2a by ovine and bovine
endometrial tissue in vitro (Silvia and Homanics, 1988; Lafrance and Goff, 1990;
Silvia et al., 1994). However, further studies demonstrated that considerable PGF2a
release occurred with little or no detectable increase in PLC (Raw and Silvia, 1991;
Mirando et al., 1993; Silvia and Raw, 1993a). It appears that PGF2a release from
ovine endometrial tissue is mediated through the activation of PLA2 rather than
through activation of PLC (Lee and Silvia, 1994).
1:21 Activity of PLA2 in the uterus
Both exogenous PLA2 and melittin (a stimulator of PLA2) stimulated uterine
PGF2a release (Poyser, 1987a; Johnson and Poyser, 1991) whereas p-bromophenacyl
bromide (an inhibitor of PLA2) suppressed the basal synthesis of PGF2a by
homogenates of guinea-pig uterine tissue (Mitchell, Poyser and Wilson, 1977). An
increase in guinea-pig uterine PLA2 activity has also been shown to occur towards the
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end of the cycle when PG secretion is maximal (Downing and Poyser, 1983). PLA2
activity was investigated in guinea-pig endometrium on days 7 and 15 of the oestrous
cycle (days of low and high PG production, respectively) and was found to be present
in both microsomal and supernatant fractions with 90 % activity present in the
microsomal fraction (presumably membrane-bound). The PLA2 activity in both
fractions was optimal at pH 8.0 requiring 7 mM and 2 mM Ca^+ in the microsomal
and supernatant fractions respectively. The microsomal PLA2 activity appeared to
require an increase in free intracellular Ca^+ concentration for stimulation of maximal
enzymal activity (Downing and Poyser, 1983). Several studies have shown that the
guinea-pig endometrium has a potential for arachidonic acid release that far exceeds
the observed PG production (Downing and Poyser, 1983; Poyser and Brydon, 1983;
Poyser and MauleWalker, 1979). It was therefore proposed that the activation of
PLA2 could be partly responsible for regulating uterine PG production during the
oestrous cycle. Activation of PLA2 also appears to play an important role in
regulating the uterine secretion of PGs in the sheep (Lee and Silvia, 1994) and in the
human (Bonney, Beesley and Franks, 1991). A PLA2-stimulating protein (PLAP),
which is antigenically and functionally related to the PLA2-stimulating peptide
melittin, has been isolated from various cultured cell lines, and is an "intracellular
messenger" in the stimulation of PG synthesis (Clark, Conway, Shorr and Crooke,
1987; Clark, Chen, Crooke and Bomalaski, 1988). Further work has identified PLAP
as a new member of the (3-transducin (G(0 superfamily, strengthening the evidence
that G-proteins play a key role in the activation of PLA2 (Peitsch, Borner and
Tschopp, 1993). However, it is unclear whether PLAP is produced by the guinea-pig
endometrium (Leckie and Poyser, 1993).
The concentration of lipocortin has been shown to increase during pregnancy
in the rat (Kaetzel, Hazarika and Dedman, 1989). In the sheep, PLA2 activity was
shown to decrease by 58 % in day 16 pregnant endometrium compared to day 16
nonpregnant endometrium. This inhibition appeared to be due to a PLA2 inhibitor
present in the pregnant uterus which possibly acted as a lipocortin (Tamby,
Charpigny, Reinaud and Martal, 1993). It has been proposed that a PLA2 inhibitor
(possibly a lipocortin) is secreted from the early pregnant ovine endometrium which
may contribute to the changes in PG synthesis during early pregnancy (Tamby et a/.,
1993).
1:22 Role of calcium in prostaglandin synthesis
Administration of A23187 results in the stimulation of PG production in
several different tissues (Knapp, Oelz, Roberts, Sweetman, Oats and Reep, 1977)
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whereas treatment with EDTA prevents this stimulatory effect (Kunze et a/., 1974).
Addition of exogenous arachidonic acid to cultured guinea-pig endometrium lead to a
rise in PG production comparable to that seen following treatment with A23187
(Leaver and Seawright, 1982). The stimulatory action of A23187 was abolished when
a Ca2+-free medium was used confirming that A23187 was acting as a calcium
ionophore and not by some other unspecified mechanism (Poyser, 1984b). This lead
to the suggestion that a rise in the intracellular free Ca^+ concentration may regulate
the availability of PG precursor. This mechanism of action was further confirmed by
the observation that treatment with the intracellular calcium antagonist TMB-8,
inhibited the A23187-induced increase in PGF2a (and 6-keto-PGFja) from day 15
superfused guinea-pig uterus (Poyser, 1985b). Maximal stimulatory calcium
concentrations are in the mM range, whereas intracellular calcium concentrations exist
in the pM range. Flowever, a small increase in calcium concentration in the pM range
may be sufficient to stimulate PLA2 to an adequate level resulting in increased PG
synthesis. Although calcium may activate PLA2 directly, it may also be acting via a
mediator.
1:23 Role of calmodulin in prostaglandin synthesis
Calmodulin is a calcium binding protein (17 kDa) possessing a single
polypeptide chain with 2 high and 2 low affinity calcium ion binding sites. Binding of
Ca-+ to the lower affinity binding sites causes a conformational change in the protein
revealing a hydrophobic area that can then interact with a protein that it controls.
Each Ca^+ binding site consists of a helix-loop-helix structure, Ca-+ being bound in
the loop connecting the helices. Calmodulin was demonstrated to play an important
role in the activation and regulation of many Ca^+ dependent processes in eukaryote
cells including several enzyme activities (Cheung, 1980). PLA2 was shown to be both
Ca21 and calmodulin dependent (Wong and Cheung, 1979; Moskowitz, Andres, Silva,
Shapiro, Schook and Puszkin, 1985). The calmodulin inhibitor, trifluoperazine (TFP)
which acts by binding to the hydrophobic domain on the surface of the calmodulin and
therefore blocks interaction of calmodulin with its surface receptor protein
(Andersson, Drakenberg, Thulin and Forsen, 1983), abolished the release of
arachidonic acid and synthesis of PGs induced by A23187, vasopressin, NaCl and
mannitol in rat renal medulla (Craven and DuRubertis, 1983). TFP was also shown to
inhibit PLA2 and therefore arachidonic acid release from platelets (Walenga, Opas
and Feinstein, 1981) and PG production from dispersed human amnion cells (Olson,
Challis, Opavsky, Smeija, Kramar and Skinner, 1985). A role for calmodulin in the
control of PGF2a synthesis and therefore PLA2 activity was also demonstrated in the
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guinea-pig uterus when A23187-stimulated PGF2a output was prevented by TFP and
W-7 (another calmodulin antagonist) in superfused guinea-pig uterus in vitro (Poyser,
1985a,b). Oestradiol treatment increased the concentration of calmodulin in rat
(Flandroy, Cheung and Steiner, 1983) and rabbit (Matsui, Higashi, Fukunaga,
Miyazaki, Maeyama and Miyamoto, 1983) uterine tissue. Therefore, calmodulin may
also contribute to the regulation ofPGF2a secretion in these species.
1:24 Arachidonic acid turnover and prostaglandin release
1:24:1 Introduction
It is now well established that in most tissues, such as the guinea-pig uterus,
the synthesis of PGs is limited by the availability of their precursor, arachidonic acid,
which must be liberated from esterified stores. Since the majority of arachidonate is
esterified in the fatty acyl chains of gylcerophospholipids, almost exclusively in the 2-
acyl position, it was previously suggested that the phospholipases are responsible for
the control of free arachidonic acid levels (van Dorp et a/., 1964; Bergstrom et a/.,
1964; Lands and Samuelsson, 1968; Vonkeman and van Dorp, 1968; Vogt, 1978;
Kroener, Peskar, Fischer and Ferber, 1981). However, free fatty acid level in a tissue
actually represents a balance between the liberation of the acid by hydrolysis and its
re-esterification into complex lipids by acyl transferase reactions (Trotter and Ferber,
1981).
Studies on the guinea-pig uterus have demonstrated that 93 % of the total
arachidonic acid is esterified to phospholipids, 80 % of which is bound to PC and PE.
A significant decrease in arachidonic acid bound to PC and an apparent decrease from
PE between days 7 and 15 of the oestrous cycle were observed in the guinea-pig
uterus (Leaver and Poyser, 1981). During 24 h tissue culture of guinea-pig
endometrial tissue, significantly greater quantities of labelled arachidonic (but not
oleic acid) were incorporated into phospholipids (particularly PC and PE) on day 15
compared to day 7 of the oestrous cycle (Ning, Leaver and Poyser, 1983). In 1984,
Ning and Poyser demonstrated that PC was the major phospholipid present in the
guinea-pig uterus with lesser amounts of PE, PI and PS. However, no significant
changes in the actual amounts of endometrial phospholipids were observed during the
oestrous cycle. Therefore, the observed increased incorporation of arachidonic acid
into endometrial tissue of mid- and late-cycle guinea-pigs cannot be due to a change
in phospholipid content. This is further clarified by measurement of the de novo
synthesis of the phospholipids, which remains unchanged between the two days in
question (Ning and Poyser, 1984). Incorporation of arachidonic acid into
phospholipids appears to be achieved by its acylation to a glycerolysophospholipid,
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such as lysophosphatidylcholine, rather than during de novo synthesis of
phospholipids (van den Bosch, 1974). This mechanism of arachidonic acid
incorporation into phospholipids has been previously suggested by Hill and Lands
(1968) and Yamashita, Hosaka and Numa (1973).
The two phospholipases (PL), PLA] and PLA2, exist in many tissues, and
play an important role in the formation of specific phospholipid structures containing
the appropriate fatty acids in the sn-1 and sn-2 positions. Many fatty acyl-CoA
transferases and phospholipid synthesizing enzymes lack the specificity required to
account for the asymmetric position or distribution of fatty acids found in many tissue
phospholipids. The fatty acids found in the sn-1 and sn-2 positions of the various
phospholipids are often not the same ones originally transferred to the glycerol
backbone in the initial acyl-transferase reactions of the phospholipid biosynthetic
pathways, indicating that a certain amount of fatty acid exchange between
phospholipids occurs after phospholipid synthesis. PLAj and PLA2 catalyse the
reactions shown in Figure 4. The products formed are called lysophosphatides. If it
becomes necessary for a cell to remove some undesired fatty acid, such as stearic acid
from the sn-2 position of PC, and replace it by a more unsaturated one such as
arachidonic acid, then this can be accomplished by the action of PLA2 followed by a
reacylation step.
In the guinea-pig uterus a refractoriness is observed following repeated
stimulation with PLA2, but not with arachidonic acid which always induces maximum
PG synthesis (Poyser, 1991). It may be that, in the guinea-pig, the refractoriness of
uterine PGF2a synthesis is a consequence of the depletion of the arachidonic acid
pool which is esterified to phospholipids. This arachidonic acid pool would appear to
be readily releasable for prostaglandin synthesis, but requires 3-5 h to be refilled.
However, in this study extracellular Type I (Group I) PLA2 from Naja Naja venom
was used. The PLA2(s) responsible for arachidonic acid mobilization for PG synthesis
in the guinea-pig endometrium has not been defined, but it is known that an increase
in PGF2a synthesis requires intracellular Ca2~ (Poyser, 1985 a,b). Type III PLA2
(cPLA2) (85 kDa) is found in the cytosol, is regulated by Ca2 and G-proteins and
may therefore be the PLA2, or one of the PLA2s, responsible for PG synthesis in the
guinea-pig endometrium. The A23 187-stimulated increase in PGF2a output from the
superfused guinea-pig uterus in vitro is dependent on intracellular Ca2 (Poyser. 1985
b), presumably resulting in a stimulation of PLA2 and therefore PG synthesis.
However, there is no cross-refractoriness between PLA2 (from Naja Naja venom) and
A23187 as regards their stimulatory effects on PG production by the guinea-pig
uterus (Poyser and Ferguson, 1993), suggesting that the intracellular processes
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involved in the stimulation of uterine PG output by PLA2 from Naja Naja venom and
A23187 are different. It is possible that extracellular PLA2 from Naja Naja venom
used in these studies acts in a different way to that of guinea-pig endometrial PLA2 in
vivo stimulated by A23187; this would explain the lack of cross-refractoriness. The
catalytic mechanisms of other PLA2s have not yet been clarified in detail, but do
appear to be different from that of low molecular weight PLA2s (Type I, such as PLA2
from Naja Naja venom) (Mayer and Marshall, 1993).
The mechanisms that control arachidonic acid incorporation into
phospholipids may be as essential as those which control arachidonic acid release from
phospholipid stores in the regulation of endometrial PGF2a synthesis. Indeed, several
studies have demonstrated increased arachidonic acid incorporation into endometrial
phospholipids at the time of increased uterine PG production in the guinea-pig (Ning,
Leaver and Poyser, 1983) and human (Downing, Hutchon and Poyser, 1983; Ishihara,
Tsutsumi and Mizuno, 1986). The two enzymes involved in fatty acid incorporation
into phospholipids are acyl-CoA synthetase and acyl-CoA:lysophospholipid
acyltransferase. In this pathway (Lands and Crawford, 1976) acyl moieties of
glycerophospholipids are initially cleaved by PLA2 and then reacylated by acyl-
CoA:lysophospholipid acyltransferase, using acyl-CoA formed from free fatty acids by
the action of acyl-CoA synthetase. This reacylation system may be designated as the
CoA- and ATP-dependent reacylation system and is shown in Figure 4.
Arachidonic acid turnover between membrane phospholipids may therefore
provide an indirect method by which the concentration of free arachidonic acid
available for PG synthesis is controlled. Greater amounts of arachidonic acid could be
selectively esterified into particular phospholipids that are more likely to undergo
hydrolysis by PLA2 thereby resulting in greater quantities of arachidonic acid being
released and available for PG synthesis.
1:24:2 Acyl-CoA synthetase
Long chain acyl-CoA synthetase was first demonstrated by Kornberg and
Pricer (1953) and later purified (Tanaka, Hosaka, Hoshimaru and Numa, 1979) from
rat liver mitochondria and microsomes.
Most enzymes utilize more than one substrate, or they act upon one substrate
plus a coenzyme and generate one or more products. Mechanistically, multisubstrate
enzyme reactions are divided into two major categories, ping-pong or sequential. The
ping-pong mechanism can be diagrammatically outlined as follows:
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Figure 4. The de- and re-acylation of glycerophospholipids, where X represents
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E + A -> EA -> E' -» E'B —> P2 + E
in which substrate A reacts with the enzyme (E) to produce product one (Pi), which is
released before the second substrate B will bind to the modified enzyme (E').
Substrate B is then converted to product two (P2) and the enzyme regenerated.
In the sequential mechanism, if the two substrates A and B can bind in any
order, it is a random mechanism. However, if the binding of A is required before B
can be bound, then it is an ordered mechanism. In either case the reaction is
bimolecular i.e. both A and B must be bound before reaction occurs.
The enzymatic reaction of acyl-CoA synthetase was concluded by Berg (1956)
to occur via a ping-pong mechanism. As a first step, the enzyme, fatty acid and ATP
form a complex, leading to the generation of an acyl-AMP enzyme complex. This
complex reacts with CoA to liberate acyl-CoA and AMP.
Fatty acid + ATP —> acyl-AMP + PPi
Acyl-AMP + CoA —» acyl-CoA + AMP
Long chain fatty acyl-CoA synthetase has also been purified from Candida lipolytica
(Hosaka, Mishina, Tanaka, Kamiryo and Numa, 1979) and E.coli (Kameda, Suzuki
and Imai, 1985). cDNA encoding the long chain acyl-CoA synthetase of rat liver
microsomes has been isolated and sequenced (Suzuki, Kawarabayasi, Kondo, Abe,
Nishikawa, Kimura, Hashimoto and Yamamoto, 1990). Acyl-CoA synthetase was
predicted to contain 699 amino acid residues with a calculated molecular weight of
78,177. The messenger RNA of the long chain acyl-CoA synthetase is expressed in
liver, heart, epididymal adipose tissue and to a much lesser extent (about 10 %) in
brain, small intestine and lung. The level of the mRNA is increased 7- to 8-fold in rat
liver by feeding a diet high in carbohydrate or fat, in accordance with the physiological
role of the enzyme in fatty acid metabolism.
It has been proposed that acyl-CoA synthetase activity is responsible for fatty
acid uptake into cells i.e. transmembrane transport of fatty acids. It is widely believed
that free fatty acids enter the cytosolic compartment of cells passively by diffusion
through lipid bilayer membranes. Two mechanisms of fatty acid uptake into the cell
across the plasma membrane involving acyl-CoA synthetase have been suggested
(Neufeld, Wilson, Sprecher and Majerus, 1983).
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i. The acyl-CoA synthetase enzymes convert fatty acids that have diffused into the cell
across the plasma membrane to polar fatty acyl-CoA metabolites. These are unable to
diffuse through lipid bilayers and are rapidly esterified into more complex lipids.
ii. The acyl-CoA synthetase enzymes reduce the mass of cellular free fatty acid by
converting it to fatty acyl-CoA creating a gradient, which via mass action, brings
more free fatty acid from exogenous pools into the cell through the plasma membrane.
Neufeld et ol. (1983) have demonstrated two distinct fatty acid uptake systems
(defined as esterification of fatty acids into phospholipids) in human platelets, namely
a high affinity system specific for eicosanoid precursor fatty acids such as arachidonic
acid, and a low affinity system specific for non-eicosanoid precursor fatty acids.
Interestingly, while there is an increase in the uptake of arachidonic acid into
phospholipids by day 15 guinea-pig endometrium, there is not an increase in the
uptake of oleic acid (Ning et a/., 1983) suggesting that there may be an acyl-CoA
synthetase present in the endometrium specific for arachidonic acid. Such an
arachidonic acid specific acyl-CoA synthetase has been demonstrated in a wide variety
of tissues such as human platelets (Wilson, Prescott and Majerus, 1982), brain (Reddy
and Bazan, 1983), murine T lymphocytes (Taylor, Sprecher and Russell, 1985) and
rabbit coronary microvessel endothelial cells (Gerritsen and Perry, 1990). This
enzyme, known as arachidonyl-CoA synthetase (ACS), has been shown to be a
protein distinct from the previously described nonspecific long chain acyl-CoA
synthetase (Laposanta, Reich and Majerus, 1985), although other workers have
disputed this finding (Bakken, Farstad and Holmsen, 1991). Several lines of evidence
suggest that ACS plays an essential role in eicosanoid production. In one study, a
mutant cell line derived from HSDM]C] fibrosarcoma which contained no ACS, was
found to have a significantly decreased PG production (Neufeld, Bross and Majerus,
1984). Furthermore, ACS was shown to recognise arachidonate and only those
polyunsaturated acids that are converted by cyclooxygenase and lipoxygenase to
eicosanoids. The enzyme apparently "counts" double bonds from the carboxy
terminus (Neufeld, Sprecher, Evans and Majerus, 1984). If such enzymes are present
in the guinea-pig endometrium, a specific increase in the activity of ACS towards the
end of the oestrous cycle could explain the specific uptake of arachidonic acid, but not
oleic acid, into phospholipids which occurs at that time.
1:24:3 Acyl-CoA:lysophospholipid acyltransferase
The difference in the turnover rates of fatty acyl moieties and glycerol moieties
led to the discovery of the presence of enzymes known as acyl-CoA:lysophospholipid
acyltransferases in rat liver (Lands, 1958, 1960) which catalyse the reaction of acyl-
CoA with lysophospholipid liberating phospholipid. The enzyme system acylating the
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1-position of 2-acylglycerylphosphorylcholine has been shown to be more active with
saturated acyl-CoAs, whereas the one acylating the 2-position is more active with
unsaturated acyl-CoAs (Lands and Hart, 1965). These findings originally emphasised
the importance of these enzyme systems in the selective placement of different fatty
acids between the two positions of glycerophospholipids. The specificity of the fatty
acid transfer to lysophosphatides was shown to depend exclusively on the nature of
the transferred fatty acid and not on the composition of the lysophosphatides in the
microsomal membranes of stimulated rabbit lymphocytes (Ferber and Resch, 1973)
supporting the previous findings of Lands and Hart (1965), Stoffel, Schiefer and Wolf
(1966), Brandt and Lands (1967), Stoffel, de Thomas and Schiefer (1967), van den
Bosch, van Golde, Eibl and van Deenen (1967), van den Bosch, van Golde, Slotboom
and van Deenen (1968), and Sarzala, van Golde, Kruyff and van Deenen (1970). A
later study led to the proposition that different enzymes or different sites on a single
enzyme existed in rat liver microsomes for the transfers of different acyl-CoAs
(Okuyama, Yamada and Ikezawa, 1975), and that the preference of microsomal
acyltransferase for arachidonyl-CoA over other acyl-CoAs was greatly enhanced if the
concentration of the acyl acceptor was lowered (Holub, MacNaughton and Piekarski,
1979). It was demonstrated that a CoA-dependent transfer of fatty acyl chains
between phospholipids could provide a means of achieving turnover of phospholipid
acyl chains in homogenates ofmurine thymocytes. The maximal activity of the enzyme
acylCoA:lysophospholipid acyltransferase (ACLS) (extracted from rat liver
microsomes) with arachidonyl-CoA was found to occur at pH 8.0 (Trotter el al.,
1982) indicating that esterification by this pathway is increasingly favoured with more
unsaturated fatty acids such as arachidonic acid (Hasegawa-Sakai and Ohno, 1980).
Polyunsaturated fatty acids, such as arachidonic acid, are liberated in many
tissues by the action of PLA2. Cleavage of phospholipids by this enzyme not only
generates free fatty acids, but also lysophosphatides, which are very toxic due to their
detergent-like properties (Weltzien, 1979). In order to protect the cell from such toxic
action, lysophosphatides must be rapidly degraded or reacylated. The latter reaction
was first described by Hill and Lands (1968), and is mediated by the enzyme ACLS
(also known as lysophosphatide acyltransferase). In many cells ACLS activity far
exceeds that of PLA2, compatible with its role as a "safety" enzyme (Van den Bosch,
1974). It was therefore proposed that the cellular levels of free fatty acids may be
controlled by the activity of the reacylating enzymes, mainly ACLS, rather than by
PLA2 activity (Irvine, 1982). Indeed, this has been demonstrated in bone marrow-
derived macrophages (Kroener el a/., 1981), lung fibroblasts (Hunter, Burstein and
Sedor, 1984), rat peritoneal-derived macrophages and human platelets (Goppelt-
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Struebe, Kroener, Hausmann, Gema and Resch, 1986). Also, a unique cardiac
cytosolic acyltransferase from rabbit heart has been demonstrated to be selective for
fatty acids that are substrates for the cyclooxygenase or lipoxygenase pathway
(Needleman, Wyche, Sprecher, Elliott and Evers, 1985). Therefore, selective
incorporation of arachidonic acid into cardiac phospholipids can possibly be achieved
by the unique cytosolic acyltransferase, whereas platelets utilise an arachidonate-
specific ACS (Wilson et al., 1982).
Various reports have demonstrated that ACLS can also operate in reverse,
such as in mouse lymphocytes and macrophages (Trotter, Flesch, Schmidt and Ferber,
1982), human platelets (Kramer and Deykin, 1983) and guinea-pig alveolar
macrophages (Nijssen and van den Bosch, 1986). This pathway was first described by
Irvine and Dawson (1979) and involves the CoA-dependent and ATP-independent
breakdown of PC and transfer of arachidonic acid to another lysophospholipid,
commonly lysophosphatidylethanolamine, generating lysophosphatidylcholine and PE.
The intermediate product in this reaction sequence is arachidonyl-CoA, whereas
cleavage of the arachidonic acid from PC by PLA2 would generate free arachidonic
acid. The addition of excess cold arachidonic acid does not inhibit the transfer of
arachidonyl moieties from PC to PE, providing further evidence that the transfer does
not reflect reacylation of free arachidonic acid released by the action of PLA2 (Trotter
et a/., 1982). The presence of the acyltransferase operating in reverse can lead to a
direct ATP-independent formation of acyl-CoA ester. Since ACLS exhibits a high
preference for arachidonyl-CoA, the reverse reaction could provide a specific
cleavage of arachidonate from glycerophospholipids and may contribute to the
redistribution of arachidonate over lipid classes (Nijssen, Oosting, Nykamp and van
den Bosch, 1986). This would explain why, when labelling guinea-pig endometrium
with [^Hj-AA, more of the [^Hj-AA goes into PC rather than into PE, yet most of
the endogenous AA is found in PE (Leaver, Ning and Poyser, 1983).
1:24:4 Transacylase reactions
Arachidonic acid remodelling can also take place via two arachidonyl-specific
transacylases, one being CoA-dependent (Kramer et al., 1984) and the other being
CoA-independent (Kramer and Deykin, 1983). In the latter study the transacylase
enzyme present in human platelets demonstrated a high specificity towards the acyl
donor PC transferring fatty acids in the order of preference of arachidonic acid >
eicosatrienoic acid > oleic acid and preferentially acylating lysoplasmenylethanolamine
rather than lysophosphatidylethanolamine. This is in contrast to platelet
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acyltransferase which acylates ethanolamine lysophosphates with free arachidonic acid
in the order of lysophosphatidylethanolamine > lysoplasmenylethanolamine.
1:24:5 Arachidonic acid turnover and pregnancy
It has been previously discussed (section 1:14) that in the guinea-pig, the
presence of conceptuses inhibits uterine PGF2a synthesis (Blatchley el a/., 1975b) by
preventing the stimulatory influence of oestradiol on endometrial PGF2a synthesis
(Poyser, 1984a). The mechanism of this inhibition is unclear, except that some anti-
luteolytic factor, most probably a protein, is produced. In other species, such as the
sheep and cow, the conceptus secretes a protein (ovine or bovine trophoblast protein-
1) which prevents the stimulation of PGF2a output from the uterus (Anthony,
Flelmer, Sharif, Roberts, Hansen, Thatcher and Bazer, 1988). The conceptus proteins
belong to a new class of interferons, namely interferon-x (see Poyser, 1995).
Human uterine tissue, including decidua and fetal membranes, has been shown
to be greatly enriched with arachidonic acid in the sn-2 position of phospholipids
(Okita, Johnston and MacDonald, 1983). Although the stimulus for this selective
uptake of arachidonic acid into uterine phospholipids is unclear, evidence from
experiments with perifused human endometrium demonstrated a marked enhanced
capacity for release of PGF2a in the late luteal phase (Skinner, Liggins, Wilson and
Neale, 1984). This would suggest that such a specific uptake may be due to the action
of progesterone on an oestradiol-primed tissue. The clinical observation of absence of
dysmenorrhoea in anovulatory menstrual cycles is in keeping with this hypothesis.
More recently, other workers isolated a 58 kd protein from amniotic fluid that
specifically inhibits arachidonic acid release from dispersed, perfused decidual cells
(Wilson, Liggins and Joe, 1989). The protein isolated from women in labour was
found to be inactive and in smaller quantities than that obtained before the onset of
labour. It was therefore proposed that this protein secreted by the chorion throughout
pregnancy and, by diffusing into nearby tissues, inhibits PG synthesis and contributes
to the maintenance of pregnancy. At term, the protein is inactivated and inhibition of
PG synthesis ceases, facilitating the onset of labour
In a study measuring the incorporation of ['^Cj-arachidonic acid into ovine
conceptus and endometrial lipids, triacylglycerols were shown to be an important
reservoir for both conceptal and endometrial arachidonic acid (Lewis, Wood and
Caldwell, 1992). Although phospholipids are regarded to be the primary source of
arachidonic acid for PG synthesis, arachidonic acid may very well be transferred from
neutral lipids to phospholipids, liberated from the phospholipids and then used for PG
synthesis (Lewis and Waterman, 1985). Indeed, arachidonic acid, as suggested from
studies on human endometrium, may be cycled through several lipid stores prior to its
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use in PG synthesis (Bonney, Samih and Franks, 1990). Studies with the guinea-pig
uterus have also indicated that arachidonic acid can be transferred from "storage
reservoirs" to reservoirs that provide the immediate substrate for PG synthesis
(Poyser, 1991).
Conceptuses from several species synthesize PGs in vitro (Lewis, 1989). If
conceptuses produce PGs, they must have the ability to manage the flux of esterified
arachidonic acid from lipid stores to free arachidonic acid available for PG synthesis.
If so, this may provide a mechanism by which the conceptus prevents the release of
uterine PGF2a during early pregnancy, thus preventing luteal regression.
PGs produced by the uterus and conceptus during pregnancy have been
proposed to have a variety of roles including, intrauterine migration of embryos,
blastocyst hatching from the zona pellucida, ion transport across the trophectoderm,
fluid accumulation in the blastocoele, increased endometrial capillary permeability,
blastocystic glucose metabolism, regulation of blood flow, immunosuppression and
induction of labor (Lewis, 1989; Kelly, 1994). Therefore, the rate of arachidonic acid
turnover during pregnancy may be an important factor in the control of PG synthesis
by both the endometrium and the conceptus.
1:25 Summary and aims
The processes controlling arachidonic acid uptake into and between
phospholipids are of major importance in ensuring a continuous supply of arachidonic
acid for endometrial PG synthesis. An increase in the rate of arachidonic acid uptake
may be beneficial in providing a more rapid turnover of arachidonic acid for PG
synthesis. However, such an increase may also limit the amount of PGs synthesized
since, following its release by phospholipase, the amount of free arachidonic acid
available will be reduced at a faster rate if the uptake processes for arachidonic acid
are stimulated. This may be of consequence during early to mid-pregnancy when PG
output from the uterus must be kept low. Likewise, reduced uptake of arachidonic
acid may lead to an abnormal or overproduction of uterine PGs, which may explain
certain menstrual dysfunctions such as dysmenorrhoea and menorrhagia. Indeed,
inhibition of acyl-CoA synthetase and acyl-CoA:lysophospholipid acyltransferase in
macrophages and lung fibroblasts resulted in increased concentrations of free
arachidonic acid and PGs synthesized and released (Kroener et al., 1981; Hunter el
al., 1984; Goppelt-Streube et al., 1986).
Consequently, the aim of this study has been to investigate the presence of the
enzymes which regulate arachidonic acid uptake into phospholipids in the control of
PG synthesis in the endometrium. The presence of endometrial acyl-CoA synthetase
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(ACS), acyl-CoA:lysophospholipid acyltransferase (ACLS) and, for comparison,
phospholipase (PL) A2 have therefore been investigated in guinea-pig uterus and the
influences of stage of oestrous cycle, ovarian steroid hormones and pregnancy on the
presence of the enzymes has been studied. The presence of the enzymes have also
been investigated in fetal tissues at different stages of pregnancy, and the effects of
inhibition of ACS, ACLS and PLA2 activities on endometrial and fetal tissue PG
synthesis have also been studied.
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CHAPTER 2 : MATERIALS AND METHODS
Materials and General Methods
2:1 Introduction
Many of the methods carried out in this thesis have been used in several
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Medium 199 (plus Earles salts)
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Rathburn Chemicals Ltd., U.K.
B.D.H. Chemicals Ltd., U.K.
Rathburn Chemicals Ltd., U.K.
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Source
Radioactive compounds
[5,6,8,9,11,12,14,15(n)-3H] prostaglandin F2a (specific activity 179 Ci/mmol).
[5,6,8,11,12,14,15(n)-^H] prostaglandin E2 (specific activity 185-200 Ci/mmol).
6-keto [5,8,9,11,12,14,15(n)-3H] prostaglandin F la (specific activity 151-170
Ci/mmol).
L-3-phosphatidylcholine, l-stearoyl-2-[l-14c]arachidonyl (toluene:ethanol 1:1 v/v)
(specific activity 56 mCi/mmol)
L-lyso-3-phosphatidylcholine, l-[l-14c]palmitoyl (toluene.ethanol 1:1 v/v) (specific
activity 56 mCi/mmol).
[9,10(n)-3H]Oleic acid (specific activity lOCi/mmol).
[5, 6, 8, 9, 11, 12, 14, 15--^H]-arachidonic acid (specific activity 120-130 Ci/mmol).
All radioactive compounds were supplied by Amersham International Ltd., U.K.
All the [^H] PG stock solutions were diluted to 5 p.Ci/ml and stored at -20°C
prior to use for radioimmunoassay. [^H]-PGF2a and [^H]-PGE2 were diluted in
methanol and [3H]-6-keto-PGF ja was diluted in acetonitrile:water (9:1).
Antibodies Source
Normal rabbit serum (NRS) Scottish Antibody Production Unit,
Donkey anti-rabbit serum (DARS) Scotland
PGF2a antiserum All raised in the Department of
PGE2 antiserum Pharmacology,
6-keto-PGFja antiserum University of Edinburgh
Gases
95 % air and 5 % CO2
95 % O2 and CCD









Sterilin Ltd., Teddington, U.K.
Alltech Associates/Applied Science,U.K.
2:3 Composition of solutions
2:3:1 Krebs solution




Potassium chloride (10 % w/v)






Potassium dihydrogen orthophosphate (10 % w/v) 8.0 ml
Calcium chloride (1M) 12.6 ml
Made up to 5 1 with distilled water and stored at 4°C. The calcium chloride was
added at the end to avoid precipitation.
2:3:2 Culture medium
Medium 199 was developed by Morgan, Morton and Parker (1950) as a synthetic
medium for the nutrition of animal cells in tissue culture. The medium contains amino
acids, vitamins, nucleic acids and necessary growth factors supplemented with Earles'
salts. Earles' salts are a synthetic mixture of inorganic salts and provide a
"physiological" or balanced salt solution by maintaining pH (sodium bicarbonate),
osmotic pressure and providing energy in the form of glucose (Table 1).
Glutamine, an essential component for maintenance of tissue in culture (Fischer,
Astrup, Ehrensvard and Oehlenschlager, 1948) is not stable above -10°C. Therefore,
glutamine was stored at -20°C and added to the culture medium as required. An
antibiotic and fungicide were also added to prevent bacterial and fungal growth.
The medium was dispensed into 25 ml glass bottles and stored at -20°C until
required.
Medium 199 (plus Earles' salts)
Glutamine (200 mM)







Table 1. Composition of Medium 199 (modified) with Earle's salts and 2.2g/l sodium
bicarbonate without glutaminc
Ingredient mg/litre Ingredient mg/litre
L-alanine 25.00 Nicotinic acid 0.025
L-arginine HC1 70.00 Nicotinamide 0.025
L-aspartic acid 30.00 p-aminobenzoic acid 0.05
L-cysteine HC1 .0987 Pyridoxal HC1 0.025
L-cysteine disodium 23.66 Pyridoxine HC1 0.025
salt Riboflavin 0.01
L-glutamic acid 66.82 Thiamine HC1 0.01
L-glutamine 100.0 DL-a tocopherol 0.01
Glutathione 0.05 phosphate disodium salt
Glycine 50.0 Vitamin A acetate 0.1147
L-histidine HC1 21.88 CaCl2.2H20 264.9
h2o Fe(N03)3.9H20 0.10
L-hydroxyproline 10.0 KC1 400.0
L-isoleucine 20.0 MgS04.7H20 200.0
L-leucine 60.0 NaCl 6800
L-lysine HC1 70.0 NaHC03 2200
L-methionine 15.0 NaH2P04.2H20 158.3
L-phenylalaninc 25.0 Adenine sulphate 10.0
L-proline 40.0 5'AMP 0.20
L-serine 25.0 Cholesterol 0.20
L-threonine .30.0 2-deoxyribose 0.50
L-tryptophan 10.0 D-glucose 1000
L-tyrosine disodium 49.72 Guanine HCL 0.30
salt Hypoxanthine 0.30
L-valine 25.0 D-ribose 0.50
L-ascorbic acid 0.05 Sodium acetate 36.71
Biol in 0.01 Phenol red sodium salt 17.00
Calciferol 0.10 Thymine 0.30
D-calcium- 0.01 Tvveen 80 5.00
pantothenatc Uracil 0.30
Choline chloride 0.50 Xanthine 0.30
Folic acid 0.01 Menaptothone sodium 0.019
i-inositol 0.05 bisulphate 3H20
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2:3:3 Radioimmunoassay solutions
i. Solution for PGF2a radioimmunoassay (" PGF2a diluent "1
Tris buffer 0.05 M, pH 8.0:-
Tris base 30.25 g
NaN3 0.5 g
Make up to 5 1 with distilled water, and adjust to pH 8.0 using concentrated HC1. 1.0
g gelatine (heat gently to dissolve) added to 1 1 of Tris buffer (pH 8.0). Store at 4°C.
ii. Solution for 6-keto-PGF|a radioimmunoassay (" 6-keto-PGF]a diluent "1
Take 11 of Tris buffer (pH 8.0) and adjust pH to 6.8 using 1M HC1. Add 1.0 g
gelatine. Store at 4°C.
iii Solution for PGE2 radioimmunoassay (" PGE2 diluent "1
Phosphate buffer, pH 7.5:-
Di-sodium hydrogen orthophosphate 34.5 g
NaN3 0.5 g
Sodium dihydrogen orthophosphate (1M) 56.0 ml
Make up to 5 1 with distilled water and adjust to pH 7.5 with concentrated HC1. To
make up the diluent, take 1 1 of phosphate buffer (pH 7.5) and add 1.0 g gelatine
Store at 4°C.
iv. Scintillation fluid for prostaglandin radioimmunoassays
2:4 Animals used
Guinea-pigs were housed in a 14 h light, 10 h dark cycle (lights on between
0500 - 1900 h) and received a diet of RGP pellets (Labscure, Manea, U.K.), hay.
vegetables and water supplemented with ascorbic acid. Virgin guinea-pigs weighing
500-900 g were examined daily and a vaginal smear taken when the vagina was open.
Smears were observed using a light microscope. The first day of the oestrous cycle
was taken as the day preceding the postovulatory influx of leucocytes when
cornification was at a maximum (Selle, 1922; Stockard and Papanicolaou, 1917; Nicol
and Snell, 1954). Animals were only used after they had exhibited at least two cycles
of normal length (16-18 days). Guinea-pigs were used on day 7 or day 15 of the cycle
(days of low and high PGF2a output from the uterus respectively; Blatchley et al.,
1972) or on days 15, 22, 29 and 36 of pregnancy. Ovariectomized guinea-pigs treated
with steroid hormones were also used (details given in results section). Guinea-pigs







2:5 Radioimmunoassay (RIA) technique
2:5:1 Introduction
Prostanoic acid derivatives such as prostaglandins, prostacyclin and their
derivatives are generally present in biological solutions at very low concentrations
(10~9-10~H M). Therefore assays with high sensitivity are required for their
measurement. One such method that is widely used is that of radioimmunoassay
(RIA). This is a technique developed during the 1960's which makes use of an
antibody method to measure the concentration of an unknown unlabelled antigen.
Specific antigen-antibody reactions are combined with the sensitivity of radioisotopic
detection. The concentration of the unknown unlabelled antigen is found by
comparing its inhibitory effect on the binding of radioactively labelled antigen (tracer)
to a specific antibody with the inhibitory effect of known standards. Bound and
unbound antigen are separated by precipitating the antigen-antibody complexes with
antiserum raised against the antibody or by some other method.
2:5:2 Methods of radioimmunoassay
i. Preparation of standards
Assay tubes (3 ml plastic insert scintillation vials) numbered 1-38 for the
PGF2a assay and 1-35 for the PGE2 and 6-keto-PGF]a assays contained a set of
standard solutions. Tubes 1-4 measured non-specific binding of the radioactive tracer
to sites other than the specific prostaglandin binding sites e.g. the tube itself non¬
specific sites on the antiserum and to other compounds in the assay. For the assay to
be valid, this non-specific binding should be < 10%. The "counting standards", tubes
5-8, only contained radioactive tracer which when averaged gave an estimate of the
number of radioactive counts within each tube.
Tubes 9-35 (PGE2 and 6-keto-PGFia) or 9-38 (PGF2a) consisted of 9 or 10
standard concentrations, respectively, (Table 2) and each standard solution was
dispensed in triplicate. From the results obtained with these standard solutions, a
standard curve for each assay was constructed. The standard PG concentrations were
made up from stock PG solutions stored in methanol at -20°C at a concentration of 1
pg/ml. 200 pi of stock PG solution was removed and placed in a 30 ml glass vial. The
methanol was blown off under a stream of air, after which the PG was resuspended in
20 ml of the appropriate diluent to give a 10 ng/ml solution. 500 pi of this solution
was placed into tubes 1-4 of the assay to measure the non-specific binding (i.e. the
concentration of unlabelled PG is high enough to prevent labelled PG binding to any
specific sites on the antibody, and therefore any binding is non-specific). The next PG
concentration was made up by taking 10.24 ml of the 10 ng/ml solution and adding
9.76 ml of diluent. This gave a PG solution of 5 .12 ng/ml from which the other
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Table 2. Concentrations and volumes of standard solutions of
prostaglandin (PG) F2a, PGE2 and 6-keto-PGFja used to construct each
radioimmunoassay standard curve
Concentration of standard solution (ng/mO
Tube No. PGF2a PGE2 / 6-keto-PGFla Volume (p.1)
1-4 10.0 10.0 500
5-8 0.00 0.00 0.00
9-11 0.005 0.02 500
12-14 0.01 0.04 500
15-17 0.02 0.08 500
18-20 0.04 0.16 500
21-23 0.08 0.32 500
24-26 0.16 0.64 500
27-29 0.32 1.28 500
30-32 0.64 2.56 500
33-35 1.28 5.12 500
36-38 2.56 _ 500
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standards were made by a series of 2-fold dilutions down to 0.005 ng/ml (for PGF2a)
and 0.02 ng/ml (for PGE2 and 6-keto-PGFia). The 5.12 ng/ml concentration was not
used for constructing the PGF2a standard curve as a maximum of 10 standards could
be used by the Spline Curve-fit programme on the IBM-personal computer linked to
the scintillation counter. The standards were stored at -20°C. The last four tubes of
the assay contained 500 pi of diluent in duplicate (zero standards) and 500 pi of the
0.32 ng/ml standard solution in duplicate (for calculation of inter-assay coefficients of
variation).
ii. Preparation of radioactive tracers
The amount of [^Ffj-PG in a 50 pi aliquot used in each assay was calculated to
give between 15,000-20,000 counts per tube when counted in a scintillation counter
for 4 min (PGF2a and 6-keto-PGFja) or for 10 min (PGE2). Prior to use, the
required volume was dispensed into a glass vial and the solvent blown off under a
stream of air, and pH]-PGF2a was diluted to 0.125-0.17 pCi/ml, [^H]-PGE2 was
diluted to 0.05-0.0625 pCi/ml, and [-^H]-6-keto-PGFia to 0.17-0.2 pCi/ml in the
appropriate diluent.
iii. Preparation of antibodies
The dilution of antiserum used in the radioimmunoassay was that which bound
60 % of the [^H]-PG in the absence of non-radioactive standard PG (zero standard).
Antibodies were stored at 100-fold dilutions in the appropriate diluent at -20°C, and
diluted to the required dilution (1/1200 for PGF2a and 6-keto-PGF]a and 1/150 for
PGE2) prior to use. Donkey anti-rabbit serum (DARS) and normal rabbit serum
(NRS) were stored at -20°C and diluted immediately prior to use. DARS was used
10-fold diluted in all PG assays, and NRS was used at a 100-fold dilution. The NRS
was added to ensure that, at high dilutions of the antiserum, there was sufficient
gamma-globulin present for adequate precipitation of the bound prostaglandins.
However, no NRS was required in PGE2 asssays since a low dilution of PGE2
antiserum had been used.
iv. Cross-reactivities of antisera
PGF2a - Axitisera to PGF2a had been raised in rabbits by immunizing
with PGF2a conjugated to bovine serum albumin (BSA) (Dighe, Emslie, Henderson,
Rutherford and Simon, 1975). The % cross-reactivity of the antiserum was
determined by finding the concentration of PG or PG metabolite which resulted in 30
% binding with the zero standard (i.e. 50 % drop from 60 % binding for the zero
standard), and comparing it to the concentration ofPGF2a which also produced 30 %
binding with the zero standard. The % cross-reactivity was calculated using the
following formula:
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Concentration ofPGF2a resulting in 30 % binding
x 100
Concentration ofPG or PG metabolite resulting in 30 % binding
These cross-reactivities previously determined by Dighe et al. (1975), Poyser
and Scott (1980) and Lytton and Poyser, (1982a) are shown in Table 3. The only
significant cross-reactivity with PGF2a antibody used was with PGF]a (28 %).
Flowever, work by Poyser (1983 a) analysing prostaglandins produced by the guinea-
pig uterus by gas chromatography-mass spectrometry (GC-MS) has shown that
PGFja production is only 1-2 % of total PGF production. Therefore the PGF2a
antiserum will measure predominantly PGF2a from guinea-pig uterus.
pge2 - Antisera to PGE2 had been raised in rabbits immunized with PGE2
conjugated to thyroglobulin using the method of Dighe, Smith, Ungar and Whelpdale
(1978). The cross-reactivities as determined previously by Poyser and Scott (1980)
and Lytton and Poyser (1982a) are shown in Table 4. PGE2 antiserum was found to
have significant cross-reactivity with PGEj, PGA2 and PGB2. However none of these
3 PGs have been detected in extracts from guinea-pig uterus when analyzed by gas
chromatography and mass spectrometry (Poyser, 1983a). Therefore the PGE2
antiserum is specifically measuring PGE2 in the guinea-pig uterus.
6-keto-PGFja - Antisera to 6-keto-PGFja had been raised in this
department in rabbits immunized with 6-keto-PGFja conjugated to thyroglobulin
(Dighe, Jones and Poyser, 1978). The cross-reactivities determined previously
(Poyser and Scott, 1980) are shown in Table 5. PGE2, PGE] and PGF]a were all
found to cross-react with 6-keto-PGF]a antiserum. However, the levels were
sufficiently low (< 5 %) to enable use of the antiserum for the specific measurement
of 6-keto-PGFja.
v. Assay procedure
All samples to be assayed for prostaglandin content were dispensed in
duplicate. The appropriate volume was taken so that the amount of prostaglandin
being measured was within the detection limits of the assay (ideally binding lay on the
steepest part of the standard curve).
Ethyl acetate extracts of prostaglandins, which had been obtained from
superfusion experiments, were taken to dryness at 45°C in a heating block under a
stream of air. 500 pi of diluent were added to the dried residue samples.
Samples from tissue culture experiments were allowed to thaw before being
dispensed out in duplicate (diluted if necessary) and 500 pi of diluent were added to
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Table 3. Cross-reactivities of prostaglandin F2a from rabbit 6, 6th bleed

















Table 4. Cross-reactivities of prostaglandin E2 antiserum from rabbit 5,















Table 5. Cross-reactivities of 6-keto-prostaglandin Fja antiserum from
rabbit NP1, 6th bleed with various prostaglandins and their metabolites at
















each tube. An equal amount of tissue culture medium was added to the prostaglandin
standard solutions to account for any changes in binding due to the medium.
All tubes were then treated in exactly the same way except for the "counting
standards" (tubes 5-8) which only contained 50 pi of radioactive tracer. The
appropriate [^H]-PG tracer (50 pi) and antiserum (50 pi) were both added to each
tube using a Hamilton™ glass syringe contained in an automatic dispenser. Each tube
was then "whirlimixed" and left to incubate for 1 h (PGFga) or 2 h (PGEg and 6-
keto-PGF]a) at room temperature. 50 pi ofNormal rabbit serum (NRS) and 50 pi of
Donkey anti-rabbit serum (DARS) were then added to each tube (except for PGE2
assay when no NRS is required). The tubes were "whirlimixed'1 once more and
incubated overnight at 4°C.
The following morning, all the tubes (except for the counting standards) were
centriftiged at 1300 x g for 30 min at 4°C. The supernatant was immediately
discarded by rapid pouring off (so that the precipitate remained firmly attached to the
bottom of each tube) and the tubes allowed to dry for 15-30 min. Scintillation fluid
(2.5 ml) was added to every tube (including the counting standards), the tubes capped
and "whirlimixed" and then placed into a Canberra Packard Series 4000 liquid
scintillation counter in order to measure the amount of radioactivity (in counts per
minute, cpm) bound in each sample. PGF2a and 6-keto-PGFia assay tubes were
counted for 4 min each and PGE2 tubes for 10 min. The general protocol for the
measurement of prostaglandin by radioimmunoassay is shown in Figure 5.
Data from the scintillation counter were passed directly to an IBM-personal
computer programmed with a Packard Data Aquisition and Analysis System (PC-
DAAS). The Spline Curve-fit programme was used which processes the standards
according to a Modified Smooth Spline Algorithm, in which the amount of non¬
specific binding was subtracted from all the standards and the co-ordinates for the
curve of best-fit calculated. The amount of prostaglandin present in each sample tube
was determined by the computer from the standard curve. Samples that lay outside
the linear part of the curve were re-assayed using a more appropriate sample volume.
vi. Intra-assav coefficient of variation
This coefficient determines the variation between each sample duplicate. It
was calculated by the computer using the following formula:
Standard deviation of sample duplicate
x 100
Mean value of sample duplicate
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Figure 5. General protocol for measurement of prostaglandins by
radioimmunoassay
Superfusion samples
Dispense appropriate volume of each
sample into tubes
Evaporate off ethyl acetate to dryness
in a stream of air at 45°C
Culture medium samples
Thaw and dispense appropriate
volume of each sample into tubes
Add appropriate diluent to equal volume of the PG standards
*****
Add 50 pi of appropriate b'H]-PG to each tube
Add 50 pi of appropriate PG antiserum to each tube except the counting standards
*****
"Whirlimix" and incubate tubes for 1 h (PGF2a) and 2 h (PGE-> and 6-keto-PGFj(X) at room
temperature
Add 50 pi appropriate NRS (not PGE2 assay) and 50 pi appropriate DARS to each tube except the
counting standards
Whirlimix and incubate tubes overnight at 4°C
Centrifuge tubes (except counting standards) at 1300 x g for 30 ntin at 4°C
*****
Discard supernatant by rapid pouring off
Add 2.5 ml PG scintillation fluid and cap every tube
Whirlimix tubes to resuspend pellet
*****
Count each tube in a liquid scintillation counter for 4 nun (PGFia and 6-keto-PGFj(X) or 10 min
(PGE2)
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The intra-assay coefficient of variation was calculated for every sample duplicate in
each assay performed. If the coefficient was > 10 %, the sample was re-assayed.
vii. Inter-assay coefficient of variation
This coefficient determines the variation between assays and is calculated
using the average value of the last two standard duplicates in each assay (0.32 ng/ml
prostaglandin) from several assays using the following formula:
Standard deviation of PG standard
x 100
Mean PG standard
viii. Precision ofPGF2a radioimmunoassay
The standard curve for the PGF2a radioimmunoassay is shown in Figure 6.
The intra- and inter-assay coefficients of variation were 6.16 % and 3.98 %
respectively. The lower limit of detection for the assay ranges from 25 to 40 pg. The
accuracy and precision of the assay were considered satisfactory for the assay of
PGF2a.
ix. Precision ofPGE2 radioimmunoassay
The standard curve for the PGE2 radioimmunoassay is shown in Figure 7. The
intra- and inter-assay coefficients of variation were 5.04% and 8.62 % respectively.
The lower limit of detection for the assay ranges from 10 to 35 pg. The accuracy and
precision of the assay were considered satisfactory for the assay of PGE2.
x. Precision of 6-keto-PGF|a radioimmunoassay
The standard curve for the 6-keto-PGFia radioimmunoassay is shown in
Figure 8. The intra- and inter-assay coefficients of variation were 6 .35 % and 5 .28 %
respectively. The lower limit of detection for the assay ranges from 10 to 40 pg. The
accuracy and precision of the assay were considered satisfactory for the assay of 6-
keto-PGFia.
2:6 Tissue culture technique
2:6:1 Introduction
Tissue was cultured by a method based on that described by Baker and Neal
(1969) for ovarian tissue, and further refined for the culture of endometrial tissue by
Abel and Baird (1980), Leaver and Poyser (1982), Ning, Leaver and Poyser (1983)
and Leckie and Poyser (1990). Tissue was cultured for 24h. Previous histological
examination (Leaver and Seawright, 1982; Ning, Leaver and Poyser, 1983; Ning and
Poyser, 1984) have shown that guinea-pig endometrium remains viable during tissue
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Figure 6. Standard curve for PGF2a radioimmunoassay. Each point is the mean
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Figure 7. Standard curve for PGE2 radioimmunoassay. Each point is the mean ±
s.e.m. (n = 5).
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Figure 8. Standard curve for 6-keto-PGFia radioimmunoassay. Each point is the
mean ± s.e.m. (n = 5).
88
culture for periods of up to 72 h. All experiments were carried out under strict aseptic
conditions within a "Microflow hood". All glass and plastic utensils were autoclaved
prior to use, and sterile culture dishes (5 cm, vented) were employed. Surgical
instruments were kept in ethanol, and flamed before use.
2:6:2 Preparation of tissue
i. Endometrium from day 7 and 15 non-pregnant guinea-pig
The uterus was removed from day 7 or 15 guinea-pigs, the uterine horn was
opened via a longitudinal incision, and the endometrium was carefully dissected from
the myometrium using a pair of fine scissors. This technique produces greater than 85
% separation (Leaver and Poyser, 1981).
ii. Endometrial, conceptal and fetal tissue from pregnant guinea-pigs
The uterine horns were removed from guinea-pigs on days 15, 22, 29 and 36
of pregnancy and each horn was opened carefully as decribed above. In day 15
pregnant animals, the conceptuses were gently removed. In day 22, 29 and 36
pregnant animals, the fetuses were gently pulled away from the endometrium and
separated into subplacenta, chorio-allantoic placenta, chorion and amnion tissue.
Endometrial tissue from day 15, 22, 29 and 36 pregnant animals was removed as
described for day 15 non-pregnant guinea-pigs.
2:6:3 Method of tissue culture procedure
Separated tissue (endometrial, conceptal or fetal) was cut into 1-2 mm-3 pieces
and placed on a section of lens tissue lying across a raised stainless steel platform in a
petri dish containing 4 ml culture medium plus any other necessary compounds
according to the nature of the experiment, as detailed later in the results chapter. All
materials used were sterile. The lens tissue had been placed in such a way that it was
in contact with the supplemented culture medium. Thus the tissue was not immersed
in medium, but had access to it via capillary action through the lens tissue.
Approximately 20 mg of tissue were placed in each petri dish.
Petri dishes were stacked in a steel rack and placed in a modified Kilner jar
(Figure 9). Each jar was pressurised to 0.7 kg/cm^ with a 1:1 mixture of air/CCb
(95%:5%) and O2/CO2 (95%:5%). A small amount of CO2 is necessary to maintain
the pH of the culture medium by creating a CO2/HCO3" situation.
H20 + C02 -> H2C03 H+ + HCO3-
The amount ofCO2 dissolved is directly related to the incubation temperature and the
CO2 will combine with the H2O to produce H2CO3 which dissociates. HCO3" tends




Figure 9. The above diagram represents the equipment used to
culture guinea-pig endometrial and conceptal tissue.
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is depressed. However, the sodium bicarbonate present in the medium tends to shift
the equation to the left resulting in an equilibrium of pH 7.4. If no CO2 were present
at 37°C, the pH would increase resulting in the sodium phenol red indicator present
changing colour to purple. In such a case, the PG output by the tissue may be
inhibited. During all tissue culture experiments carried out in this thesis the culture
medium always remained red. The high oxygen levels in the jars overcome any
diffusion problems caused by the small size of the tissue pieces.
The Kilner jars were then incubated at 37°C for the designated time of the
experiment. The culture medium was collected every 6 h and replaced with
prewarmed fresh medium. The jars were regassed every time a sample was taken. The
experiments were all performed for a total of 24 h (i.e. medium samples taken at 6 h,
12 h, 18 h and 24 h). The samples were placed in small plastic vials and stored at -
20°C until prostaglandin content was determined by radioimmunoassay. The tissue
from each dish was removed and dried in an oven at 37°C for 24 h and then weighed.
2:7 Superfusion technique
This technique was developed by Poyser and Brydon (1983) to measure the
release of prostaglandins by the superfused guinea-pig uterus. Since the guinea-pig
has two uterine horns, one is used as a control measuring basal PG output while the
other horn is exposed to the test condition. Both uterine horns were removed
immediately after each animal was killed, and placed into Krebs solution at 4°C. Any
excess vascular or fatty tissue was trimmed away, after which the horns were each
blotted dry, weighed and opened via a longitudinal incision. Each horn was then
suspended from an isotonic lever under a load of 2 g and superfused with Krebs
solution (5 ml/min) which had been pre-aerated with 95% O2 and 5% CCD and
heated to 37°C (Figure 10).
Each horn was superfused initially for a settling period of 60 min, and then
samples collected for 10-min periods over the next 80 or 100 min (i.e. 8 or 10
samples/uterine horn respectively). After collection, the pH of each sample was
lowered to 4.0 by addition of HC1. PGs were solvent extracted from the samples of
superfusate with two 50 ml volumes of redistilled ethyl acetate. Both 50 ml fractions
were combined and evaporated to dryness at 45°C using a Buchi rotary evaporator.
Each extract was redissolved in 10 ml of redistilled ethyl acetate and stored at -20°C.
During the whole supeffusion period the tone of the uterine horns was noted. The
amounts of PGF2a, PGE2 and 6-keto-PGFia present in the extracts were later
measured by radioimmunoassay. This extraction procedure gives a high rate of
recovery for PGF2a, PGE2 and 6-keto-PGF]a. The recoveries (mean ± s.e.m., n=3)
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Krebs solution
I 5mls/minute at 37°C
Figure 10. The above diagram represents the method used for
superfusion of guinea-pig uterine horn in vitro.
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of the appropriate radioactive PGs at pH 4.0 were found to be 94 ± 3% for PGF2a,
92 ± 5% for PGE2 (Poyser and Scott, 1980) and 82 ± 2% for 6-keto-PGFja (Swan
and Poyser, 1983). PG concentrations measured in samples of superfusate have not
been corrected for these losses during recovery.
2:8 Uterine homogenate incubations
The technique of whole uterine homogenisation in order to measure
prostaglandin production was first described by Poyser (1972). Specific measurement
of endometrial prostaglandins were later achieved by separation of the endometrium
from the myometrium (Poyser, 1983a).
The uterus was removed from day 7 guinea-pigs and placed into ice-cold
Krebs solution. Each uterine horn was opened via a longitudinal incision, and the
endometrium was carefully dissected from the myometrium using a pair of fine
scissors. The endometrium from a single guinea-pig was then blotted dry, weighed
and cut into fine pieces. It was then homogenised in 10 ml ice-cold Krebs solution
(plus any specified drug additions as described in results chapter) using a Jencons
ground glass homogeniser. The time interval between removal of the uterus and
completion of homogenisation was never greater than 15 min. The homogenate was
then oxygenated and incubated for 1 h at 37°C in a shaking water bath. After
incubation, the pH of the incubates was lowered to pH 4.0 by addition of HC1 and the
prostaglandins were extracted twice with 15 ml redistilled ethyl acetate as described in
section 2:7. The prostaglandin content was determined by radioimmunoassay.
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Development and Modifications to Enzyme Assays
2:9 Introduction
The following section describes the procedures taken to develop three enzyme
assays to investigate the presence of three enzymes, namely acyl-CoA synthetase
(ACS), acyl-CoA:lysophospholipid acyltransferase (ACLS) and phospholipase
(PL)A2- in various tissues from non-pregnant and pregnant guinea-pigs. The assays
were developed separately, but once all were set up and running, all three were
performed simultaneously using tissue from the same animal.
2:10 Preparation of microsomal pellet
2:10:1 Introduction
Preparation of a microsomal pellet was the initial step necessary for all three
assays and is therefore descibed in this section. The procedure used was that of
Downing and Poyser (1983) who observed that between 85 to 95% of PLA2 activity
was present in the microsomal rather than in the supernatant fraction of guinea-pig
endometrial homogenates following centrifugation at 100,000 x g for 60 min. ACS,
ACLS and PLA2 activities have been detected in the microsomal pellet isolated from
guinea-pig endometrial and fetal tissue
2:10:2 Procedure
Female guinea-pigs were killed by stunning and rapid incision of the neck.
Non-pregnant animals on days 7 and 15 of the cycle, pregnant animals on days 15, 29
and 36 of gestation, ovariectomised animals which had received steroid hormone
treatment (as outlined in the results section) were used. Both uterine horns were
immediately removed and placed into ice-cold Tris buffer (one uterine horn in 0.05 M,
pH 8.0 for ACS and PLA2 assays, and the other uterine horn in 0.05 M pH 7.5 for
ACLS assay). Each uterine horn was opened longitudinally and the endometrium
dissected away from the myometrium by cutting away 1-2 mm-* sections of
endometrium using a pair of fine scissors. In pregnant animals, the conceptuses (day
15 pregnant) or the fetal tissues (i.e. subplacenta, chorio-allantoic placenta, chorion
and amnion in day 29 and 36 pregnant animals) were also removed, gently separated
and each tissue type equally divided between the two buffers.
The endometrium and fetal tissues were homogenised separately in Tris buffer
(0.05 M, pH 8.0 for ACS and PLA2 assays, and 0.05 M pH 7.5 for ACLS assay)
using a ground glass homogeniser followed by sonication to give a 25 % homogenate
(250 mg in 1 ml buffer). This homogenate was then centrifuged for 15 min at 3000 x
g at 4°C, after which the supernatant fluid was removed and centrifuged for 60 min at
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100,000 x g at 4°C. The supernatant fluid was withdrawn and each microsomal pellet
was resuspended in 0.25 ml of the appropriate buffer using a 1 ml ground glass
homogeniser and immediately used in the appropriate assay.
2:11 Measurement of acyl-CoA synthetase activity
2:11:1 Introduction
The procedure used to measure acyl-CoA synthetase activity was that
described by Wilson, Prescott and Majerus (1982). This method relies on heptane
extraction of unreacted free fatty acids and the insolubility of long chain acyl-CoA
esters in heptane.
The standard reaction mixture contained:
i. 15 pmol Tris-HCl, pH 8.0
3 pmol MgClg
1 pmol ATP (disodium salt) 10 ml made up and stored at
100 nmol CoA (lithium salt) at -20°C. Known as "reaction
150 nmol 2-mercaptoethanol mix". 60 pi used per assay
0.3 pmol Triton-X-100
ii. 40 pi of a 0.5 mM solution of fatty acid in 50 mM NaHCC>3 (cold fatty acid
solution)
0.1 pCi radiolabeled fatty acid (stored in ethanol, blown off and redissolved
in the cold fatty acid solution.)
iii. 50 pi of enzyme (resuspended microsomal pellet)
The total volume of the reaction mixture was 0.15 ml.
Wilson et al. (1982) found that enzymatic activity in platelet preparations had an
absolute requirement for the presence of ATP, CoA and Mg2^. The presence of a
detergent such as Triton-X-100 increased the activity of the enzyme by approximately
25 %.
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2:11:2 Measurement of arachidonyl-CoA synthetase activity
Wilson et al. (1982) utilized human platelet membrane, and rat liver
microsomal, preparations. The microsomal pellet from guinea-pig uterine tissue used
in subsequent experiments was prepared as described in section 2:10 and was
resuspended in 0.25 ml 0.05 M Tris-HCl, pH 8.0. Two 10 pi portions were removed
and used for estimation of protein content by the method of Lowry, Rosebrough, Farr
and Randall (1951) (section 2:15). The enzyme assay was performed in duplicate, and
thus two 50 pi portions of enzyme were taken and used as shown in Figure 11.
Aliquots of 60 pi of "reaction mix" and 40 pi of a 0.5 mM solution of radiolabeled
fatty acid in 50 mM NaHCC>3 were placed in an eppendorf tube kept ice-cold. The
cold fatty acid used for this assay was arachidonic acid along with [^Hj-arachidonic
acid in order to measure specific arachidonyl-CoA synthetase activity. The reaction
was initiated by addition of the enzyme to the eppendorf, and incubated at 37°C for
10 min. The reaction mixture was then immediately added to a 25 ml pear-shaped
separating flask containing 2.25 ml of isopropanol:heptane:2 M sulphuric acid
(40/10/1, by volume) which terminated the reaction. Heptane (1.5 ml) and 1 ml
distilled water were then added and the mixture vortexed vigorously. The upper phase
was withdrawn and placed into a 20 ml scintillation vial. The aqueous phase remaining
in the separating flask was extracted three times with 2 ml heptane containing 4
mg/ml of carrier palmitic acid (which removes unreacted radiolabeled fatty acid). The
final aqueous phase contained the soluble long chain acyl-CoA esters. Each upper
phase and the final aqueous phase were also placed into 20 ml scintillation vials.
Emulsifier Safe scintillant (10 ml) was added to each vial, and all the vials were
vortexed vigorously. They were then allowed to equlibrate for 1 h prior to liquid
scintillation counting in a Canberra Packard Tricarb 4000 series liquid scintillation
analyser. The activity of acyl-CoA-synthetase was calculated as the conversion of
[-^HJ-fatty acid to [^Hj-fatty acid-CoA during a 10 min incubation period as a
percentage of the total radioactivity recovered. In the methods ofWilson et al. (1982)
only the aqueous phase (1 ml) (containing the soluble long chain acyl-CoA esters) was
collected and counted in a scintillation counter. However, it was felt, that by
collecting and scintillation counting all the phases, there would possibly be a more
accurate detection of acyl-CoA-synthetase, since activity was calculated as a
percentage of total radioactivity recovered, rather than as radioactivity recovered
compared to original radioactivity in the reaction mix.
2:11:3 Identification of reaction product
The radiolabeled product collected in the arachidonyl-CoA synthetase assay
was shown to be arachidonyl-CoA by co-chromatography with authentic arachidonyl-
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Figure 11. General Protocol for measuring acyl-CoA synthetase
activity
60 |il "reaction mix" + 40 pi of a 0.5 mM solution of + 50 pi enzyme
(i) radiolabeled fatty acid in (iii)
50 mM NaHC03(ii)
Total reaction mixture : 150 f_il (i + ii + iii)
Incubated for 10 min at 37 °C
Add 2.25 ml isopropanol:heptane:H2S04 (40:10:1)
Add 1.5 ml heptane + 1 0 ml water
Vortex vigorously
Upper phase removed
Aqueous phase extracted 3 times with 2 ml heptane containing 4 mg/ml palmitic acid
Aqeous phase remaining removed
10 ml Scintillation fluid added to each removed phase
Vortexed vigorously
Vials scintillation counted for 4min
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CoA using the method of Mishina, Kamiryo, Tashiro and Nuraa (1978) in a solvent
system of isopropanol:pyridine:acetic acid:water (60:15:1:25). It was found that 80-
90 % of the radioactivity co-chromatographed with the authentic arachidonyl-CoA.
The Rf value was found to be 0.29; these results agree with those of Wilson et al.
(1982), and therefore this extraction method was assumed to be predominantly
collecting arachidonyl-CoA.
2:12 Measurement of AcylCoA:Iysophospholipid acyltransferase activity
2:12:1 Introduction
Arachidonyl-CoA:lysophospholipid acyltransferase activity was measured in
guinea-pig microsomal pellet using a modified version of the procedures described by
Severson and Fletcher (1984) and Fuse, Iwanaga and Tai (1989). The conversion of
labelled lysophosphatidylcholine to phosphatidylcholine in the presence of donor
arachidonyl-CoA was measured. The general procedure is shown in Figure 12.
2:12:2 Assay procedure
i. Acvl-CoA:lysophospholipid acyltransferase assay
The acyltranferase activity was routinely determined in duplicate in eppendorf
tubes in assay incubations (0.2 ml final volume) containing 250 pM cold L-a-
lysophosphatidylcholine,palmitoyl (LPC) with 0.1 pCi (1.78 nmol, approximately
200,000 dpm per assay) L-lyso-3-phosphatidylcholine-l(l-^C)-palmitoyl (solvent
base blown off under stream of N2 and redissolved in cold LPC 0.05M Tris-HCl
solution, pH 7.5), 20 nmol arachidonyl-CoA, 5 mM MgCl2 and a source of enzyme
(resuspended microsomal pellet in 0.25 ml 0.05M Tris pH 7.5 ). Two 10 pi volumes
of resuspended microsomal pellet were taken for estimation of protein content. The
reaction was initiated by the addition of the enzyme and incubated at 37°C for 10
min, after which the reaction mixture was immediately placed into a 10 ml glass
centrifuge tube containing 3 ml CHC^CH^OH (2:1 v/v) with 0.05% antioxidant to
terminate the reaction. 0.1 M CaCl2 (1 ml) was also added and the mixture vortexed
vigorously. The aqueous and solvent phases were separated by centrifugation at 1000
x g for 5 min. The lower phase was dried under a stream of N2, resuspended in 50 pi
(rather than 150 pi as used by Severson and Fletcher, 1985, as this made application
of the sample easier to TLC plate - smaller sample spot achieved) of CHC^CHjOFl
(2:1 v/v) and stored at -20°C until subjected to thin layer chromatography (TLC).
ii. Separation of LPC and PC fractions
Lysophosphatidylcholine and phosphatidylcholine fractions (labelled and
unlabelled) were separated by thin layer chromatography on thin layer silica gel
chromatographic glass plates. The lower phase collected in the assay was applied to
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Figure 12. General protocol for measuring acyICoA:Iysophospholipid
acyltransferase activity
130 |_il 0.05M Tris buffer + 20 pi 250 pM cold + 50 pi
pH 7.5 containing 20 nmol LPC containing 0.1 pCi enzyme
arachidonyl-CoA and [^C]-LPC (1.78 nmol)
5 mM MgCl2
Total reaction mixture 200 pi
Incubate for 10 min at 37°C
3 ml CHCl3:CH30H (2:1 v/v) containing 0.05% antioxidant
and 1 ml 0.1 M CaCl2 added
Vortex vigorously
Phases separated by centrifugation at 1000 x g for 5 min
Lower phase dried under stream ofN2 gas
Dried sample resuspended in 50 pi CHC^CH^OH (2:1 v/v)
Sample stored at -20°C until required for TLC
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the plate using a microsyringe along with LPC (25 pg) and PC (10 pg) as carriers.
LPC and PC markers were also applied on either sides of each TLC plate and the
plates developed in a solvent system of CHCl3:CH30H:H20 (75:25:3) to a height of
15 cm. Once the samples had all reached the solvent front, the plates were allowed to
dry flat. Plates were gently covered with a sheet of paper covering all sample columns
except the marker columns. Marker LPC and PC zones were visualised by spraying
on molybdo-phosphoric acid in 5% ethanol. Plates were dried in an oven at 37°C for
15 min, and the marker LPC and PC zones were clearly visible as light green spot
where the molybdo-phosphoric acid had attached to the phospholipids.
The specified quantities of LPC and PC markers/carriers were selected after
several TLC trial runs. These quantities (LPC (25 pig) and PC (10 pg)) achieved clear
indication of their positions following solvent and molybo-phosphoric exposure. The
solvent system of CHC^CF^OFlFbO (75:25:3), used by Fuse et al., 1989, resulted
in the best separation of LPC and PC zones (to a height of 15 cm, in approximately 1
h) compared to the solvent system used by Severson and Fletcher, 1985
(CHC13 :CH30H:H20:CH3C00H (280:120:16:8)). Therefore the
CFlCl3:CH30H:Fl20 (75:25:3) solvent system was selected for use in our
experiments.
The silica gel zones corresponding to the LPC and PC in the samples were
dampened using a "fine mist spray" of distilled water and scraped off separately into 5
ml scintillation vials containing 0.5 ml methanol (to extract the silica gel). During
initial TLC trials, it was discovered that dampening of silica gel reduced loss of
samples in the form of dust and made collection of gel much easier. Scintillation fluid
(4 ml) was then added to each vial and the vials vortexed vigorously. Vials were left
to equlibrate for 1 h prior to liquid scintillation counting to determine the amount of
radioactivity present. ACLS activity was calculated as the conversion of [^C]-LPC
to [14C]-PC during a 10 min incubation as a percentage of the total radioactivity
recovered.
2:13 Measurement of phospholipase A2 activity
2:13:1 Introduction
The procedure used for determination of PLA2 activity was based on the
method described originally by Consentino and Ellis (1981) and modified by
Downing and Poyser (1983). The method was further modified for use in the
experiments descibed in this thesis. The general procedure is shown in Figure 13.
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Figure 13. General Protocol for measuring PLA2 activity
50 pi 0.1 M Tris, pH 8.0, 7 mM Ca2+ + 50 pi enzyme
containing 0.1 j_iCi [14C]-PC (1.78 nmol)
and 70 pM cold PC sonicated prior to use
to solubilise the phospholipids
Total reaction mixture 100 pi
Incubate for 10 min at 37°C
Add 25 pi 2 N HC1 + 10 pg Arachidonic acid
Incubates frozen overnight at -20°C prior
to separation of PC and AA by column chromatography
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2:13:2 Assay procedure
i. Conversion of r14Cl-PC to r14Cl-AA
The microsomal pellet prepared was resuspended in PLA2 buffer (0.25 ml 0.1
M Tris, pH 8.0 containing 7 mM Ca^+) and kept at 4°C. Two 50 pi volumes were
taken for the assay along with two 10 pi volumes for the purpose of protein
concentration determination. Phosphatidylcholine with [^C]-arachidonic acid in the
carbon-2 position (0.1 pCi) was used as the labelled substrate. It was blown off from
its solvent base and redissolved in an eppendorf tube with 50 pi buffer containing 70
pM unlabelled PC which had been previously sonicated to solubilise the
phospholipids. The final reaction volume was 100 pi. The reaction was initiated by
addition of the enzyme to the phospholipids, and incubated for 10 min at 37°C.
Addition of 25 pi 2 N HC1 terminated the reaction and 10 pg arachidonic acid were
added to act as a carrier for the [^C]-AA released from the labelled substrate. The
incubates were frozen at -20°C overnight.
ii. Separation of PC and AA by column chromatography
Glass pasteur pipettes plugged with teflon wool (one for each incubate) were
packed with silica gel (100-200 mesh) suspended in hexane to a height of 3 cm and
then washed through with 1 ml of Solvent 1 (hexane: l,4-dioxan:acetic acid, 85:15:1).
The columns were not allowed to run dry at any point during the experiment. Solvents
were applied to the columns with glass pasteur pipettes and allowed to drip through
by gravity. Each incubate was then added to the top of a column, and the fatty acid
([l^Cj-AA) eluted into ten 3 ml plastic scintillation vials with ten 1 ml fractions of
Solvent 1. The unmetabolised substrate ([^C]-PC) was then eluted and collected in
the same way but using ten 1 ml fractions of Solvent 2 (chloroform:methanol:water,
65:35:4). During intial trial column chromatography runs, it was found that a greater
recovery of the labelled PC and AA was achieved using 10 x 1 ml fractions of each
solvent rather than just 6 fractions of Solvent 1 followed by 7 fractions of Solvent 2 as
described by Downing and Poyser (1983). The solvents collected in each vial were
evaporated off under a stream of air in a heating block at 45°C, after which 2.5 ml
scintillation fluid were added and the vials vortex mixed. The tubes were counted in a
Canberra Packard Tricarb 4000 series liquid scintillation analyser for 4 min. The
PLA2 activity was calculated as the conversion of [^C]-PC to [^C]-AA during a 10




A set of experiments was performed to try to identify potentially better
conditions for each enzyme assay. The results obtained were observed in at least two
different animals. Curves were drawn in to "best fit" manually, and extrapolated to
zero.
2:14:2 Cold substrate concentration
The cold substrate concentration is of great importance in each assay to ensure
that the enzyme is not being limited, and that optimum enzyme activity is being
measured. The cold substrate concentrations listed in the following experiments
represent the actual concentration of cold substrate present in the reaction mix (not
the concentration of cold stock solution added).
i.ACS assay
A set of control assay experiments were carried out using non-labelled
arachidonic acid concentrations of 5, 25, 50, 100, 200, 300, 400, 500 and 600 pM.
The results are shown in Figure 14. A substrate concentration of 500 pM was used in
all further experiments.
ii. ACLS assay
A set of control assay experiments was carried out using cold
lysophospholipid concentrations of 5, 25, 50, 100, 150, 200, 250, 300 and 350 pM.
The results are shown in Figure 15. A substrate concentration of 250 pM was used in
all further experiments.
iii. PLA2 assay
A set of control assay experiments was carried out using non-labelled
phospholipid concentrations of 10, 20, 30, 40, 50, 60, 70, 80 and 90 pM. The results
are shown in Figure 16. A substrate concentration of 70 pM was used in all further
experiments.
2:14:3. Incubation time
A set of control experiments were carried out for each assay using different
incubation times of 1, 2, 5, 8, 10 and 20 min using the appropriate substrate
concentrations determined in 2:14:2. The results are shown in Figure 17. It was
decided to use an incubation time of 10 min for each assay as this appeared to result
in measurable enzyme activity.
2:14:4. Protein concentration
The effect of protein concentration was investigated by diluting the
resuspended microsomal pellet in both a series of one-in-two and one-in ten fold
dilutions. The results obtained (Figure 18) indicated that the amount of protein in the
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|iM Cold Arachidonic acid
Figure 14. Effect of non-labelled arachidonic acid concentration on detected
acyl-CoA synthetase activity.
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Figure 18. Influence of protein concentration on detected ACS, ACLS and PLA2
activities.
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undiluted microsomal pellet obtained from animals (200-300 |_ig in 50 pi) resulted in
measurable enzyme activity. Therefore protein samples used in the assays were not
diluted.
2:14:5. Calcium concentration
Dependence of the enzyme assays on calcium concentration was investigated
in a series of experiments, the results of which are illustrated in Figure 19. The
presence of both re-acylating enzymes did not appear to be dependent on calcium;
however, PLA2 presence was enhanced at 7 mM Ca~+. Therefore, PLA2 assays were
carried out in the presence of 7 mM Ca^+.
2:15 Lowry protein assay
2:15:1 Introduction
In order to determine the amount of protein present in each microsomal pellet
used in each enzyme assay performed, a protein assay was carried out every time. The
procedure followed was that of Lowry et al. (1951), and is based on the ability of
protein molecules to combine with tartrate ions and Folin's phenolic reagent to form a
complex which has a spectrophotometric absorbance at 750 nm. The optical
absorbance of this complex is proportional to the total amount of protein present in
the sample.
2:15:2 Standards and solutions
Six standard protein solutions were prepared using Bovine serum albumin
(BSA). A stock solution of BSA (2.5 mg/ml in distilled water) was prepared from
which 0, 0.1, 0.2, 0.3, 0.4 and 0.5 ml were taken and each made up to a total volume
of 5 ml with distilled water. Thus, in 0.3 ml of each solution there was 0, 15, 30, 45,
60 and 75 ug protein present, respectively. Stock solutions were prepared as listed
below:
Solution A 1 % w/v CUSO4.5H2O
Solution B 2 % w/v NaK tartrate
Solution C 2 % w/v Na2CC>3 dissolved in 0.1 M NaOH
Solution D Folin's phenolic reagent diluted 1:1.5 with distilled water
2:15:3 Assay procedure
An aliquot of 0.3 ml was removed from each of the six standard protein
solutions and placed into six labelled 10 ml test tubes at room temperature. In a
beaker, 0.5 ml of Solution A was added to 0.5 ml of Solution B, after which 50 ml
Solution C were added and all the solutions mixed. To each of the 0.3 ml standard
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Figure 19. Influence of calcium concentration on detected ACS, ACLS and
PLA2 activities.
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"whirlimixed". Following a 15 min incubation time (at room temperature), 0.3 ml
Solution D was added to each test tube, the tubes "whirlimixed" again, and then
allowed to incubate for a further 30 min. The optical absorbance of each protein
standard was measured in a Cecil™ spectrophotometer at 750 nm wavelength. From
the data obtained, a plot of optical absorbance against protein present was
constructed.
Samples that were to be measured for protein content (having been diluted to
a volume of 0.3 ml) were subjected to exactly the same procedure as for the standard
solutions. Absorbance values obtained from the unknown samples were applied to the
standard plot and the protein content determined. Standard plots were constructed for
every protein assay performed to account for any variations between assays. A
regression line was constructed (Figure 20) by combining data from several assays
carried out. The line had a regression coefficient of 0.99. It was therefore concluded
that the method of Lowry et al. was a reliable method for measuring protein
concentration. To establish that the Lowry assay was linear for the protein (ie.
microsomal) solutions used during the assays, a graph was constructed of absorbance
against protein concentration of endometrial microsomal protein which had been
obtained by a series of one-in-two dilutions. This graph is illustrated in Figure 20a,
with the Lowry standard curve for comparison, and illustrates that the Lowry assay
did appear to be linear for the microsomal protein solutions. Thus, the method of
Lowry was used for measuring protein concentrations in guinea-pig microsomal
preparations.
2:16 Limitations of methods
Several points should be considered when interpreting the results observed in
the following investigations.
The ability of the Lowry assay to measure protein accurately in the presence
of phospholipid has been previously documented (Peterson, 1979). The problem
arises from the insolubility of the phospholipids present in the microsomal
preparations, which can result in turbid solutions (and thus influence absorbance
readings) and interfere with the ability of the protein to react in the aqueous solutions
of the Lowry assay. Therefore, protein estimation by the method used in these
investigations should be treated with caution, especially since the quantity of
phospholipid present in different uterine tissues and at different times of the oestrous
cycle and pregnancy, may vary. The problem can be overcome with the addition of
sodium dodecyl sulphate (SDS) (Lees and Paxman, 1977; Markwell, Haas, Bieber and
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Figure 20. Standard curve for Lowry protein assay. Each point is the mean ±
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Figure 20a. Lowry assay of a series of one-in-two microsomal protein dilutions
(n=l) (G466 - protein dilutions), in comparison to standard curve for Lowry
protein assay (mean ± s.e.m., n=5). The graph would suggest that the Lowry
assay was linear for the microsomal protein solutions measured during these
investigations.
is added to the reaction mixture dissolving lipids and maintaining them in solution.
This detergent binds to hydrophobic regions of molecules causing them to be freed
from their associations from other proteins or lipid molecules, and thus render the
protein freely soluble in the solution. The Lowry method is also known to give a non¬
linear calibration curve (Lowry et al., 1951). Therefore, for better precision it is
advisable to assay at least three different dilutions of the protein sample. This non¬
linear behaviour appears to be inherent in the reaction mechanism (Peterson, 1979).
Various attempts have been made to improve linearity, either by variation of the
reaction conditions or by the application of curve-fitting techniques (Peterson, 1979).
It would have been advisable to carry out control Lowry assays with varying dilutions
of, not only endometrial microsomal preparations, but of all the different tissue
protein solutions (ie. varying dilutions of microsomal preparations from subplacenta,
chorio-allantoic placenta and fetal membranes) to investigate whether the Lowry
assay was linear for all the different tissue types. Protein/phospholipid content may
vary between different uterine and fetal tissues at different times of the oestrous cycle
and during pregnancy. The colour given by a protein in the Lowry assay depends on
its content of tyrosine and tryptophan residues. Thus, variation of response with
various proteins can be quite significant.
In the ACS and PLA2 assays, the substrate solutions contained phospholipid in
aqueous solution. This poses a problem in achieving a homogeneous and properly
dissolved substrate solution so that the substrates are accessible to the enzymes. The
ACS assay mix contained the detergent Triton X-100 to aid solubilization of the
phospholipids. The PLA2 assay mix was sonicated to disrupt micelle formation.
Amphipathic compounds, such as phosphoglycerides, have a hydrophilic head and
hydrophobic tail. At an appropriate concentration, the lipid molecules will come
together spontaneously to form spheres, termed micelles. The hydrophobic tails
interact to exclude water and the charged polar head groups will interact with water
and be on the outside of the sphere. The specific concentration of lipid required for
micelle formation is referred to as the "critical micelle concentration". Micelles with a
single lipid or a mixture of lipids can form. The formation of the micelle depends on
the temperature of the system and, if a mixture of lipids are used, on the ratio of
concentrations of the different lipids in the mixture. The micelle structure is very
stable due to the hydrophobic interaction of the hydrocarbon chains and the attraction
of the polar head groups to the water. The critical micelle concentrations for the lipid
substrates used in the enzyme assays were unknown. It is not possible to state
whether the substrate solutions in the following investigations were homogeneous and
fully dissolved. Kinetic studies with PLA2 are particularly problematic since classical
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Michaelis-Menten kinetics do not apply. It is frequently not recognized that enzyme
activity increases exponentially when the substrate concentration reaches or exceeds
the critical micelle concentration. In addition, PLA2 can exist in either the inactivated
or activated state. The problem of determining enzyme activity is further compounded
by the fact that the enzyme may exist in solution as monomers or dimers of varying
stability. Unless experimental conditions are well-defined, these differences illustrate
some of the problems encountered with the study of this enzyme (Chang, Musser and
McGregor, 1987).
Microsomes are membranous vesicles formed by the fragmentation of the
endoplasmic reticulum. The precise location of ACS, ACLS and PLA2 on the
endoplasmic reticulum (ie. inside, outside) in guinea-pig uterine and fetal tissues is
unknown. These enzymes may have differing positions, and thus have differing
abilities to react with exogenous substrate during the enzyme assays performed. It is
considered that activation of a microsomal (presumably membrane-bound) PLA2 by
intracellular calcium is responsible for controlling the supply of free arachidonic acid
for PG synthesis in the guinea-pig uterus during the oestrous cycle (Downing and
Poyser, 1983). In calf thymus lymphocytes and rabbit lymphocytes, ACLS activity is
located preferentially in the plasma membrane. However, in other cells, such as liver,
much of the activity resides in the endoplasmic reticulum (Szamel and Resch, 1973,
1981). In rat heart myocardial cells, ACLS activity is also localized in microsomes
(Severson and Fletcher, 1984). ACS and ACLS activities are usually ascribed to the
microsomal or mitochondrial fraction of cellular homogenates, however rabbit cardiac
cytosol has also been demonstrated to contain both ACS and ACLS necessary for
phospholipid synthesis (Needleman, Wyche, Sprecher, Elliott and Evers, 1985).
In the ACS assay, control cold substrate experiments were only carried out to
investigate the effects of different concentrations of arachidonic acid on the enzyme
activity. However, CoA can also be considered as a substrate for ACS and thus CoA
concentration will also influence the activity of ACS. Therefore, for measurement of
ACS activity it is also necessary to determine the optimum concentration of CoA
required for the enzyme assay. When establishing an enzyme assay, the Michaelis-
Menten constant (Km) should be measured for all substrates. The Km is equivalent to
the substrate concentration at which V0 (the initial velocity) is equal to one-half of the
Vmax (maximium velocity) at steady-state kinetics. The Km is measured by a plot of V„
(enzyme activity) versus the substrate concentration ([S]) (approaching a rectangular
hyperbola), or through a linear Lineweaver-Burk plot (1/[S] versus 1/V0). The line
will have a slope of Km/Vmax, an intercept of 1/Vmax on the 1/V„ axis, and an intercept
of -1/Km on the 1/[S] axis. Unfortunately the Km was not determined during these
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investigations (or Vmax, since insufficient [S]s were tested, Vmax was not clearly
reached). Optimum substrate concentrations should ideally represent at least 10 times
the substrate concentration that results in the Km value for a particular assay. This was
not the case in these investigations. Using such substrate concentrations will ensure
that the enzyme is not limited by a lack of substrate.
An appropriate concentration of enzyme (protein) must also be established for
use in an enzyme assay in order for accurate quantitative determination of enzyme
activity. A concentration should be selected which results in steady-state enzyme
kinetics, where the enzyme activity is linearly proportional to the quantity of enzyme
used. In control experiments carried out in section 2:14:2, an inappropriate
concentration of enzyme was selected for further enzyme assays, since this
concentration did not lie on the linear part of the curve. By using enzyme
concentrations that lie on the linear part of the standard curve, different enzyme
assays can be assumed to have similar steady-state kinetics and thus their activities
can be directly related. With varying quantities of enzyme present in different assays,
enzyme activity can be detected, but comparisons cannot be made between activities,
since reaction rates will vary meaning that enzyme activity cannot be directly related
to the concentration of enzyme present.
Due to the above reasons, the ACS, ACLS and PLA2 assays performed are




INVESTIGATIONS INTO THE PRESENCE OF ACYL-CoA SYNTHETASE,
ACYL-CoA:LYSOPHOSPHOLIPID ACYLTRANSFERASE AND
PHOSPHOLIPASE A7 IN THE GUINEA-PIG UTERUS
3:1 Investigation into the presence of arachidonyl-CoA synthetase (ACS),
acyl-CoA:lvsonhospholipid acyltransferase (ACLS) and phospholipase A?
(PLA2) in day 7 and day 15 non-pregnant guinea-pig endometrium.
Introduction
There is much evidence that PGF2a is the uterine luteolytic hormone in the
guinea-pig (Poyser, 1976). The output of PGF2a from the guinea-pig uterus increases
approximately 20-fold between days 7 and 15 of the oestrous cycle when measured
either in vivo or in vitro (Blatchley et al., 1972; Poyser and Brydon, 1983). The
release of free arachidonic acid from some bound source is regarded as the rate
limiting step in PG synthesis by tissues. In the guinea-pig uterus 93 % of the total
arachidonic acid present is bound to phospholipids, of which 80 % is bound to PC and
PE (Leaver and Poyser, 1981). This bound arachidonic acid is readily releasable by
PLA2 (Downing and Poyser, 1983). In the guinea-pig uterus a refractoriness is
observed following repeated stimulation with PLA2, but not with arachidonic acid
which always induces maximum PG synthesis (Poyser, 1991). This refractoriness in
uterine PGF2a synthesis may be due to the depletion of the arachidonic acid pool
esterified to phospholipids. This arachidonic acid pool would appear to be readily
releasable for PG synthesis, but requires 3-5 h to be refilled (Poyser, 1991). The rate
of incorporation of arachidonic acid into phospholipids of the guinea-pig endometrium
has been shown to be 2- to 3-fold higher on day 15 than on day 7 of the oestrous
cycle (Ning et a/., 1983). Therefore, the mechanisms controlling arachidonic acid
incorporation into phospholipids may be as essential as those which control
arachidonic acid release from phospholipid stores in the regulation of endometrial
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PGF2a synthesis. The three enzymes, ACS, ACLS and PLA2 control arachidonic acid
turnover via deacylation (PLA2) and reacylation (ACS and ACLS) of
gylcerophospholipids. Consequently, all three enzymes may be important in
controlling the supply of free arachidonic acid for conversion into PGF2a within the
endometrium. Therefore, the presence of all three enzymes has been investigated in
day 7 and day 15 (days of low and high PGF2a output from the uterus, respectively)
non-pregnant guinea-pig endometrium.
Methods
The uteri from five day 7, and five day 15 non-pregnant guinea-pigs were
removed. The two uterine horns were immediately separated and placed into ice-cold
Tris-HCl buffer (one horn into 0.05 M, pH 8.0 for ACS and PLA2 assays, and the
other horn in 0.05 M, pH 7.5 for ACLS assay). Each uterine horn was opened
longitudinally and the endometrium dissected away from the myometrium by cutting
away 1-2 mm' sections of endometrium using a pair of fine scissors. The endometrial
tissue from each horn was then homogenised separately in the appropriate Tris buffer
using a ground glass homogeniser, followed by sonication to give a 25 %
homogenate. From these homogenates, two microsomal pellets were prepared as
decribed in section 2:10.
ACS assay
The microsomal pellet prepared was resuspended in 0.25 ml Tris-HCl, pH 8.0.
Two 10 pi aliquots were removed and used for the estimation of protein content by
the method of Lowry et al. (1951) as described in section 2:15. The enzyme assay
was performed in duplicate as described in section 2:11. The cold fatty acid used was
arachidonic acid along with [^H]-arachidonic acid in order to measure specific
arachidonyl-CoA synthetase activity. The activity of acyl-CoA-synthetase was
calculated as the conversion of [^H]-fatty acid to PH]-fatty acid-CoA during a 10
inin incubation period as a percentage of the total radioactivity recovered.
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ACLS Assay
The microsomal pellet prepared was resuspended in 0.25 ml Tris-HCl, pH 7.5.
Two 10 pi aliquots were removed and used for the estimation of protein content by
the method ofLowry etal. (1951).
ACLS activity was measured using a modified version of the procedures
described by Severson and Fletcher (1984) and Fuse, Iwanaga and Tai (1989). The
conversion of labelled lysophosphatidylcholine to phosphatidylcholine in the presence
of donor arachidonyl-CoA was measured as described in section 2:12. The ACLS
activity was routinely determined in duplicate in eppendorf tubes in 10 min assay
incubations containing 250 pM cold L-a-lysophosphatidylcholine-palmitoyl (LPC)
with 0.1 pCi (1.78 nmol) L-lyso-3-phosphatidylcholine-l[l-l4C]-palmitoyl, 20 nmol
arachidonyl-CoA, 5 mM MgCl2 and a source of enzyme (50 pi resuspended
microsomal pellet). The reaction was initiated by the addition of the enzyme and
incubated at 37°C for 10 min, after which the reaction mixture was immediately
placed into a 10 ml glass centrifuge tube containing 3 ml CHCI3CH3OH (2:1 v/v)
with 0.05% antioxidant to terminate the reaction. 0.1 M CaCl2 (1 ml) was also added
and the mixture vortexed vigorously. The aqueous and solvent phases were separated
by centrifugation at 1000 x g for 5 min. The lower phase was dried under a stream of
N2, resuspended in 50 pi of CFIC^CF^OFl (2:1 v/v) and stored at -20°C.
Lysophosphatidylcholine and phosphatidylcholine fractions (labelled and unlabelled)
were separated by thin layer chromatography on glass thin layer silica gel
chromatographic plates. ACLS activity was calculated as the conversion of [^C]-
LPC to [14C]-PC during a 10 min incubation, as a percentage of the total
radioactivity recovered.
PLA? Assay
The microsomal pellet resuspended in 0.25 ml Tris-HCl, pH 8.0 for the ACS
assay was also used as a source of enzyme for the PLA2 assay. The procedure used
for determination of PLA2 activity was based on the method described originally by
Consentino and Ellis (1981) and modified by Downing and Poyser (1983). The assay
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was carried out in duplicate using 50 pi aliquots of resuspended microsomal pellet and
phosphatidylcholine with [14C]-arachidonic acid in the carbon-2 position (0.1 pCi) as
the labelled substrate as described in section 2:13. The unmetabolised substrate, [I4C]-
PC, and the fatty acid, [14C]-AA, were separated on silica gel columns using two
different solvent systems. [14C]-AA was eluted in hexane/l,4-dioxan/glacial acetic
acid (85:15:1) and [I4C]-PC was eluted using the more polar solvent,
chloroform/methanol/water (65:35:4). The radioactivity in each solvent fraction was
measured by counting in a liquid scintillation counter for 4 min. The PLA2 activity
was calculated as the conversion of [14C]-PC to [14C]-AA during a 10 min incubation
period calculated as a percentage of the total radioactivity recovered.
ACS, ACLS and PLA2 assays were carried out at both high and low substrate
concentrations. These concentrations are listed in the table below:-
ASSAY LOW SUBSTRATE SUBSTRATE
CONCENTRATION CONCENTRATION
ACS 100 pM 500 pM
ACLS 25 pM 250 pM
PLA2 16 pM 70 pM
Results
For the reasons listed in section 2:16, the assays carried out were only able to
establish the presence of, but not changes in, the activities of ACS, ACLS and PLA2.
Detected ACS, ACLS and PLA2 activities, in day 7 and day 15 non-pregnant
guinea-pig endometrium at low and high substrate concentrations, are illustrated in
Figures 21 and 22, respectively.
ACS, ACLS and PLA2 activities were all detected in the endometrium of day
7 and day 15 non-pregnant guinea-pigs, at both low and high substrate
concentrations.
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Figure 21. Mean (± s.e.m., n=5) detected activities of ACS, ACLS and PLA2 at low
substrate concentration in day 7 and day 15 guinea-pig endometrium.
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Figure 22. Mean (± s.e.m., n=5) detected activities of ACS, ACLS and PLA2 at high
substrate concentration in day 7 and day 15 guinea-pig endometrium.
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Discussion
The three enzymes, ACS, ACLS and PLA2, which control arachidonic acid
turnover via deacylation (PLA2) and reacylation (ACS and ACLS) of
glycerophospholipids, were detected to be present in the endometrium of both day 7
and day 15 non-pregnant guinea-pigs. Unfortunately, due to the limitations of the
assay methods (see section 2:16), changes in the activities of the enzymes in the
endometrium at different times of the oestrous cycle, could not be measured.
Therefore, whether these enzymes have a role in the control of arachidonic acid
turnover towards the end of the oestrous cycle, coincident with the large increase in
PGF2a production by the endometrium which occurs at this time, is unknown.
The activation of PLA2 by calcium is considered to be responsible for the
release of arachidonic acid from phospholipids in the guinea-pig endometrium towards
the end of the cycle (Downing and Poyser, 1983). Stimulation of PLA2 activity would
lead to an increase in the concentration of free arachidonic acid released from
phospholipid stores and therefore an increase in endometrial PGF2a production.
Endometrial ACS and ACLS activities could possibly be specifically stimulated
towards the end of the cycle or could increase as a consequence of an increase in the
concentration of free arachidonic acid released by PLA2 which needs to be "mopped
up" and taken back into phospholipids.
Oestradiol acting on a progesterone-primed uterus is considered to be the
physiological stimulus for increased PGF2a production by the guinea-pig uterus
(particularly the endometrium) towards the end of the oestrous cycle (Blatchley et a/.,
1972; Earthy et ctl., 1975; Antonini et al., 1976). In the following experiment, the
presence of ACS, ACLS and PLA2 activities in the endometrium of ovariectomized
guinea-pigs treated with oestradiol and/or progesterone, or vehicle-treated, has been
investigated. All further enzyme assays were carried out at a high substrate
concentration.
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3:2 Investigations into the presence of arachidonyl-CoA synthetase, acvl-
CoA:lysophospholipid acyltransferase and phospholipase A? in the
endometrium of ovariectomized guinea-pigs treated with oestradiol
and/or progesterone
Introduction
During the guinea-pig oestrous cycle, oestradiol secretion from the ovary
increases from day 10 (Joshi et al., 1973) which precedes the increase in PGF2a
secretion from the uterus by 24 h (Blatchley et al., 1972; Earthy et al., 1975; Antonini
et al., 1976). Oestradiol administered to ovariectomized guinea-pigs maintained on
progesterone stimulates uterine PGF2a output (Blatchley and Poyser, 1974; Poyser,
1983b). Also, the administration of onapristone (a progesterone antagonist) or ICI
182780 (an oestrogen antagonist) to non-pregnant guinea-pigs on days 11-14 of the
cycle significantly reduces uterine PGF2a output on day 15 (Poyser, 1993). Therefore
oestradiol acting on a progesterone-primed uterus appears to be the physiological
stimulus for increased secretion of endometrial PGF2ct, especially as oxytocin has no
stimulatory effect on endometrial PGF2a synthesis in guinea-pigs (Poyser and Brydon,
1983; Riley and Poyser, 1987). It has been proposed that oestradiol may have a dual
action increasing uterine PG synthesizing capacity and directing synthesis toward
PGF2a (Poyser, 1983b). Whether oestradiol and progesterone can control endometrial
PG synthesis by controlling the necessary supply of free arachidonic acid towards the
end of the cycle is not known. The following experiment was carried out to
investigate whether the enzymes that control arachidonic acid turnover (ACS, ACLS
and PLA2) were present in the endometrium of ovariectomized guinea-pigs treated
with oestradiol and/or progesterone.
Methods
Twenty guinea-pigs weighing approximately 600 g, which had normal
oestrous cycles, were ovariectomized during the luteal phase of the cycle. The guinea-
pigs were anaesthetized by injection of 30 mg/kg sodium pentobarbitone, and a dorsal
incision was made on either side of the backbone. The Fallopian tubes were ligated in
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two places and severed between the ligatures, enabling the ovaries to be removed. To
confirm that the guinea-pigs had undergone successful ovariectomy, the animals
continued to be examined daily to check that they no longer displayed oestrous cycles.
Eight weeks later, the guinea-pigs were divided randomly into four groups of five
animals and received subcutaneous injections of arachis oil vehicle (vehicle)
containing the following additions:-
Group 1 No additions - 0.5 ml vehicle daily for 10 days.
Group 2 0.5 ml vehicle daily for 7 days followed by 0.5 ml vehicle containing
10 pg oestradiol benzoate daily for 3 days.
Group 3 0.5 ml vehicle containing 2.5 mg progesterone daily for 10 days.
Group 4 0.5 ml vehicle containing 2.5 mg progesterone daily for 7 days,
followed by 0.5 ml vehicle containing 10 pg oestradiol benzoate + 2.5
mg progesterone daily for 3 days.
All guinea-pigs were injected between 09:00 and 09:30 h. On the 11th day after
starting treatment, each guinea-pig was killed by stunning and incision of the neck.
The uterus was removed and separated into its two uterine horns. ACS, ACLS and
PLA2 assays were then carried out using exactly the same methods as described in
experiment 3:1.
Statistical Tests
The differences between the uterine weights of ovariectomized guinea-pigs
treated with vehicle, oestradiol, progesterone and oestradiol + progesterone were
analysed by Student's t-test.
Results
For the reasons listed in section 2:16, the assays carried out were only able to
establish the presence of, but not changes in, the activities of ACS, ACLS and PLA2.
Detected ACS, ACLS and PLA2 in the endometrium of ovariectomized guinea-pigs
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Figure 23. Mean (± s.e.m., n=5) detected activities of ACS, ACLS and PLA2 in the
endometrium of ovariectomized (OVX) guinea-pigs treated with vehicle (OXC),
oestradiol (OXE), progesterone (OXP), and oestradiol and progesterone (OXP+E).
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were detected in both control (vehicle-treated only) and treated, (oestradiol and/or
progesterone-treated), ovariectomized guinea-pig endometrium.
Figure 24 illustrates the influence of progesterone and/or oestradiol treatment
on the uterine weight of ovariectomized guinea-pig uterus. It is clear that both
oestradiol and progesterone treatment used in this experiment significantly increased
uterine weight, with oestradiol having the major effect.
Discussion
The significant increase in uterine weight in ovariectomized animals following
steroid treatment suggests that the combined effects of oestradiol and progesterone
on the uterus are to prepare the uterus for implantation and pregnancy.
ACS, ACLS and PLA2 activities were found to be present in the endometrium
of control and steroid-treated ovariectomized guinea-pigs and thus, may have a role in
the control of arachidonic acid turnover and PG synthesis in the guinea-pig
endometrium. Due to the limitations of the assay methods (see section 2:16), changes
in the activities of the enzymes in the endometrium of ovariectomized animals
following steroid treatment, could not be measured. Therefore, whether these
endometrial enzymes are influenced by the action of oestradiol acting on a
progesterone-primed uterus (considered to be the physiological stimulus for increased
PGF2a synthesis towards the end of the oestrous cycle) is unknown.
If an increase in the rate of arachidonic acid uptake (reacylation) back into
phospholipids by ACS and ACLS were to occur, this could be beneficial in providing
a faster turnover of arachidonic acid for PG synthesis. However, if such an increase
did occur, this may actually limit the amounts of PGs synthesized. Following its
release by PLA2, the amount of free unesterified arachidonic acid available for PG
synthesis would be reduced at a faster rate if the uptake processes were stimulated.
During early pregnancy, PGF2a output from the uterus must be kept low so that luteal
regression does not occur and progesterone secretion is maintained. ACS and ACLS
may be of importance during this time in the control of available arachidonic acid for
PG synthesis. Consequently, the presence of ACS, ACLS and PLA2 in early pregnant




Figure 24. Mean (+ s.e.m., n=5) uterine weights of ovariectomized guinea-pigs
treated with vehicle (Control), oestradiol (Oest.), progesterone (Prog ), oestradiol and





3:3. Investigations into the presence of acyl-CoA synthetase, acyl-
CoA:lysophospholipid acyltransferase and phospholipase A? in uterine
and conceptal tissues of day 15, 29 and 36 pregnant guinea-pigs.
Introduction
If an animal becomes pregnant, the luteolytic influence of the uterus must be
prevented, since continued progesterone secretion is necessary for the whole of
gestation in some species (e.g. cow, goat and pig), or during the first third of
gestation in others (e.g. sheep and guinea-pig) (Poyser, 1992). In pregnant guinea-
pigs, the increase in uterine PGF2g( output from the uterus after day 11 of the cycle is
prevented by the presence of conceptuses and luteal function is therefore maintained
(Antonini el a/., 1976; Blatchley et al., 1975a, b). It has been proposed that the
guinea-pig conceptus secretes an anti-luteolytic factor which may act by suppressing
the stimulatory effect of oestradiol on endometrial PGF2a synthesis and release
(Poyser, 1984a). Conceptuses from several species have been shown to synthesize
PGs in vitro (Lewis, 1989). The fact that conceptuses produce PGs indicates that
conceptuses must influence the control of arachidonic acid turnover and therefore the
amount of free arachidonic acid available for PG synthesis. If so, this may provide a
mechanism by which the conceptus prevents the release of uterine PGF2a during early
pregnancy, thus maintaining luteal function and progesterone secretion.
Implantation in the guinea-pig is completed during a period of 6-8 hours on
the sixth day following fertilization (Blandau, 1949). The terms "superficial" and
"interstitial" describe different implantation mechanisms, and separate those in which
the blastocyst remains in the uterine lumen and those in which it penetrates the luminal
epithelium and embeds itself in the uterine wall. The guinea-pig blastocyst was first
classed as one demonstrating a true type of interstitial implantation by Graf v. Spee in
1883.
The fertilized egg (zygote) of all mammals is surrounded by a
mucopolysaccharide coat called the "zona pellucida". This is transparent, tough and
elastic. As the zygote passes along the oviduct (or Fallopian tube, in man), it divides
forming a solid clump of cells, known as the morula. The morula is then transformed
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into the blastocyst, usually soon after it has reached the uterine lumen. This is a
hollow ball of cells with a two-layered wall containing a cavity, referred to as the
blastocoele (Perry, 1981). The term "blastocyst" is applicable both before and after
the development of the inner layer, or endoderm. The embryo will form from a thicker
portion of the ectoderm, known as the embryonic knot or disc. The orientation of the
embryonic disc is a species characteristic. The remaining portion of the ectoderm is
called the trophoblast, which plays an important role in the formation and structure of
the future placenta. The endodermal layer of cells in the blastocyst usually form by
tangenital division of a few cells of the embryonic disc and then increase around the
inner side of the ectoderm surrounding the blastocoele which then becomes the yolk
sac. At this stage, the zona pellucida is lost. In some species, the contents are
extruded or "hatched" whilst in others the zona may be dissolved by processes that
involve lytic enzymes which may originate from either the uterine or embryonic
tissues. In the mouse, it has been suggested that PGE2 produced by the blastocyst
promotes water passage across the trophectoderm causing the blastocyst to swell and
the zona to burst (Biggers, Leonov, Baskar and Fried, 1978).
Once the zona pellucida has been lost, the fetal membranes are developed.
These comprise the amnion, yolk sac, chorion and allantois, all of which are of
embryonic origin, interposed between embryo and mother. These structures, together
with the fetus, can be referred to collectively as the conceptus. The placenta is formed
when fetal tissues contact or fuse with maternal tissue for physiological exchange; in
mammals, this always involves the chorion, and either the yolk sac or the allantois.
The amnion remains avascular, and is turgid under the hydrostatic pressure of its
contained fluid, providing the "private pond" in which the embryo develops. The
development of the fetal membranes is somewhat dependent upon the type of
implantation which varies between species. In superficial implantation, the blastocyst
normally becomes distended, filling and sometimes swelling the uterine lumen prior to
trophoblast attachment to the luminal epithelium. During interstitial implantation, as in
the guinea-pig (Spee, 1883) the blastocyst remains small, lodging in a groove or fold
of the uterine mucosa where it penetrates the epithelium thus reaching the decidua; a
thick cushion created by hypertrophy of the uterine wall at the point of implantation, a
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major part of which consists of polyploid cells or "decidual cells". They are formed in
response to the blastocyst in what is referred to as the "decidual cell reaction".
Implantation in the guinea-pig involves the formation of an "egg cylinder"
with an "embryonic pole" and an "ectoplacental pole". The latter pole contains
numerous lacunae which fill with maternal blood as the invasive cells break down the
walls of the endometrial capillaries. As the embryo develops, uterine swelling
increases due to the distension of the exocoele, the allantois grows out from the
ventral surface of the embryo, extends across the exocoele and connects with the
mesoderm under the ectoplacental trophoblast to form a chorio-allantois. The
ectoplacental trophoblast, and consequently the chorio-allantoic placenta, are directly
attached to the mesometrial wall of the uterus, adjacent to the entry of the uterine
vessels (Perry, 1981). Implantation in man is also interstitial, but does not involve an
ectoplacental mass of trophoblast. The conceptus simply enlarges within the uterine
wall at the point of implantation and the overlying tissue constitutes the decidua
capsularis.
The guinea-pig has a "haemochorial placenta" which is also found in rat, rabbit
and man (Perry, 1981). In this placental type, blood is released from maternal vessels
to circulate through channels within the trophoblast before returning to the maternal
circulation (Perry, 1981). The guinea-pig has an haemochorial placenta of
"labyrinthine" form (Mossman, 1937), whilst in man it is of a "villous" nature (Perry,
1981). The distinction is between a condition where the trophoblast covers
vascularized lamellae of fetal mesenchyme (connective tissue of mesodermal origin)
and one in which it covers finger-like growths. The guinea-pig conceptus also has a
structure known as the "subplacenta", a specialized area of chorion between the
haemochorial placenta and the decidua basalis, which has been described in detail in a
study by Davies, Dempsey and Amoroso (1961). This structure was stated to only
exist in two animals; the guinea-pig and porcupine, both members of the
Hystricomorph group of rodents (Mossman, 1937), however it was later found to be
present in other members of this group including the chinchilla and agouti (Perrotta,
1959). The subplacenta, which arises around day 16 of pregnancy, consists of folded
lamellae of cytotrophoblast, which is in contact with fetal mesenchyme on its fetal
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surface, and which gives rise to synctial trophoblast on its maternal surface. The
subplacenta and chorio-allantoic (haemochorial) placenta are separated by a plane of
fetal mesenchyme which passes between the cytotrophoblastic lamellae of the
subplacenta and carries vessels to them. The subplacenta merges peripherally with the
marginal synctium of the haemochorial placenta through an "intermediate" zone. An
area of necrotic decidua lies deep in the subplacenta through which the vessels
supplying the haemochorial placenta pass. During early development, the endothelial
walls of these vessels are replaced by invasive trophoblastic elements of the
subplacenta. The subplacenta appears to degenerate after day 50 of pregnancy and is
necrotic at term. A thin layer of normal decidua lies between the necrotic zone and
myometrium; the plane of cleavage of the placenta at term occurs between this layer
and the myometrium (Davies et al., 1961).
PGs originating from the conceptus appear to have numerous roles, including,
intrauterine migration of embryos, blastocyst hatching from the zona pellucida, ion
transport across trophectoderm, fluid accumulation in the blastocoele, increased
endometrial capillary permeability and blastocystic glucose metabolism (see Lewis,
1989). Between days 7 and 12 of pregnancy, pig embryos migrate and become spaced
in the uterus. Local myometrial contractions appear to be involved in controlling this
migration, and blastocystic PGs may stimulate these contractions (Pope, Maurer and
Stormshak, 1982). Before blastocyst implantation, its protective covering, the "zona
pellucida" must be shed. It has been demonstrated that inhibitors of PG synthesis and
PG antagonists reduce the rate of hatching ofmouse embryos from the zona pellucida
(Biggers, Leonov, Baskar and Fried, 1978). Since PGE2 is able to promote water
movement across epithelia, it was proposed that PGE2 produced by the blastocyst
promotes water passage across the trophectoderm resulting in the accumulation of
blastocoelic fluid, and the eventual "hatching" of the blastocyst from the zona
pellucida (Biggers et al., 1978). Later studies supported this hypothesis (Hurst and
Farlane, 1981; Chida, Uehara, Hoshiai and Yajima, 1986). In a study by Lewis
(1986b) it was demonstrated that indomethacin decreased PG synthesis by, and
transport of, 22Na across day 16 sheep trophoblast and also prevented the formation
of trophoblastic vesicles in vitro. This study suggested that PGs may be involved in
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the control of fluid accumulation during the period of rapid blastocystic elongation
(prior to implantation) in sheep. Localized increases in endometrial capillary
permeability precede implantation in numerous mammals, and PGs appear to be
involved in initiating these increases (see Lewis, 1989). Other studies have also
suggested a role for PGs (possibly of blastocystic origin) in the control of energy
metabolism in blastocysts (see Lewis, 1989).
During pregnancy, the conceptus must be able to modulate the maternal
humoral (antibody-mediated) and cellular (killer-cell mediated) immune responses.
Several mechanisms that have been demonstrated appear to utilize PGE2. An
immunosuppressive agent produced by cultured human decidual cells has been
identified as PGE (Parhar, Kennedy and Lala, 1988).
PGs produced by the endometrium and conceptus appear to be involved in the
establishment, maintenance and termination of pregnancy. Therefore, the control of
arachidonic acid turnover during pregnancy may be an essential factor in the control
of PG synthesis by both the endometrium and conceptus. Consequently, the presence
of ACS, ACLS and PLA2 in uterine and conceptal tissues from day 15, 29 and 36
pregnant guinea-pigs has been investigated.
Methods
Fifteen virgin female guinea-pigs which had undergone at least 3 normal
oestrous cycles were mated by placing them separately on days 14-15 of the cycle (i.e.
several days prior to oestrus) with a male guinea-pig of proven fertility. The guinea-
pigs were examined daily for signs of mating and for the presence of sperm in the
vaginal smear, with day 1 of pregnancy being designated the first day of observing any
of these signs.
Day 15 Preunant: Five guinea-pigs were killed by stunning and incision of the neck on
day 15 of pregnancy. The uterus was removed from each animal and separated into its
two horns. Each horn was placed into a separate dissecting dish; one containing ice-
cold Tris-HCl buffer, pH 8.0 (for ACS and PLA2 assays) and the other containing ice-
cold Tris-HCl buffer, pFl 7.5 (for ACLS assay). Each uterine horn was "opened" by a
longitudinal incision and the conceptuses removed by gently pulling them away from
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the endometrium. The conceptuses were then also placed into separate dishes
containing the appropriate Tris-HCl buffer. The endometrium was separated from the
myometrium by cutting away 1-2 mm3 sections of endometrium using a pair of fine
scissors. The conceptuses were also cut into 1-2 mm3 pieces. The general procedure is
shown in Figure 25a. The tissue from each dish was homogenised using a ground
glass homogeniser followed by sonication to give a 25 % homogenate (250 mg/ml
buffer). Four microsomal pellets were prepared from each tissue as described in
section 2:10. ACS, ACLS and PLA2 assays were conducted using exactly the same
methods as in experiment 3:1.
Day 29 and 36 Pregnant: Figure 25b shows the general procedure. Five guinea-pigs
were killed by stunning and incision of the neck on day 29 and day 36 of pregnancy.
The uterus was removed from each animal and separated into its two horns. Each
horn was placed into a separate dissecting dish; one containing ice-cold Tris-HCl
buffer, pH 8.0 (for ACS and PLA2 assays) and the other containing ice-cold Tris-HCl
buffer, pH 7.5 (for ACLS assay). Each uterine horn was "opened" by a longitudinal
incision and the conceptuses, along with the placentae, were removed, by gently
pulling them away from the endometrium. Figures 25c, 25d and 25e show
photographs taken from a day 36 pregnant guinea-pig, illustrating the uterine horns,
conceptuses, and dissection of the placentae. The subplacenta came away very easily
from the chorio-allantoic placenta (due to the plane of mesenchyme present between
them), which was itself separated from the conceptus by gently snipping the umbilical
cord. Separation of the subplacenta was a little more difficult from the decidua, but
once separated, the subplacenta appeared as a bulging ovoid structure of firm
consistency, greyish in colour, which is in contrast to the deep red colour of the
chorio-allantoic placenta. The subplacenta, chorio-allantoic placenta, chorion and
amnion were then separated from each conceptus. The two fetal membranes, namely
the chorion and amnion, were removed separately by gently pulling each membrane
away from the conceptus. The conceptus was then discarded. All tissues were kept
ice-cold and cut into 1-2 mm' pieces and placed into the appropriate Petri dish prior
to homogenisation. The endometrium was separated from the myometrium by cutting
away 1-2 mm' sections of endometrium using a pair of fine scissors. A microsomal
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Uterus removed and separated into its two horns.
All tissue kept ice-cold throughout dissection procedure.
w
One uterine horn placed into











One uterine horn placed into













Microsomal pellet prepared from each tissue
as described in section 2:10 and appropriate assay carried out.
Figure 25a. General procedure for preparing day 15 pregnant guinea-pig conceptal
and uterine tissue for the detection of ACS, ACLS and PLA2 enzyme activity.
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Uterus removed and separated into its two horns. All tissue kept ice-cold throughout
dissection procedure.
4
One uterine horn placed into Tris, pH 8.0 and the other uterine horn placed into Tris,
pH 7.5
i
Each uterine horn dissected to separate the endometrium from the myometrium, and





Endometrium, subplacenta, chorio-allantoic placenta, chorion and amnion from each
uterine horn kept in the appropriate Tris buffer, and cut into 1-2 mm3 sections.
I
Microsomal pellet prepared from each tissue type from one uterine horn, as described
in section 2:10 and appropriate assay carried out.
Figure 25b. General procedure for preparing day 29 and day 36 pregnant guinea-pig





Figure 25c. Photograph of ventral dissection of day 36 pregnant guinea-pig
demonstrating position of cervix, uterine horns and conceptuses.
horns
Two conceptuses present
in right uterine horn
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Figure 25d. Photograph demonstrating dissection of day 36 pregnant guinea-pig with





Subplacenta - note central mesenchyme






Figure 25e. Photograph of dissection of day 36 pregnant guinea-pig. The two
placentae, namely the subplacenta and chorio-allantoic placenta, are shown.
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pellet was prepared from each tissue and ACS, ACLS and PLA2 assays were carried
out as described in experiment 3:1.
Results
Detected ACS, ACLS and PLA2 activities in the endometrium of day 15, 29
and 36 pregnant guinea-pigs are shown in Figure 26. Detected ACS, ACLS and PLA2
activities in tissue from the conceptus of day 15 pregnant animals are also illustrated
in Figure 26. Figure 27 illustrates detected ACS, ACLS and PLA2 activities in tissue
from the endometrium, subplacenta, chorio-allantoic placenta, chorion and amnion of
day 29 and 36 pregnant guinea-pigs. All three enzymes were detected in all tissue
types on all days of pregnancy.
Discussion
Due to the limitations of the assay methods (discussed in section 2:16), it was
not possible to measure changes in the activities of ACS, ACLS and PLA2 in the
different tissues, or on different days of pregnancy. However, since ACS, ACLS and
PLA2 activities were all detected to be present in the uterine and conceptal tissues of
day 15, 29 and 36 pregnant guinea-pigs, it is possible that these enzymes may have a
role in the regulation of arachidonic acid turnover, and therefore prostaglandin
synthesis, during pregnancy in the guinea-pig.
In order to fully understand the role of arachidonic acid turnover in relation to
uterine PG production, both in non-pregnant and pregnant animals, it is necessary to
investigate the actual quantities of PGs produced by uterine and conceptal tissues
Manipulation of the control of arachidonic acid turnover by inhibition of ACS, ACLS
and PLA2, and the subsequent changes in PG production, have therefore been
investigated.
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Figure 26. Mean (± s.e.m., n=5) detected activities of ACS, ACLS and PLA2 in the
endometrium of day 15 pregnant (D15-P), day 29 pregnant (D29-P), day 36 pregnant






























Figure 27. Mean (± s.e.m., n=5) detected activities of ACS, ACLS and PLA2 in the
endometrium (END), subplacenta (S-P), chorio-allantoic placenta (C-P), chorion
(CHO), and amnion (AMN) in day 29 and 36 pregnant guinea-pigs.
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INVESTIGATIONS INTO THE INVOLVEMENT OF ACYL-CoA
SYNTHETASE, ACYL-CoA:LYSOPHOSPHOLIPID ACYLTRANSFERASE
AND PHOSPHOLIPASE A. ACTIVITIES IN THE REGULATION OF
PROSTAGLANDIN RELEASE FROM THE GUINEA-PIG UTERUS.
3:4 Effects of inhibitors of arachidonic acid turnover on prostaglandin
synthesis by day 7 and day 15 guinea-pig endometrium in culture.
Introduction
ACS, ACLS and PLA2 activity have been shown to be present on days 7 and
15 of the oestrous cycle (experiment 3:1) and in the presence of steroid hormones in
ovariectomized animals (experiment 3:2). The following experiment has been carried
out to investigate the role of arachidonic acid turnover in relation to actual PG
synthesis in the uterus.
p-Hydroxymercuribenzoic acid (HMB) has been previously shown to inhibit
both ACS and ACLS (also known as lysolechithin acyltransferase) at a concentration
of 100 pM in the subcellular fraction of human lung fibroblasts (Hunter et al., 1984).
Inhibition of ACS by HMB led to decreased [14C]arachidonyl-CoA formation and also
reduced the concentration of ['^phosphatidylcholine generated as a result of
inactivation of ACLS. It was concluded that this nonspecific inhibitor of many
sulphydryl enzymes (it is a sulphydryl binding agent) could block the re-uptake of free
arachidonic acid into lipid pools (Hunter el al., 1984). Decreased incorporation into
lipid pools following inhibition was unlikely to be attributed to the toxic effects of
HMB, since greater than 90% of fibroblasts remained viable at the end of incubations
and the fibroblasts were still capable of synthesizing arachidonic metabolites. This also
suggests that HMB was probably without effect on PLA2, and since it has been
indicated that PLA2 does not contain sulphydryl groups, HMB would be unable to
form mercaptide bonds with the acylhydrolases (Hunter et al., 1984). 150 pM HMB
resulted in a large, dose-dependent stimulation of PGE2 synthesis of 1490%,
implicating the pathway of free arachidonic acid reacylation as a possible mechanism
for the control of synthesis of arachidonic acid metabolites (Hunter et al., 1984), such
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as PGs. In rat peritoneal macrophages thimerosal (THM), (ethyl[2-
mercaptobenzoato-S]mercury sodium salt, also known as merthiolate), treatment
resulted in a large increase in PGE2, PGI2 and TXB2 synthesis (Goppelt-Struebe et al
1986). THM was demonstrated to be a rather selective inhibitor of ACLS, whilst
PLA2 remained unaffected, and dose-dependently inhibited the incorporation of free
arachidonic acid into cellular phospholipids (at lower concentrations, specifically into
PC) (Goppelt-Struebe et al., 1986). The incorporation of arachidonic acid into PI was
less sensitive towards THM than the incorporation into other lipids, suggesting that
THM did not unspecifically inhibit the reacylation but rather specifically inhibited the
ACLS (Goppelt-Struebe et al., 1986). Unfortunately, this study could not investigate
the effect of THM on ACS (the first enzyme in the reacylation pathway) since one of
the substrates is CoA which would react with THM immediately. Therefore, the
evidence for the specificity of action of THM remains indirect. In human platelets,
THM treatment resulted in a 3 5-fold increase in thromboxane release. In rat
peritoneal macrophages, high concentrations of exogenous free arachidonic acid
resulted in greater quantities of prostanoids synthesized than could be achieved by
THM treatment ie. when only endogenous arachidonic acid was available. The
quantities of synthesized prostanoids in the presence of optimal concentrations of
THM could be further enhanced by the addition of exogenous arachidonic acid. This
would suggest that THM increased prostanoid synthesis by increasing the intracellular
pool of precursor arachidonic acid, without activating the biosynthetic pathway
(Goppelt-Struebe et al., 1986). Sulphydryl reagents, such as HMB and THM, are
usually mercury-containing compounds which readily react with sulphydryl (-SH)
groups. Coenzyme A (CoA) contains a sulphydryl group and therefore, HMB and
THM inhibit arachidonic acid turnover by reacting with CoA and arachidonyl-CoA,
blocking ACS and ACLS activity.
Aristolochic acid (3,4-methylenedioxy-8-methoxy-10-nitro-l-
phenanthrenecarboxylic acid), a nitrophenanthrene derivative isolated from
Aristolochia species, is an herbal medicine used to neutralize snake venom toxicity. It
binds directly (but not covalently) to Vipera russelli PLA2 at domains other than the
active site altering the o-helical content of the protein (which results in an alteration of
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the secondary structure of the molecule) thus inhibiting in vitro enzymatic activity
(see Rosenthal, Vishwanath and Franson, 1989; Rosenthal, Lattanzio and Franson,
1992). Aristolochic acid has been demonstrated to inhibit various calcium-dependent
PLA2s, such as those from human synovial fluid, neutrophils and platelets, as well as
snake venom (see Rosenthal et a/., 1992). Calcium ionophore A23187-stimulated
mobilization of fH]-arachidonate was effectively antagonised by the protein-targeted
PLA2 inhibitor, aristolochic acid, in human neutrophils (Rosenthal et al., 1992). PLA2
activity is not only a function of substrate concentration and pH, but is greatly
influenced by the physiochemical state of the phospholipid substrate. PLA2 is
essentially inactive against monomeric substrate whereas enzyme activity is greatly
increased at concentrations equal or above the critical micelle concentration. Even
with concentrations far exceeding the critical micelle concentration, any perturbation
of the lipid-water interface diminishes enzyme activity. Complex formation between
phospholipid substrate and drug also prevents enzyme attack of the substrate.
Quinacrine (also known as mepacrine) has been shown to inhibit PLA2 activity and
does so by interfering with the substrate-enzyme interface and via complex formation
(Chang, Musser and McGregor, 1987). However, under the strictest terms, it is
inaccurate to consider quinacrine as a direct enzyme inhibitor, and conclusions drawn
from its use in physiological experiments should be considered cautiously (Chang et
al., 1987). Quinacrine has also previously been shown to inhibit PGH synthase
(Flower and Blackwell, 1976) and so the effect of this compound on PG production
should be treated with some caution, since quinacrine may not only influence PG
production by inhibiting PLA2, but also by inhibiting PGH synthase. The potential
effects of all the above inhibitors on PG metabolism should also be considered. If any
of these compounds were also able to inhibit the activity of PGDH, this may result in
increased PG production, since PG metabolism would be reduced. The potential
effects of the inhibitors on the activity of PGDH are unknown.
The effects of p-hydroxymercuribenzoic acid, thimerosal (TPIM) (ACS and
ACLS inhibitors), aristolochic acid (ARA) and quinacrine (QUIN) (PLA2 inhibitors)




The uteri were removed from five day 7 and five day 15 virgin guinea-pigs
that had each displayed at least 3 normal oestrous cycles. Under aseptic conditions,
the two uterine horns from each guinea-pig were "opened" by a longitudinal incision
and the endometrium was dissected away from the myometrium. The endometrium
was cut into 1-2 mm3 pieces and approximately 15 and 40 mg wet weight (5-15 mg
dry weight) of endometrium were placed in each Petri dish for culturing as explained
in section 2:6. Sixteen dishes containing endometrium from each uterus were prepared
with eight dishes being cultured in each of two modified Kilner jars. Each Kilner jar
contained two control dishes (no treatment) which were regularly the top and bottom
dishes to allow for any variation in culturing which may occur in the jars. Three
concentrations of two inhibitor compounds were placed in the remaining six dishes
per jar. The four inhibitors tested were p-hydroxymercuribenzoic acid (HMB) and
thimerosal (THM) at 20, 100 and 500 pM, and aristolochic acid (ARA) and
quinacrine (QUIN) at 10, 50 and 100 pM. The general set up (per animal) is shown
below:-
The Petri dishes were incubated at 37°C for 24 h, and the culture medium was
removed and replaced with fresh medium containing the same treatments every 6 h.







Dish 2-HMB (20 pM)
Dish 3-HMB (100 pM)
Dish 4-HMB (500 pM)
Dish 5-THM (20 pM)
Dish 6-THM (100 pM)
Dish 7-THM (500 pM)
Dish 8-Control
Dish 10-ARA (10 pM)
Dish 11-ARA (50 pM)
Dish 12-ARA (100 pM)
Dish 13-QUIN (10 pM)
Dish 14-QUIN (50 pM)
Dish 15-QUIN (100 pM)
Dish 16-Control
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for PGF2a, PGE2 and 6-keto-PGF ia by radioimmunoassay (as described in section
2:5). After culture, the pieces of endometrium were removed from each Petri dish into
preweighed containers and dried by placing in an oven at 37°C for 24 h. Each
container was then reweighed and the amount of dry endometrium from each Petri
dish was calculated. The outputs of prostaglandins were calculated per mg dry weight
of endometrium per 6 h of culture.
Statistical Tests
Changes in the output of PGs with time were analysed by Duncan's multiple
range test. Differences between treated and control groups were analyzed by
Student's t-test or, if the variances of the two groups were significantly different by
the variance ratio F test, by a modified t-test for unequal variances.
Results
Basal PG outputs
The basal outputs of PGF2a, PGE2 and 6-keto-PGFia from day 7 and day 15 guinea-
pig endometrium cultured for 24 h and sampled at 6 h intervals are shown in Figure
28. The outputs of PGF2a, PGE2 and 6-keto-PGFia from day 15 endometrium and of
6-keto-PGFia from day 7 endometrium significantly (P < 0.05) decreased with time.
During culture of day 7 endometrium, PGF2ct output significantly (P <0.05) increased
with time, whilst PGE2 output remained unchanged. Figure 29 illustrates the total PG
output of PGF2a, PGE2 and 6-keto-PGFia from day 7 and day 15 guinea-pig
endometrium during 24 h culture, and the percentage of each PG produced. PGF2a
was the major PG released from day 15 endometrium (approximately 80 % of total
PG output), with much lower quantities of 6-keto-PGFia and PGE2 (approximately 15
and 5 %, respectively). Initially, 6-keto-PGFia was the major PG released from day 7
endometrium (approximately 60 % of total PG output), with lower amounts of PGF2a
and PGE2 (approximately 30 and 10 % of total PG output). However, as 6-keto-
PGFia output declined and PGF2a output increased, PGF2oc was the major PG released
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Figure 28. Mean (± s.e.m., n=5) outputs of PGF2a, PGE2 and 6-keto-PGFia from day
7 and day 15 non-pregnant guinea-pig endometrium cultured for 24 h and sampled
every 6 h. Columns with the same number for one particular PG on one particular day










































Figure 29. Total PG output from day 7 and day 15 endometrium cultured for 24 h
and sampled every 6 h (Fig. a ), and the percentage PGF2«, PGE2 and 6-keto-PGFia
outputs of the total PG output in day 7 (Fig. b.) and day 15 (Fig. c.) non-pregnant
guinea-pig endometrium.
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keto-PGFia were significantly (P < 0.05) greater from day 15 endometrium than from
day 7 endometrium at all times (see Figure 28).
Effects ofHMB. THM. ARA and QUIN treatments on PG output
i. Day 7 endometrium - The effects of HMB, THM, ARA and QUIN treatments on
PGF2a, PGE2 and 6-keto-PGF)a outputs from day 7 guinea-pig endometrium cultured
for 24 h and sampled at 6 h intervals are shown in Figures 30, 31, 32 and 33,
respectively. HMB, THM, ARA and QUIN had no effect on the outputs of PGF2a,
PGE2 and 6-keto-PGFia from day 7 endometrium during the first 6 h of culture.
PGF2a output - HMB (500 pM), THM (100 and 500 pM) and ARA (10, 50 and 100
pM) significantly (P < 0.05) decreased PGF2a output at 12, 18 and 24 h of culture. 20
pM THM also significantly (P < 0.05) decreased PGF2a output at 18 and 24 h. 100
pM QUIN significantly (P < 0.05) decreased PGF2a output at 12 and 18 h of culture
PGE2 output - None of the inhibitors caused any significant changes in PGE2 output.
6-keto-PGFia output - The output of 6-keto-PGFia was significantly (P < 0.05)
increased by 100 pM HMB at 12 h, by 100 pM THM at 12 and 18 h, and by 20 pM
THM at 18 and 24 h of culture. No significant changes in 6-keto-PGFia output were
observed with ARA and QUIN treatment, except for 50 pM ARA which caused a
significant (P < 0.05) decrease in 6-keto-PGFia output at 18 h of culture.
ii. Day 15 endometrium - The effects of HMB, THM, ARA and QUIN treatments on
PGF2a, PGE2 and 6-keto-PGFia outputs from day 15 guinea-pig endometrium
cultured for 24 h and sampled at 6 h intervals are shown in Figures 34, 35, 36 and 37,
respectively.
PGF2a output - PGF2a output was significantly (P < 0.05) decreased by 500 pM HMB
at 18 h, by 500 and 100 pM THM at 6, 12, 18 and 24 h, and by 20 pM THM at 12
and 18 h of culture. PGF2a output was significantly (P < 0.05) decreased by 50 and
100 pM ARA at 12 h and by 10, 50 and 100 pM ARA at 6, 18 and 24 h of culture.
QUIN also tended to decrease PGF2a output, but this was only significant at 6 h of
culture with 50 pM QUIN (P < 0.05). With regard to PGF2a output, THM and ARA
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Figure 30. Mean (± s.e.m., n—5) outputs of PGF2«, PGE2 and 6-keto-PGFia from day
7 non-pregnant guinea-pig endometrium cultured for 24 h and sampled every 6 h, in
the absence (control) and presence ofHMB (20, 100 and 500 pM). Significantly (P <
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Figure 31. Mean (± s.e.m., n=5) outputs of PGF2a, PGE2 and 6-keto-PGFla from day
7 non-pregnant guinea-pig endometrium cultured for 24 h and sampled every 6 h, in
the absence (control) and presence ofTHM (20, 100 and 500 pM). Significantly (P <
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Figure 32. Mean (± s.e.m., n=5) outputs of PGF2a, PGE2 and 6-keto-PGFia from day
7 non-pregnant guinea-pig endometrium cultured for 24 h and sampled every 6 h, in
the absence (control) and presence of ARA (10, 50 and 100 pM). * Significantly (P <
0.05) lower than the control value for the same PG at the same time.
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Figure 33. Mean (± s.e.m., n=5) outputs of PGF2a, PGE2 and 6-keto-PGFia from day
7 non-pregnant guinea-pig endometrium cultured for 24 h and sampled every 6 h, in
the absence (control) and presence of QUIN (10, 50 and 100 pM). * Significantly (P
< 0.05) lower than the control value for the same PG at the same time.
6 - k©to - R C3 F1 oc
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PGE2 output - PGE2 output was significantly (P < 0.05) decreased by 20 pM HMB at
24 h, by 500 pM THM at 6, 12, 18 and 24 h and by 100 pM THM at 24 h of culture.
100 pM ARA at 6, 12 and 18 h, and 10 pM AJRA at 18 h of culture, also significantly
reduced PGE2 output (P < 0.05). PGE2 output was significantly (P < 0.05) decreased
by 50 pM QUIN at 6 and 12 h and by 100 pM QUIN at 6 h of culture. However, at
24 h of culture, 50 pM QUIN significantly (P < 0.05) increased PGE2 output.
6-keto-PGFia output - HMB had no effect on 6-keto-PGFia output. 500 pM THM
significantly (P < 0.05) decreased 6-keto-PGFia output at 6 and 12 h, whilst 100 pM
THM significantly (P < 0.05) increased output at 24 h of culture. 6-keto-PGFia
output was significantly (P < 0.05) decreased by 10 pM ARA at 6 h, by 50 pM ARA
at 12 and 18 h, and by 100 pM ARA at 6 h of culture. 6-keto-PGFia output was
significantly (P < 0.05) decreased by 50 pM QUIN at 12 h and significantly (P < 0.05)
increased by 100 pM QUIN at 24 h of culture.
Table 7. Summary of the general effects of the four inhibitors on PG output from day
7 and day 15 endometrium during 24 h culture, where t and 4 represent an increase
and decrease in PG output, respectively. The greater the number of arrows, the
greater the influence of the inhibitors on PG output i.e. TTT represents a much
greater increase in PG output than T. "Sig." illustrates whether the change was
significant.
reatmcnt Dav 7 Dav 7 Dav 7 Dav 15 Dav 15 Dav 15
pgf2a pge; 6-keto- pgf2a pge2 6-keto-
pgfla pgfia
HMB 444 sig. No effect T sig. 4 sig. 4 sig. No effect
THM 444 sig. No effect It sig. 444 sig. 44 sig. 4 & t sig.
ARA 444 sig. No effect 4 sig. 44 sig. 4 sig. 4 sig.
QUIN 4 sig. No effect No effect 4 sig. 4 & f sig. 4 & t sig.
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Figure 34. Mean (± s.e.m., n 5) outputs of PGF201, PGE2 and 6-keto-PGFja from day
15 non-pregnant guinea-pig endometrium cultured for 24 h and sampled every 6 h, in
the absence (control) and presence ofHMB (20, 100 and 500 pM). * Significantly (P
< 0.05) lower than the control value for the same PG at the same time.
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Figure 35. Mean (± s.e.m., n=5) outputs of PGF2a, PGE2 and 6-keto-PGFi„ from day
15 non-pregnant guinea-pig endometrium cultured for 24 h and sampled every 6 h, in
the absence (control) and presence of THM (20, 100 and 500 p.M). Significantly (P <
0.05) lower (*) or higher (+) than the control value for the same PG at the same time.
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Figure 36. Mean (± s.e.m., n=5) outputs of PGF2a, PGE2 and 6-keto-PGF]a from day
15 non-pregnant guinea-pig endometrium cultured for 24 h and sampled every 6 h, in
the absence (control) and presence of ARA (10, 50 and 100 pM). * Significantly (P <




















Figure 37. Mean (± s.e.m., n=5) outputs of PGF2a, PGE2 and 6-keto-PGFla from day
15 non-pregnant guinea-pig endometrium cultured for 24 h and sampled every 6 h, in
the absence (control) and presence of QUIN (10, 50 and 100 pM). Significantly (P <
0.05) lower (*) or higher (+) than the control value for the same PG at the same time.
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Discussion
By inhibiting arachidonic acid reacylation into lysophosphospholipids with
HMB and THM (i.e. by inhibiting acyl-CoA synthetase and acyl-
CoAdysophospholipid acyltransferase activities), it was thought that an increase in
free arachidonic acid would occur, thereby resulting in an increase in prostaglandin
production by the guinea-pig endometrium in culture. However, HMB and THM
treatment actually decreased PGF2a production from both day 7 and day 15
endometrium. In contrast to PGF2a, 6-keto-PGFia output from day 7 endometrium
was significantly increased by HMB and TFEM treatment, suggesting that PGF2cc and
PGI2 (as detected by 6-keto- PGF]a) syntheses are controlled differently.
The effects of HMB and THM treatment on prostaglandin production were
found to be different in day 15 animals. PGF2a output was still decreased by the
inhibitors, however PGE2 output was also significantly decreased. The output of 6-
keto-PGFia was unaffected by HMB, and was both increased and decreased by THM
treatment. The lack of effect of the inhibitors on PGE2 output from day 7
endometrium may be due to the very low quantities of the prostaglandin produced at
that time of the cycle (approximately 0.5 ng / mg tissue / 6 h). This would explain why
the inhibitors affected PGE2 output from day 15 (when greater quantites of
prostaglandin are produced) and not from day 7 endometrium.
ARA, and to a lesser extent QUIN, significantly inhibited PGF2a production
from both day 7 and day 15 endometrium, thus PLA2 appears to have a crucial role in
the regulation of arachidonic acid release for endometrial PGF2a synthesis in the
guinea-pig. The inhibition of PLA2 had no effect on PGE2 output from day 7 animals,
but did reduce PGE2 output from day 15 endometrium. Similarly to the results
observed following HMB and THM treatment, the lack of effect of ARA and QUIN
on PGE2 output from day 7 animals may be due to the very low concentrations of
PGE2 produced at that time. ARA treatment significantly reduced 6-keto-PGFia
output from both day 7 and day 15 endometrium. However, the reduction in
prostaglandin output was not as striking as that seen with PGF2a output. QUIN had
very little effect on 6-keto-PGFia output.
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The results with ARA and QUIN clearly indicate the vital role PLA2 plays in
the control of prostaglandin production, particularly of PGF2a, from the guinea-pig
endometrium. The role of the reacylation enzymes, ACS and ACLS, is not as well
defined. The use of inhibitors which supposedly prevent the reacylation of arachidonic
acid did not increase prostaglandin output from guinea-pig endometrium on either day
7 or day 15 of the oestrous cycle. Therefore ACS and ACLS do not appear to play a
significant role in the regulation of endometrial prostaglandin synthesis. However,
inhibition of ACS and ACLS will not only inhibit the "mopping up" of free
arachidonic acid but will also inhibit the turnover of arachidonic acid between
membrane phospholipid stores, thus possibly limiting the amount of arachidonic acid
available in phospholipid stores suitable for the action of PLA2. This may be
particularly true during 24 h tissue culture, due to the long time period of the
experiment, and may explain why ACS and ACLS inhibited PGF2a output.
Another point that should not be overlooked is the potential toxic effects of
the inhibitors on the tissue. This may be of relevance when using high inhibitor
concentrations and during long-term 24 h culture experiments, such as these. This
may explain the decrease, rather than increase, in PG production following
arachidonic acid uptake inhibition. However, if toxic effects were being felt, one may
have expected all PG synthesis to decrease during the 24 h culture, but this was not
the case.
In order to further investigate the role of arachidonic acid turnover in the
guinea-pig uterus, the effects of arachidonic acid turnover inhibitors have been
investigated in uterine and conceptal tissues of early- and mid-pregnant guinea-pigs
during 24 h tissue culture. Only THM and ARA were used in the following
experiment since these had been shown to be the most effective inhibitors in the
previous experiment.
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3:5 Effects of thimerosal and aristolochic acid on prostaglandin synthesis by
day 22, 29 and 36 pregnant guinea-pig uterine and conceptal tissue in
culture.
Introduction
PGF2a output from the guinea-pig uterus increases from about day 11 of the
oestrous cycle. This increase does not occur if the animals are pregnant. The results
observed in section 3:3 suggested that the control of arachidonic acid turnover may
have a role in conceptal tissues during early- and mid-pregnancy in the guinea-pig.
Consequently, the prostaglandin output from endometrium, subplacenta, chorio¬
allantoic placenta and fetal membranes (chorion and amnion) of day 22, 29 and 36
pregnant guinea-pigs, and the effects of inhibitors of arachidonic acid turnover on PG
output, during 24 h of tissue culture and sampled every 6 h have been investigated.
Methods
Fifteen virgin female guinea-pigs which had undergone at least 3 normal
oestrous cycles were mated by placing them separately on days 14-15 of the cycle
(several days prior to oestrus) with a male guinea-pig of proven fertility. The guinea-
pigs were examined daily for signs of mating and for the presence of sperm in the
vaginal smear, with day 1 of pregnancy being designated the first day of observing any
of these signs. Five guinea-pigs were each killed by stunning and incision of the neck,
on days 22, 29 and 36 of pregnancy. Under aseptic conditions the uterus was removed
from each animal and separated into its two horns. Each uterine horn was "opened"
by a longitudinal incision and the conceptuses, along with the placenta, were removed,
by gently pulling them away from the endometrium. The subplacenta, chorio-allantoic
placenta, chorion and amnion were then separated from each conceptus in exactly the
same way as described in section 3:3. All tissues were kept ice-cold and cut into 1-2
mnr pieces. The endometrium was separated from the myometrium by cutting away
1-2 mm3 sections of endometrium using a pair of fine scissors. Approximately 15-40
mg wet weight (5-15 mg dry weight) of each tissue type (endometrium, subplacenta,
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chorioallantoic placenta and fetal membranes) were placed in each Petri dish for
culturing as explained in section 2:6.
Day 29 and 36 pregnant guinea-pigs
Thiry-two Petri dishes containing tissue from each guinea-pig were prepared with
eight dishes being cultured in each of four modified Kilner jars. Each Kilner jar
contained two control dishes (no treatment) which were regularly the top and bottom
dishes to allow for any variation in culturing which may occur in the jars. Three
concentrations of two inhibitor compounds were placed in the remaining six dishes
per jar. The two inhibitors tested were thimerosal (THM) at 20, 100 and 500 pM and















































Day 22 pregnant guinea-pigs
Exactly the same procedure was used to set up uterine and conceptal tissue from day
22 pregnant animals as from day 29 and 36 pregnant guinea-pigs. However, in day 22
pregnant guinea-pigs, insufficient fetal membrane tissue was available to prepare all
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eight Petri dishes for culture. Therefore, in day 22 pregnant animals, only two dishes














































All Petri dishes were incubated at 37°C for 24 h, and the culture medium was
removed and replaced with fresh medium containing the same treatments every 6 h
The samples of culture medium obtained were stored at -20°C before being assayed
for PGF2a, PGE2 and 6-keto-PGFia by radioimmunoassay (section 2:5). After culture,
the pieces of tissue were removed from each Petri dish into preweighed containers
and dried by placing in an oven at 37°C for 24 h. Each container was then reweighed
and the amount of dry tissue from each Petri dish was calculated. The outputs of
prostaglandins were calculated per mg dry weight of tissue per 6 h.
Statistical Tests
Changes in the output of PGs with time were analysed by Duncan's multiple
range test. Differences between treated and control groups were analyzed by
Student's t-test or, if the variances of the two groups were significantly different by
the variance ratio F test, by a modified t-test for unequal variances.
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Results and Discussion
A. Basal PG outputs during culture
Results
Basal PG outputs from the endometrium
The basal outputs of endometrial PGF2a, PGE2 and 6-keto-PGFia from day 22, 29 and
36 pregnant guinea-pigs during 24 h culture are illustrated in Figure 38. Whilst
endometrial PGF2a output was seen to decrease during pregnancy (i.e. PGF2a output
on day 22 > day 29 > day 36 pregnant animals), 6-keto-PGFia output increased
during pregnancy (i.e. 6-keto-PGFia output on day 36 > day 29 > day 22 pregnant
animals). In comparison to measurements on day 22 of pregnancy, PGF2a output was
significantly (P < 0.05) lower on day 29 of pregnancy at 18 h and on day 36 of
pregnancy at 6, 12, 18 and 24 h of culture. Endometrial PGF2a output was also
significantly (P < 0.05) lower on day 36 compared to day 29 of pregnancy at 6, 12, 18
and 24 h of culture. PGE2 output was not significantly different at 12, 18 and 24 h of
culture on any day of pregnancy, although output from day 29 endometrium appeared
to be highest. Indeed, at 6 h of culture PGE2 output was significantly (P < 0.05)
greater from day 29 compared to day 22 pregnant endometrium, and significantly (P <
0.05) lower from day 36 compared to day 29 pregnant endometrium. Endometrial 6-
keto-PGFia output was significantly (P < 0.05) greater on day 29 of pregnancy at 18
h and on day 36 of pregnancy at 12, 18 and 24 h of culture compared to 6-keto-
PGFia output on day 22 of pregnancy. At 18 h of culture, 6-keto-PGFia output was
also significantly (P < 0.05) greater in day 36, compared to day 29, pregnant guinea-
pigs.
Endometrial PGF2a and PGE2 outputs tended to increase during culture on all
days of pregnancy. The output of 6-keto-PGF]a from day 22 pregnant animals
appeared to decrease during culture, whilst output tended to increase during culture in
day 29 and day 36 pregnant animals.
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Figure 38. Mean (± s.e.m., n=5) outputs of PGF2a, PGE2 and 6-keto-PGFla from
endometrium of day 22, 29 and 36 pregnant guinea-pigs cultured for 24 h and
sampled every 6 h. Significantly (P < 0.05) different to day 22 (*) or day 29 (+) value
for the same PG at the same time.
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Basal PG outputs from the subplacenta
The basal outputs of PGF2a, PGE2 and 6-keto-PGFia from the subplacenta of day 22,
29 and 36 pregnant guinea-pigs during 24 h tissue culture are illustrated in Figure 39.
PGF2a, PGE2 and 6-keto-PGFi„ outputs from the subplacenta all appeared to be
greatest on day 29 of pregnancy. PGF2a output was significantly (P < 0.05) lower in
day 36, compared to day 22 pregnant animals, at 6, 12 and 24 h of culture and in day
36, compared to day 29 pregnant animals, at 6, 12, 18 and 24 h of culture. PGE2
output was significantly greater from day 29 pregnant animals at 12, 18 and 24 h, and
from day 36 pregnant animals at 18 and 24 h of culture, compared to PGE2 output
from day 22 pregnant guinea-pigs. However, PGE2 output was significantly lower on
day 36, compared to day 29 of pregnancy, at 12, 18 and 24 h of culture. The output
of 6-keto-PGFia was similar on all days of pregnancy, except for a significant increase
in output on day 29, compared to day 22 of pregnancy, at 18 and 24 h of culture. The
outputs of all the prostaglandins tended to decrease during culture.
Basal PG outputs from the chorio-allantoic placenta
The basal outputs of PGF2a, PGE2 and 6-keto-PGFia from the chorio-allantoic
placenta of day 22, 29 and 36 pregnant guinea-pigs during 24 h tissue culture are
illustrated in Figure 40. All PG outputs from the chorio-allantoic placenta in culture
increased from day 22 to day 36 of pregnancy. PGF2a output was significantly (P <
0.05) greater on day 29 of pregnancy at 6, 12, 18 and 24 h and on day 36 of
pregnancy at 6, 12, 18 and 24 h of culture, compared to PGF2a output on day 22 of
pregnancy. PGF2a output was also significantly (P < 0.05) greater on day 36,
compared to day 29, of pregnancy at 24 h of culture. PGE2 output increased
throughout pregnancy, but these increases were only significant on day 36, compared
to day 22, of pregnancy at 6 and 18 h (P < 0.05) of culture. Similarly, 6-keto-PGFia
output tended to increase throughout pregnancy, but these increases were only
significant (P < 0.05) on day 36, compared to day 22, of pregnancy at 6 and 24 h of
culture and on day 36, compared to day 29, of pregnancy at 6 h of culture. All PG
outputs on all days of pregnancy tended to decrease during culture.
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Figure 39. Mean (± s.e.m., n=5) outputs ofPGF2a, PGE2 and 6-keto-PGF]a from the
subplacenta of day 22, 29 and 36 pregnant guinea-pigs cultured for 24 h and sampled
every 6 h. Significantly (P < 0.05) different to day 22 (*) or day 29 (+) value for the
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Figure 40. Mean (± s.e.m., n=5) outputs of PGF2a, PGE2 and 6-keto-PGFla from the
chorio-allantoic placenta of day 22, 29 and 36 pregnant guinea-pigs cultured for 24 h
and sampled every 6 h. Significantly (P < 0.05) different to day 22 (*) or day 29 (+)
value for the same PG at the same time.
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Basal PG outputs from the fetal membranes
The basal outputs of PGF2a, PGE2 and 6-keto-PGFia from the fetal membranes of day
22, 29 and 36 pregnant guinea-pigs during 24 h tissue culture are illustrated in Figure
41. PG outputs tended to be higher in late pregnant guinea-pigs; this was especially
true at 18 and 24 h of culture. PGF2a output was significantly (P < 0.05) greater on
day 29, compared to day 22, of pregnancy at 18 and 24 h of culture. PGE2 output was
significantly (P < 0.05) greater on day 29 of pregnancy at 12, 18 and 24 h and on day
36 of pregnancy at 18 and 24 h of culture compared to PGE2 output on day 22 of
pregnancy. PGE2 output was significantly (P < 0.05) lower on day 36 compared to
day 29 of pregnancy at 12 h of culture. The output of 6-keto-PGFia was significantly
(P < 0.05) greater in day 29 pregnant animals at 18 and 24 h of culture and in day 36
pregnant animals at 18 and 24 h of culture, compared to day 22 pregnant guinea-pigs.
At 18 h of culture, 6-keto-PGF!a output was significantly (P < 0.05) lower in day 36,
compared to day 29, pregnant animals. All PG outputs on day 22 of pregnancy tended
to decrease during culture, whilst on day 29 and 36 of pregnancy, PG outputs tended
to increase during culture.
Discussion
In previous tissue culture experiments it has been demonstrated that the
presence of indomethacin in the culture medium greatly inhibits the output of all three
PGs (Riley and Poyser, 1990), indicating that PG synthesis and secretion from guinea-
pig endometrium occurs during tissue culture. In the above experiment all basal PG
outputs from the endometrium, particularly PGF2a, increased during 24 h tissue
culture. This may result from the removal of the inhibitory influence of progesterone
on endometrial PGF2ct synthesis in the guinea-pig (Leaver and Seawright, 1982; Riley
and Poyser, 1987a), due to the removal of the tissue from the animal. It is also clear
that endometrial PGF2a and 6-keto-PGFia outputs decreased and increased,
respectively during pregnancy (i.e. between days 22 and 36 of pregnancy) in the
guinea-pig. Therefore, a certain amount of redistribution from PGF2a synthesis to 6-
keto-PGFla synthesis may occur as gestation advances.
The outputs of PGF2a and 6-keto-PGFia were generally greatest from the
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Figure 41. Mean (± s.e.m., n=5) outputs of PGF2a, PGE2 and 6-keto-PGFla from the
fetal membranes of day 22, 29 and 36 pregnant guinea-pigs cultured for 24 h and
sampled every 6 h. Significantly (P < 0.05) different to day 22 (*) or day 29 (+) value
for the same PG at the same time.
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fold increase in PGF2(X output between days 22 and 36 of pregnancy in the chorio¬
allantoic placenta (when compared at 6 h of culture). PGE2 output was similar in all
tissues. The results indicate that in the pregnant guinea-pig, the endometrium
continues to be a major source of prostaglandins, with the chorio-allantoic placenta
having a role in increased prostaglandin, particularly PGF2a, output later in pregnancy.
B. Effects of THM and ARA treatment on endometrial PG outputs
Results
i. Endometrium from day 22 preunant animals
The effects of THM and ARA treatment on endometrial PG outputs from day
22 pregnant guinea-pigs during 24 h tissue culture and sampled every 6 h are
illustrated in Figures 42 and 43.
PGF2aoutput - PGF2a output was significantly (P < 0.05) decreased by 500 pM THM
at 6, 12, 18 and 24 h, by 100 pM THM at 12, 18 and 24 h, and by 20 pM THM at 18
and 24 h of culture. 10, 50 and 100 pM ARA all significantly (P < 0.05) decreased
PGF2a output at 6 h of culture. PGF2a output was also significantly (P < 0.05)
decreased by 100, 50 and 10 pM ARA at 12, 18 and 24 h of culture.
PGEi output - Both THM and ARA treatment inhibited PGE2 output; these decreases
were significant at 12, 18 and 24 h of culture. 500 and 100 pM THM significantly (P
< 0.05) decreased PGE2 output at 12, 18 and 24 h of culture, and 20 pM THM
significantly (P < 0.05) decreased PGE2 output at 24 h of culture. 100, 50 and 10 pM
ARA significantly (P < 0.05) decreased PGE2 output at 12, 18 and 24 h of culture.
6-keto-PGFia output - 6-keto-PGFja output was significantly (P < 0.05) increased by
THM treatment at 12 h by 500, 100 and 20 pM, at 18 h by 500 and 100 pM and at 24
h of culture by 100 pM THM. Treatment of endometrium with ARA decreased 6-
keto-PGFia output; these decreases were significant at 6, 12 and 24 h of culture. 6-
keto-PGFia output was significantly (P < 0.05) decreased by 100 pM ARA at 6, 12
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Figure 42. Mean (± s.e.m., n=5) outputs of PGF2a, PGE2 and 6-keto-PGFla from day
22 pregnant guinea-pig endometrium cultured for 24 h and sampled every 6 h, in the
absence (control) and presence of THM (20, 100 and 500 pM). Significantly (P <
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Figure 43. Mean (± s.e.m., n=5) outputs of PGF2a, PGE2 and 6-keto-PGFia from day
22 pregnant guinea-pig endometrium cultured for 24 h and sampled every 6 h, in the
absence (control) and presence of ARA (10, 50 and 100 pM). * Significantly (P <
0.05) lower than the control value for the same PG at the same time.
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ii. Endometrium from day 29 pregnant animals
The effects of THM and ARA treatment on endometrial PG outputs from day
29 pregnant guinea-pigs during 24 h tissue culture and sampled every 6 h are
illustrated in Figures 44 and 45.
PGF2aoutput - PGF2« output was significantly (P < 0.05) decreased by 500 pM THM
at 6, 12, 18 and 24 h, by 100 pM THM at 6, 12, 18 and 24 h, and by 20 pM THM at
6, 18 and 24 h of culture. All concentrations of ARA at all times of culture
significantly (P < 0.05) decreased PGF2a output.
PGE2 output - THM treatment decreased PGE2 output in general. Significant (P <
0.05) decreases resulted from treatment with 500 pM THM at 12, 18 and 24 h, with
100 pM THM at 18 and 24 h, and with 20 pM THM at only 24 h of culture. PGE2
output was also significantly (P < 0.05) decreased by 100 pM and 50 pM ARA at 18
and 24 h, and by 10 pM ARA at 12 and 24 h of culture.
6-keto-PGFia output - 20 pM THM significantly (P < 0.05) increased 6-keto-PGFia
output at 6, 12 and 18 h of culture. 100 pM THM also significantly (P < 0.05)
increased output at 12 and 24 h of culture. 500 pM THM significantly (P < 0.05)
increased and decreased 6-keto-PGFia output at 12 and 24 h of culture, respectively.
ARA treatment tended to decrease endometrial 6-keto-PGFia output from day 29
pregnant animals. These decreases were significant (P < 0.05) following treatment
with 10, 50 and 100 pM at 12 h, and with 50 pM and 100 pM at 18 h and 24 h of
culture.
iii. Endometrium from day 36 pregnant animals
The effects of THM and ARA treatment on endometrial PG outputs from day
36 pregnant guinea-pigs during 24 h tissue culture and sampled every 6 h are
illustrated in Figures 46 and 47.
PGF2a output - Both THM and ARA treatment decreased endometrial PGF2ct output
on day 36 of pregnancy. These decreases were significant (P < 0.05) with 500 pM
and 100 pM ARA at 6, 12, 18 and 24 h, with 100 pM THM at 18 and 24 h, with 20
pM THM at 18 h, with 50 pM ARA at 6 and 24 h, and with 10 pM ARA at 18 and























Figure 44. Mean (± s.e.m., n=5) outputs of PGF2a, PGE2 and 6-keto-PGFia from day
29 pregnant guinea-pig endometrium cultured for 24 h and sampled every 6 h, in the
absence (control) and presence of THM (20, 100 and 500 pM). Significantly (P <
0.05) lower (*) or higher (+) than the control value for the same PG at the same time.
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Figure 45. Mean (± s.e.m., n=5) outputs of PGF2a, PGE2 and 6-keto-PGFia from day
29 pregnant guinea-pig endometrium cultured for 24 h and sampled every 6 h, in the
absence (control) and presence of ARA (10, 50 and 100 pM). * Significantly (P <
0.05) lower than the control value for the same PG at the same time.
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Figure 46. Mean (± s.e.m., n=5) outputs of PGF2«, PGE2 and 6-keto-PGFla from day
36 pregnant guinea-pig endometrium cultured for 24 h and sampled every 6 h, in the
absence (control) and presence of THM (20, 100 and 500 pM). Significantly (P <
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Figure 47. Mean (± s.e.m., n—5) outputs of PGF2a, PGE2 and 6-keto-PGFia from day
36 pregnant guinea-pig endometrium cultured for 24 h and sampled every 6 h, in the
absence (control) and presence of ARA (10, 50 and 100 pM). * Significantly (P <
0.05) lower than the control value for the same PG at the same time.
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PGE2 output - Both THM and ARA treatment tended to decrease endometrial PGE2
output on day 36 of pregnancy. PGE2 output was significantly (P < 0.05) decreased by
20 p.M THM at 6, 18 and 24 h, by 100 pM THM at 6 and 24 h, by 500 pM THM at
18 and 24 h, by 10 pM ARA at 12, 18 and 24 h, by 50 pM ARA at 18 and 24 h, and
by 100 pM ARA at 12, 18 and 24 h of culture.
6-keto-PGFia output - Variable changes in 6-keto-PGFia output due to THM
treatment were measured during culture, since 100 pM THM significantly(P < 0.05)
decreased output at 6 h, but 500 pM and 100 pM THM significantly (P < 0.05)
increased output at 12 and 24 h of culture, respectively. Similarly to, but not as
dramatically as PGF2a and PGE2 outputs, 6-keto-PGFJa output was decreased by
ARA treatment. At 6 h of culture, 6-keto-PGFia output was significantly (P < 0. 05)
decreased by 10, 50 and 100 pM ARA and at 24 h of culture by 10 pM ARA.
Discussion
On all days of pregnancy, treatment with THM (an inhibitor of arachidonic
acid reacylation) resulted in a reduction in the outputs of both endometrial PGF2a and
PGE2. In contrast, 6-keto-PGFi„ output was increased by THM treatment. ARA, the
PLA2 inhibitor, decreased the outputs of all PGs on all days of pregnancy illustrating
the essential role that PLA2 plays in the control of the release of free arachidonic acid
for prostaglandin production by the guinea-pig endometrium
C. Effects of THM and ARA treatment on PG output from the subplacenta
Results
i. Subplacenta from day 22 pregnant animals
The effects of THM and ARA treatment on PG outputs from the subplacenta
of day 22 pregnant guinea-pigs during 24 h tissue culture and sampled every 6 h are
illustrated in Figures 48 and 49.
PGF2a output - PGF2a output from the subplacenta of early (day 22) pregnant guinea-
pigs appeared to be generally unaffected by either THM or ARA treatment. However,
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Figure 48. Mean (± s.e.m., n=5) outputs of PGF2a, PGE2 and 6-keto-PGFla from the
subplacenta of day 22 pregnant guinea-pigs cultured for 24 h and sampled every 6 h,
in the absence (control) and presence ofTHM (20, 100 and 500 pM).
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Figure 49. Mean (± s.e.m., n=5) outputs of PGF2a, PGE2 and 6-keto-PGFla from the
subplacenta of day 22 pregnant guinea-pigs cultured for 24 h and sampled every 6 h,
in the absence (control) and presence of ARA (10, 50 and 100 pM).
+ Significantly (P < 0.05) higher than the control value for the same PG at the same
time
182
THM (20 pM, but not 100 and 500 pM) at 12, 18 and 24 h of cuture; this
potentiation was significant (P < 0.05) at 24 h of culture.
PGE2 output - PGE2 output was significantly (P < 0.05) increased with 20 pM THM
at 24 h, with 100 pM THM at 12, 18 and 24 h, and with 500 pM THM at 6, 12, 18
and 24 h of culture. ARA treatment dose-dependently increased PGE2 output;
significant (P < 0.05) increases were measured with 10 pM ARA at 18 and 24 h, with
50 pM ARA at 12, 18 and 24 h, and with 100 pM ARA at 6, 12 and 24 h of culture.
6-keto-PGFia output - The output of 6-keto-PGFia did not significantly change
following either THM or ARA treatment. However, both inhibitors did appear to
slightly potentiate 6-keto-PGFia output; this was particularly true of 100 pM THM at
all times during culture.
ii. Subplacenta from day 29 pregnant animals
The effects of THM and ARA treatment on PG outputs from the subplacenta
of day 29 pregnant guinea-pigs during 24 h tissue culture and sampled every 6 h are
illustrated in Figures 50 and 51.
PGF2a output - PGF2a output was generally unaffected by either THM or ARA
treatment, except for 100 pM THM which increased PGF2a output at 12, 18 and 24 h
of culture, although the increase was significant (P < 0.05) only at 12 and 24 h. Also,
PGF2a output was significantly decreased by 50 and 100 pM ARA at 12 h of culture
(P <0.05).
PGE2 output - PGE2 output was generally increased following THM or ARA
treatment. Increases were significant (P < 0.05) with 100 pM THM at 18 and 24 h,
and with 100 pM ARA at 12 h of culture.
6-keto-PGFia output - No significant changes in 6-keto-PGFia output were measured
folowing either THM or ARA treatment of subplacenta tissue from day 29 pregnant
guinea-pigs, except for 100 pM ARA which significantly increased 6-keto-PGF\a
output (P < 0.05) at 12 h of culture.
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Figure 50. Mean (± s.e.m., n=5) outputs of PGF2a, PGE2 and 6-keto-PGFla from the
subplacenta of day 29 pregnant guinea-pigs cultured for 24 h and sampled every 6 h
in the absence (control) and presence ofTFIM (20, 100 and 500 pM).
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Figure 51. Mean (± s.e.m., n=5) outputs of PGF2a, PGE2 and 6-keto-PGFla from the
subplacenta of day 29 pregnant guinea-pigs cultured for 24 h and sampled every 6 h,
in the absence (control) and presence of ARA (10, 50 and 100 |aM). Significantly (P <
0.05) lower (*) or higher (+) than the control value for the same PG at the same time.
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iii. Subplacenta from day 36 pregnant animals
The effects of THM and ARA treatment on PG outputs from the subplacenta
of day 36 pregnant guinea-pigs during 24 h tissue culture and sampled every 6 h are
illustrated in Figures 52 and 53.
PGF2a output - The output of PGF2a appeared generally unaffected following either
THM or ARA treatment, except with 500 pM THM which significantly (P < 0.05)
decreased PGF2a output at 6 h, and with 20 and 100 pM THM which significantly (P
< 0.05) increased PGF2a output at 24 h of culture.
PGE2 output - Both THM and ARA treatment appeared to increase PGE2 output.
However, this was only to a significant (P < 0.05) level with 100 pM THM at 18 and
24 h, and with 500 pM THM at 12 and 18 h of culture.
6-keto-PGFia output - Significant (P < 0.05) increases in 6-keto-PGFia output were
measured with 20 pM THM at 24 h, with 100 pM THM at 12 and 18 h, with 500 pM
THM at 12 h, and with 50 pM and 100 pM ARA at 12 h of culture.
Discussion
In contrast to the results demonstrated in the endometrium, PGF2a and PGE2
outputs tended to be increased slightly by an inhibitor (THM) of the reacylation of
arachidonic acid. The output of 6-keto-PGFia was generally unaffected by THM
treatment, except for a slight increase on day 36 of pregnancy. ARA treatment had no
effect on PGF2a output (except for a slight decrease in day 29 pregnant animals)
indicating that PLA2 is not involved in the control of PGF2a synthesis from the
subplacenta. Unexpected results were found as with regard to PGE2 and 6-keto-
PGFia outputs; ARA treatment increased PGE2 output on days 22 and 29 of
pregnancy and increased 6-keto-PGFia on days 29 and 36 of pregnancy.
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Figure 52. Mean (± s.e.m., n=5) outputs of PGF2a, PGE2 and 6-keto-PGFia from the
subplacenta of day 36 pregnant guinea-pigs cultured for 24 h and sampled every 6 h,
in the absence (control) and presence of THM (20, 100 and 500 |iM). Significantly (P
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Figure 53. Mean (± s.e.m., n=5) outputs of PGF2a, PGE2 and 6-keto-PGFla from the
subplacenta of day 36 pregnant guinea-pigs cultured for 24 h and sampled every 6 h,
in the absence (control) and presence ofARA (10, 50 and 100 faM). + Significantly (P
< 0.05) higher than the control value for the same PG at the same time.
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D. Effects of THM and ARA treatment on PG output from the chorio-allantoic
placenta
Results
i. Chorio-allantoic placenta from day 22 pregnant animals
The effects of THM and ARA treatment on PG outputs from the chorio¬
allantoic placenta of day 22 pregnant guinea-pigs during 24 h tissue culture and
sampled every 6 h are illustrated in Figures 54 and 55.
PGF2a output - PGF2a output was unaffected by THM or ARA treatment, except for a
significant decrease with 10 pM ARA at 12 h of culture (P < 0.05).
PGE2 output - PGE2 output was generally potentiated by THM treatment at 12, 18
and 24 h of culture. Increases were significant (P < 0.05) with 20, 100 and 500 pM
THM at 18 and 24 h of culture. ARA treatment tended to decrease PGE2 output at
low concentrations and increase PGE2 output at high concentrations. However, the
only significant (P < 0.05) change measured was the decrease in output at 6 and 12 h
of culture.
6-keto-PGF\a output - 6-keto-PGFi„ output was significantly (P < 0.05) increased
with 100 pM THM at 18 and 24 h, and with 50 pM ARA at 6 h of culture.
ii. Chorio-allantoic placenta from day 29 preitnant animals
The effects of THM and ARA treatment on PG outputs from the chorio¬
allantoic placenta of day 29 pregnant guinea-pigs during 24 h tissue culture and
sampled every 6 h are illustrated in Figures 56 and 57.
PGF2a output - THM treatment potentiated PGF2a output at 12, 18 and 24 h of
culture. Increases were significant (P < 0.05) at 24 h with 100 and 500 pM THM.
PGF2a output was unaffected by ARA treatment.
PGE2 output - THM treatment potentiated PGE2 output at 12, 18 and 24 h of culture.
Increases were significant (P < 0.05) with 100 pM THM at 18 and 24 h of culture.
PGE2 output was unaffected by ARA treatment.
6-keto-PGFia output - The output of 6-keto-PGFia was generally unaffected by both
THM and ARA treatment, except with 500 pM THM at 24 h and with 10 pM ARA
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Figure 54. Mean (± s.e.m., n=5) outputs ofPGF2a, PGE2 and 6-keto-PGFla from the
chorio-allantoic placenta of day 22 pregnant guinea-pigs cultured for 24 h and
sampled every 6 h, in the absence (control) and presence of THM (20, 100 and 500
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Figure 55. Mean (± s.e.m., n=5) outputs of PGF2a, PGE2 and 6-keto-PGF]a from the
chorio-allantoic placenta of day 22 pregnant guinea-pigs cultured for 24 h and
sampled every 6 h, in the absence (control) and presence ofARA (10, 50 and 100
pM). Significantly (P < 0.05) lower (*) or higher (+) than the control value for the
same PG at the same time.
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Figure 56. Mean (± s.e.m., n=5) outputs ofPGF2a, PGE2 and 6-keto-PGFia from the
chorio-allantoic placenta of day 29 pregnant guinea-pigs cultured for 24 h and
sampled every 6 h, in the absence (control) and presence ofTHM (20, 100 and 500
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Figure 57. Mean (± s.e.m., n=5) outputs of PGF2a, PGE2 and 6-keto-PGFia from the
chorio-allantoic placenta of day 29 pregnant guinea-pigs cultured for 24 h and
sampled every 6 h, in the absence (control) and presence of ARA (10, 50 and 100
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iii. Chorioallantoic placenta from day 36 pregnant animals
The effects of THM and ARA treatment on PG outputs from the chorio¬
allantoic placenta of day 36 pregnant guinea-pigs during 24 h tissue culture and
sampled every 6 h are illustrated in Figures 58 and 59.
PGF2a output - THM treatment resulted in little change in PGF2a output at 6, 12 and
18 h, but significant (P < 0.05) increases in PGF2a output occurred at 24 h of culture
following 100 and 500 |aM THM treatment. ARA treatment tended to potentiate
PGF2cc output, and significant (P < 0.05) increases occurred following 10 p.M ARA
treatment at 18 and 24 h, and 50 pM ARA treatment at 24 h of culture.
PGEi output - PGE2 output was unaffected by either THM or ARA treatment
throughout culture.
6-keto-PGFia output - 6-keto-PGFia output was unaffected by either THM or ARA
treatment throughout culture.
Discussion
THM treatment had no effect on PGF2a output from the day 22 pregnant
chorio-allantoic placenta, but did result in slight increases in PGF2a output from the
chorio-allantoic placenta of day 29 and 36 pregnant guinea-pigs but only after 24 h of
culture. PGE2 and 6-keto- PGFja outputs were increased by THM following 18 and
24 h of culture in day 22 and 29 pregnant animals. However, neither PG was affected
by THM on day 36 of pregnancy.
Inhibition of PLA2 with ARA had very little effect on the chorio-allantoic
placenta in comparison to its dramatic effects on the endometrium. ARA only slightly
inhibited PGF2a and PGE2 output on day 22 of pregnancy, had no effect on either of
the two PGs on day 29 of pregnancy, and increased PGF2a output after 18 and 24 h of
culture from day 36 pregnant animals. 6-keto-PGFia output was also increased
following the inhibition of PLA2 with ARA in both day 22 and 29 pregnant animals,
but was unaffected on day 36 of pregnancy. Therefore, PLA2 would not appear to
have an important role in the control of PG synthesis from the chorio-allantoic
placenta. It is particularly unexpected that ARA treatment actually increased PGF2a
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Figure 58. Mean (± s.e.m., n=5) outputs of PGF2a, PGE2 and 6-keto-PGFia from the
chorio-allantoic placenta of day 36 pregnant guinea-pigs cultured for 24 h and
sampled every 6 h, in the absence (control) and presence ofTHM (20, 100 and 500
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Figure 59. Mean (± s.e.m., n=5) outputs of PGF2a, PGE2 and 6-keto-PGFia from the
chorio-allantoic placenta of day 36 pregnant guinea-pigs cultured for 24 h and
sampled every 6 h, in the absence (control) and presence of AIFA (10, 50 and 100
pM). + Significantly (P < 0.05) higher than the control value for the same PG at the
same time.
1%
placenta after 18 and 24 h of culture in day 36 pregnant animals, especially since
relatively high concentrations of PGF2a are produced by the chorio-allantoic placenta
at that time.
E. Effects of THM and ARA treatment on PG output from the fetal membranes
Results
i. Fetal membranes from day 29 pregnant animals
The effects of THM and ARA treatment on PG outputs from the fetal
membranes of day 29 pregnant guinea-pigs during 24 h tissue culture and sampled
every 6 h are illustrated in Figures 60 and 61.
PGFia output - No significant changes in PGF2a output were measured following
THM treatment, except with 100 pM THM which significantly (P < 0.05) increased
PGF2a output at 24 h of culture. ARA treatment tended to inhibit PGF2a output, with
significant (P < 0.05) decreases measured following 10 pM ARA treatment at 6 and
24 h, following 50 pM ARA treatment at 24 h, and following 100 pM ARA treatment
at 6 and 24 h of culture.
PGE2 output - PGE2 output was generally unaffected following THM or ARA
treatment, except with 20 and 100 pM THM at 24 h which both significantly
increased PGE2 output (P < 0.05).
6-keto-PGFia output - The output of 6-keto-PGFia was significantly (P < 0.05)
decreased with 500 pM THM at 24 h and with 10 pM ARA at 6 h of culture. No
other significant changes in 6-keto-PGFla output were measured.
ii Fetal membranes from day 36 pregnant animals
The effects of THM and ARA treatment on PG outputs from the fetal
membranes of day 36 pregnant guinea-pigs during 24 h tissue culture and sampled
every 6 h are illustrated in Figures 62 and 63.
PGF2a output - The output of PGF2a appeared to be unaffected by THM treatment,
except for a significant (P < 0.05) potentiation with 100 pM THM at 24 h of culture.
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Figure 60. Mean (± s.e.m., n=5) outputs of PGF2a, PGE2 and 6-keto-PGFla from the
fetal membranes of day 29 pregnant guinea-pigs cultured for 24 h and sampled every
6 h, in the absence (control) and presence of THM (20, 100 and 500 pM).
Significantly (P < 0.05) lower (*) or higher (+) than the control value for the same PG
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Figure 61. Mean (± s.e.m., n=5) outputs of PGF2a, PGE2 and 6-keto-PGFia from the
fetal membranes of day 29 pregnant guinea-pigs cultured for 24 h and sampled every
6 h, in the absence (control) and presence of ARA (10, 50 and 100 pM).




















p =b ^ Hi EEEE
:.i
T imo ( h )
Figure 62. Mean (± s.e.m., n=5) outputs of PGF2a, PGE2 and 6-keto-PGFla from the
fetal membranes of day 36 pregnant guinea-pigs cultured for 24 h and sampled every
6 h, in the absence (control) and presence of THM (20, 100 and 500 pM).
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Figure 63. Mean (± s.e.m., n=5) outputs of PGF2a, PGE2 and 6-keto-PGFia from the
fetal membranes of day 36 pregnant guinea-pigs cultured for 24 h and sampled every
6 h, in the absence (control) and presence of ARA (10, 50 and 100 pM).
* Significantly (P < 0.05) lower than the control value for the same PG at the same
time.
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PGE2 output - No significant changes in PGE2 output were measured following either
THM or ARA treatment, except for a significant (P < 0.05) decrease in PGE2 output
at 24 h of culture following 10 p.M and 100 p.M ARA treatment.
6-keto-PGF)a output - The output of 6-keto-PGFia was significantly (P < 0.05)
increased by 20 pM THM at 18 h, by 100 pM THM at 6, 12, 18 and 24 h, and by 500
pM THM at 18 h of culture. ARA treatment significantly (P < 0.05) decreased 6-
keto-PGFia output; at 6 h with 10, 50 and 100 pM ARA, and at 12 h of culture with
50 and 100 pM ARA.
Discussion
THM treatment increased PGF2a output, but only after 24 h of culture in both
day 29 and 36 pregnant guinea-pig fetal membranes (chorion and amnion). PGE2
output was also increased in day 29 animals after 24 h of culture. 6-keto-PGF]a
output was slightly decreased on day 29, but greatly increased throughout culture in
day 36 pregnant animals. ARA treatment generally decreased PGF2a output from the
fetal membranes on both days of pregnancy. PGE2 output was unaffected by ARA
treatment on day 29 of pregnancy, and slightly reduced in day 36 pregnant animals.
The output of 6-keto-PGFia was decreased by ARA early during culture, but was
unaffected after 18 and 24 h of culture. Since PLA2 activity was detected in the fetal
membranes of day 29 and 36 pregnant animals in section 3:3, the evidence suggests
that PLA2 is involved in the control of PG synthesis in the fetal membranes.
The inhibition of arachidonic acid reacylation appeared to increase PGF2a and
PGE2 output after 24 h of culture. Interestingly, the output of 6-keto-PGFla was
greatly increased by TFfM in day 36 pregnant animals. Thus, the control of
arachidonic acid reacylation appears to be involved in the regulation of PG output,




With regard to the control of arachidonic acid turnover and the resultant PG
outputs, it would appear that the control of PGF2a, PGE2 and 6-keto-PGFia outputs
differs amongst guinea-pig uterine and conceptal tissues and at the various stages of
pregnancy investigated.
THM, an inhibitor of arachidonic acid reacylation, decreased both PGF2a and
PGE2 outputs and increased 6-keto-PGFia output from the endometrium on all days
of pregnancy. It would therefore appear that by inhibiting ACS and ACLS activity,
the concentration of free arachidonic acid remained high enabling increased 6-keto-
PGFia output. However, PGF2a and PGE2 outputs were reduced. This may be
explained by the theory that by inhibiting general arachidonic acid reacylation, the
appropriate phospholipids (i.e. containing sn-2 position arachidonic acid) available to
PLA2 became limiting. These results suggest that the control of PGF2a and PGE2
synthesis and that of PGI2 (as detected by 6-keto-PGFia) are different. This is in
agreement with the findings of Poyser (1991) which implicated that a different pool of
arachidonic acid and a PLA2 enzyme located in a different site are used for the
production of 6-keto-PGFia than those which are used for the production of PGF2a
and PGE2 in the guinea-pig endometrium. Previous studies have also demonstrated
that the syntheses of PGF2a and PGI2 are controlled by different intracellular
processes (Riley and Poyser, 1987; 1990). In contrast to the endometrium, in the
subplacenta, THM treatment did increase PGF2a and PGE2 outputs suggesting a role
for ACS and ACLS in the control of PGF2a and PGE2 outputs from this tissue. 6-
keto-PGFia output was unaffected by THM in the subplacenta, strengthening the
theory that the syntheses of these prostaglandins are controlled differently. In the
chorio-allantoic placenta, PGF2a output was unaffected by THM on day 22 of
pregnancy and increased slightly on days 29 and 36 of pregnancy, but only following
24 h of culture. The outputs of PGE2 and 6-keto-PGFia were also increased by THM
on days 22 and 29 (but not day 36) of pregnancy after 18 and 24 h of culture.
Therefore, the control of arachidonic acid reacylation does not appear to have a major
role in the control of PG synthesis from the chorio-allantoic placenta. Similarly in the
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fetal membranes (chorion and amnion), THM increased the outputs of PGF2a and
PGE2 but only after 24 h of culture. However, the output of 6-keto-PGFia was
greatly increased by THM on day 36 of pregnancy, suggesting a crucial role for
arachidonic acid reacylation in the control of 6-keto-PGFia synthesis, in particular
towards mid-pregnancy in the guinea-pig fetal membranes.
Evidently, PLA2 has a crucial role in the regulation of PG synthesis, not only
from the non-pregnant, but also from the pregnant, guinea-pig endometrium. In
contrast, the inhibition of PLA2 with ARA had very little effect on PG output from
both the subplacenta and chorio-allantoic placenta. ARA did decrease PGF2a and
PGE2 outputs slightly from day 22 pregnant chorio-allantoic placental tissue, but
unexpectedly increased PGF2a output after 18 and 24 h of culture on day 36 of
pregnancy, and 6-keto-PGFia output on days 22 and 29 of pregnancy (at 6 and 12 h
of culture). Thus, PLA2 does not appear to be vital to the regulation of PG output
from the subplacenta or chorio-allantoic placenta in the guinea-pig. However, in the
fetal membranes, ARA did decrease PGF2ct output in both day 29 and 36 pregnant
animals, PGE2 output in day 36 pregnant animals and 6-keto-PGFia output early
during culture (6-keto-PGFia output was unaffected after 18 and 24 h of culture),
suggesting a role for PLA2 in the control of PG synthesis from the fetal membranes.
The fact that 6-keto-PGFia output was unaffected by ARA treatment after 18 and 24
h of culture, would again suggest an alternative route for 6-keto-PGFi„ synthesis in
guinea-pig conceptal tissues.
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3:6 Effects of calcium ionophore A23187 on thimerosal, p-
hydroxymercuribenzoic acid and aristolochic acid inhibited
prostaglandin output from day 7 non-pregnant guinea-pig uterus
superfused in vitro.
Introduction
From the previous experiments, it is clear that the control of arachidonic acid
turnover plays an important role in the regulation of PG production by both uterine
and conceptal tissues in the guinea-pig. However, the tissue culture experiments
investigated the effects of inhibitors of arachidonic acid turnover during a 24 h period.
These conditions produced unclear results since, although the inhibition of acyl-CoA
synthetase (ACS) and acyl-CoA:lysophospholipid acyltransferase (ACLS) may
increase the concentration of free arachidonic acid available for PG synthesis and
therefore increase PG output over a short time, during a longer time period (such as a
24 h tissue culture), the inhibition of ACS and ACLS may block the entire arachidonic
acid turnover system and result in a decrease in the amount of arachidonic acid
incorporated at the appropriate sn-2 position in phospholipids suitable for PLA2
action. This would reduce the amount of available free arachidonic acid and thereby
decrease PG synthesis and output.
It is considered that activation of PLA2 by calcium (Downing and Poyser,
1983), which leads to the release of free arachidonic acid from PC and PE (Ning and
Poyser, 1984), is necessary for the stimulation of arachidonic acid release and the
initiation of PG synthesis in the guinea-pig endometrium. The calcium ionophore,
A23187, stimulates uterine PG synthesis by a mechanism dependent upon the
presence of extracellular calcium (Poyser, 1984b). Consequently, the effects of THM,
HMB and ARA on PG output and on the stimulatory actions of A23 187 from the day
7 non-pregnant guinea-pig uterus superfused in vitro have been investigated.
Methods
The uteri from fifteen day 7 guinea-pigs were removed and separated into the
two horns. Each uterine horn was weighed, "opened" by a longitudinal incision, and
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superfused with Krebs solution, aerated with 5 % C02 and 95 % 02, at 37°C at a rate
of 5 ml/min. Each horn was superfused initially for a "settling period" of 60 min and
the samples of superfusate were collected for 10-min periods over the next 100 min
(i.e. 10 samples/uterine horn).
Expt. 1 - A23187 (1 pg/ml) was present in the Krebs solution superfusing both
uterine horns from 5 guinea-pigs during the collection of samples 6 and 7. In addition,
100 pM thimerosal (THM) was present in the Krebs solution superfusing one uterine
horn from each guinea-pig during the collection of samples 4-7.
Expt. 2 - A23187 (1 pg/ml) was present in the Krebs solution superfusing both
uterine horns from 5 guinea-pigs during the collection of samples 6 and 7. In addition,
100 pM p-hydroxymercuribenzoic acid (HMB) was present in the Krebs solution
superfusing one uterine horn from each guinea-pig during the collection of samples 4-
7.
Expt. 3 - A23187 (1 pg/ml) was present in the Krebs solution superfusing both
uterine horns from 5 guinea-pigs during the collection of samples 6 and 7. In addition,
100 pM aristolochic acid (ARA) was present in the Krebs solution superfusing one
uterine horn from each guinea-pig during the collection of samples 4-7.
A concentration of 100 pM for each inhibitor was used since this
concentration had resulted in measurable changes in PG output from guinea-pig
uterine tissue in previous experiments. After collection, PGs were solvent-extracted
from the samples of superfusate and were stored in 10 ml ethyl acetate at -20°C. The
amounts of PGF2a, PGE2 and 6-keto-PGF]a present in the extracts were measured by
radioimmunoassay. The outputs of PGs were calculated per min per 100 mg wet
weight of uterus.
Statistical tests
Changes in the output of PGs with time were analysed by Duncan's multiple
range test. Other comparisons were made by Student's t-test, or if the variences of
the two groups were significantly different by the varience ratio F test, by the
modified t-test if the variances were unequal.
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Results
The effects of THM, HMB and ARA on the outputs of PGF2a, PGE2 and 6-
keto-PGFia from the day 7 superfiised guinea-pig uterus are shown in Figures 64, 65
and 66, respectively.
In all control experiments (i.e. superfused uteri not treated with either THM,
FCVEB or ARA), A23187 significantly (P < 0.05) increased the outputs of PGF2a and
6-keto-PGFia. These increased outputs in PGF2a and 6-keto-PGFia were maintained
throughout the experiment. The output of PGE2 was generally unaffected by A23187
treatment.
Expt. 1 - THM significantly (P < 0.05) increased the outputs of PGF2a, PGE2 and 6-
keto-PGFia 5.7-, 4.0- and 8.0-fold, respectively from the day 7 superfused uterus. In
the presence of THM, A23187 treatment failed to further stimulate the outputs of
PGF2a, PGE2 and 6-keto-PGFi„. In fact, following A23187 treatment, the output of
PGF2a was significantly lower from THM treated uterus compared to control uterus.
However, 6-keto-PGFla output was significantly greater from THM treated uterus
than from control uterus even during A23187 treatment.
Expt. 2 - HMB significantly (P < 0.05) increased the outputs of PGF2ct and 6-keto-
PGFia 2.9- and 2.3-fold, respectively from the day 7 superfused uterus. Treatment
with A23187 in the presence of ITMB further stimulated (P < 0.05) the outputs of
PGF2a and 6-keto-PGFia 3.3- and 2.4-fold, respectively. Following A23187
treatment, the outputs of PGF2a and 6-keto-PGFia were similar in both HMB treated
and untreated uteri. HMB and/or A23187 treatment had no effect on the output of
pge2.
Expt. 3 - ARA significantly (P < 0.05) increased the outputs of PGF2a, PGE2 and 6-
keto-PGFia 2.5-, 4.6- and 5.7-fold, respectively from the day 7 superfused uterus.
Treatment with A23187 in the presence of ARA further stimulated (P < 0.05) the
outputs ofPGF2a and 6-keto-PGF]a 4.7- and 3.9-fold, respectively. A23187 treatment
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Figure 64. Effect of THM (100 |.iM) on mean (± s.e.m., n=5) A23 187-stimulated
outputs of PGF2a, PGE2 and 6-keto-PGFkx from the day 7 guinea-pig uterus
superfused in vitro. * Significantly (P < 0.05) higher than before any treatment.
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Figure 65. Effect of HMB (100 pM) on mean (± s.e.m., n=5) A23 187-stimulated
outputs of PGF2a, PGE2 and 6-keto-PGFia from the day 7 guinea-pig uterus
superfused in vitro. * Significantly (P < 0.05) higher than before any treatment. +
Significantly higher than before A23187 treatment alone. ♦ Significantly (P < 0.05)
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Figure 66. Effect of ARA (100 |iM) on mean (± s.e.m., n=5) A23187-stimulated
outputs of PGF2a, PGE2 and 6-keto-PGFia from the day 7 guinea-pig uterus
superfused in vitro. * Significantly (P < 0.05) higher than before any treatment. +
Significantly higher than before A23187 treatment alone. ♦ Significantly (P < 0.05)
higher than before any treatment and with HMB treatment alone.
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Discussion
All three inhibitors, namely THM, HMB and ARA, significantly increased the
outputs of PGF2a and 6-keto-PGFia from the day 7 superfused guinea-pig uterus.
PGE2 output was also significantly increased by THM and ARA, but not by HMB,
treatment. THM and HMB both inhibit acyl-CoA synthetase and acyl-
CoA:lysophospholipid acyltransferase and therefore inhibit arachidonic acid
reacylation. THM and HMB do not affect PLA2 activity or the activity of the enzymes
involved in PG synthesis (Hunter et al., 1984; Goppelt-Streube et a/., 1986).
Consequently, the amount of free arachidonic acid available for PG synthesis may
actually be increased over a short time period (such as in these short supervision
experiments), since free arachidonic acid concentrations are not reincorporated into
phospholipids and remain available for PG synthesis resulting in increased PG output
from the guinea-pig uterus.
The output of 6-keto-PGFia was increased the most by THM treatment,
suggesting that the activity of ACS and ACLS are important in the control of 6-keto-
PGFia synthesis in the guinea-pig uterus. A23187 failed to further stimulate PG
synthesis from THM-treated guinea-pig uterus. Since PGF2a output was significantly
greater from control (no THM) A23187-treated uteri compared to A23187 + TFIM-
treated uteri, it would appear that THM treatment inhibited the stimulatory action of
A23187 on PGF2a synthesis from the superfused guinea-pig uterus. The outputs of
PGE2 and 6-keto-PGFia were increased by a far greater extent following THM
treatment (alone) compared to PG outputs stimulated in control A23187-treated uteri,
therefore, the addition of A23187 to THM-treated uteri may have failed to release
more free arachidonic acid for PG synthesis.
HMB was shown to be a less potent inhibitor of ACS and ACLS than THM,
since HMB increased PGF2a and 6-keto-PGFia outputs 2.9- and 2.3-fold compared to
5.7- and 8.0-fold, respectively following THM treatment. Also, PGE2 output was
unaffected by HMB treatment but was increased 4.0-fold by THM treatment. Indeed,
in contrast to THM treated uteri, the addition of A23187 to HMB-treated uteri did
further stimulate PGF2a and 6-keto-PGFia outputs 3.3- and 2.4-fold indicating that
arachidonic acid was not limiting. PGE2 was unaffected by A23187 indicating that the
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control of PGE2 synthesis in the guinea-pig uterus is probably not controlled by the
activation of PLA2 by calcium.
Unexpectedly, ARA (a PLA2 inhibitor) treatment did not decrease PG output.
This may have been due to the pretreatment time with ARA being too short to inhibit
PLA2. The reason for the increase in the outputs of PGF2a and 6-keto-PGFia
following treatment with ARA is unclear. It may be the case that ARA treatment
influenced the activities of PGH synthase and/or PGDH. Stimulation ofPGH synthase
and/or inhibition of PGDH would result in increased PG production. The addition of
A23187 further stimulated both PGF2a and 6-keto-PGF]a. This may be due to
A23187 stimulating PLC activity (which releases arachidonic acid from PI) and thus
increasing PG synthesis. Indeed, this has been suggested to occur previously in the
superfused guinea-pig uterus in vitro (Poyser, 1991) since the guinea-pig uterus has a
large source of a PLC enzyme specific for PI (Bennett and Crooke, 1987). PGE2
output was significantly increased during ARA treatment, however this was not
sustained. Similarly to the results obtained in experiment 1 and 2, A23187 did not
affect PGE2 output strengthening the evidence that the activation of PLA2 (or PLC)
by calcium is not involved in the control of PGE2 synthesis from the superfused
guinea-pig uterus.
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3:7 Effects of thimerosal, p-hydroxymercuribenzoic acid and aristolochic
acid on prostaglandin synthesis by homogenates of day 7 non-pregnant
guinea-pig endometrium.
Introduction
The previous experiment investigated the effect of inhibitors of arachidonic
acid turnover and the stimulatory effect of A23187 on PG synthesis in the presence of
the inhibitors in day 7 guinea-pig uterus. The following experiment again investigated
the effects of inhibitors of arachidonic acid turnover in day 7 animals, but during a 1 h
incubation of uterine homogenates in the presence of free arachidonic acid i.e.
arachidonic acid was not limiting for PG synthesis.
Methods
Three virgin guinea-pigs that had exhibited at least three normal oestrous
cycles were killed by stunning and incision of the neck on day 7 of the cycle. The
uterus was removed and separated into its two horns. Each uterine horn was
"opened" by a longitudinal incision and the endometrium dissected away from the
myometrium by cutting away 1-2 mmJ sections of endometrium using a pair of fine
scissors. The endometrial tissue from each animal was divided into four parts as
equally as possible, blotted dry, and each part weighed. Each part was then
homogenised using a ground glass homogeniser in 10 ml ice-cold Krebs solution
containing 2 pg/ml arachidonic acid and either no inhibitor (control), 100 pM HMB,
100 pM THM or 100 pM ARA. The time interval between removal of the uterus and
completion of homogenisation was never greater than 15 min. The homogenates were
then incubated at 37°C for 60 min in a shaking water bath. After incubation, the pH of
the incubates were lowered to 4.0 by addition of HC1 and the PGs were extracted by
shaking twice with 15 ml redistilled ethyl acetate. The two ethyl acetate extracts
obtained from each incubate were combined and evaporated to dryness at 45°C on a
rotary evaporator. Each extract was then redissolved in 10 ml redistilled ethyl acetate
and stored at -20°C. The amounts of PGF2a, PGE2 and 6-keto-PGFia present in the
extracts were later measured by radioimmunoassay (see section 2:5).
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Statisitcal Tests
Results were analysed by the Student's t-test or, if the variances of the two
groups were significantly different by the variance ratio F test, by a modified t-test for
unequal variances.
Results
The effects of THM, HMB and ARA treatment on the amounts of PGF2a,
PGE2 and 6-keto-PGFia synthesized by homogenates of endometrium from day 7
guinea-pigs are illustrated in Figure 67. The amounts of PGF2a, PGE2 and 6-keto-
PGFia synthesized by control (untreated) homogenates of guinea-pig endometrium
incubated for 1 h at 37°C were 6.36 ± 0.92, 1.80 ± 0.27 and 2.90 ± 0.64 ng/ml/100
mg tissue, respectively. THM treatment significantly (P < 0.05) reduced PGF2a
synthesis, but PGE2 and 6-keto-PGFia syntheses were unaffected. HMB treatment
also significantly reduced PGF2a synthesis (P < 0.005), and also significantly
decreased the syntheses of PGE2 and 6-keto-PGFia (P < 0.05). ARA treatment
significantly (P < 0.05) increased the amounts of PGF2a, PGE2 and 6-keto-PGFia
synthesized by 2.0-, 2.5- and 1.8-fold, respectively.
Discussion
The amounts of PGF2a, PGE2 and 6-keto-PGFla formed in the control
homogenates represent PG synthesis during a 1 h incubation period in the presence of
at least 2 pg/ml free arachidonic acid (arachidonic acid is also released from the tissue
during the homogenisation process, Mitchell, Poyser and Wilson, 1977). No inhibitors
were used in the control, thus normal arachidonic acid turnover could be assumed to
be occurring i.e. ACS and ACLS reacylated free arachidonic acid, whilst PLA2
deacylated arachidonic acid for the purpose of PG synthesis. The presence of THM (a
potent arachidonic acid reacylation inhibitor) did not affect either PGE2 or 6-keto-
PGFia synthesis, suggesting that the free arachidonic acid was not reacylated and used
for the synthesis of these two PGs in similar amounts to those synthesized by control
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Figure 67. Mean (± s.e.m., n=3) in vitro PGF2a, PGE2 and 6-keto-PGF)a production
by homogenates of uterine tissues from day 7 non-pregnant guinea-pigs in the absence
(control) and presence ofHMB (+HMB), TFLM (+THM) and ARA (+ARA).
* Significantly (P < 0.05) different to control value for the same PG.
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This possibly resulted from the reduction in appropriate phospholipids available to
PLA2 (arachidonic acid present in sn-2 position of PC and PE) due to the inhibition of
arachidonic acid turnover. Treatment with HMB significantly reduced the synthesis of
all three PGs. This may have been due to its weak inhibitory effect on ACS and ACLS
activity, and therefore, free arachidonic acid continued to be reacylated, together with
a slight reduction in appropriate phospholipids for the release of arachidonic acid by
PLA2 for PG synthesis. Both THM and HMB do not affect PLA2 activity or the
activity of enzymes involved in PG synthesis (Hunter et al., 1984; Goppelt-Streube et
al., 1986), thus the inhibition of PG synthesis by guinea-pig uterine homogenates
cannot be due to either of those factors.
The significant increase in all three PGs following ARA treatment is somewhat
surprising. It was expected that free arachidonic acid would be reacylated (since no
THM or HMB were present) and PLA2 inhibited, therefore resulting in reduced PG
synthesis. However, increased PG synthesis resulted. A possible explaination for these
findings, is that the inhibition of PLA2 resulted in the "switching on" of PLC, thus
releasing free arachidonic acid from PI for the purpose of PG synthesis. It should also
be considered that ARA may not inhibit PLA2 activity quickly. Indeed, ARA
treatment did not decrease PG output from the uterus during short 40 min treatments
in superfusion experiments (section 3.6), but did decrease PG outputs during long
term treatment of endometrium in 24 h tissue culture experiments (section 3 .4).
Also, during the homogenisation process, which disrupts cell structure, free
arachidonic acid is known to be released (Mitchell et al., 1977). It is possible that
ARA treatment may have little effect on PG synthesis during a short 1 h incubation
period since free arachidonic acid was released during homogenisation, and 2 pg/ml
arachidonic acid had also been added to the incubates. However, if this were the case,
PG synthesis similar to that observed in the control incubates would have been
expected. This was not the case. ARA treatment actually increased all three PG
syntheses significantly above that seen in control incubates. This would suggest that
ARA was having some other effect on PG synthesis. ARA treatment was also
observed to significantly increase PGE2 (but not PGF2a or 6-keto-PGFia) synthesis in
the subplacenta of day 22 pregnant guinea-pigs during 24 h tissue culture (see Figure
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49) and PGE2 synthesis from day 7 non-pregnant guinea-pig uterus superfused in
vitro (see Figure 66). Neither PGF2a or 6-keto-PGFia outputs were increased to such
an extent as that of PGE2 during superfiision following ARA treatment, however,
their outputs were increased by the presence of A23187, whilst that of PGE2 was not
enhanced by A23187 treatment (see Figure 66). Perhaps ARA may influence the
activity of other enzymes involved in PG synthesis, such as PGHS. This could explain
the observations of increased PG synthesis, significantly greater than that seen in
control incubates, in Figure 67. If we assume that normal arachidonic acid turnover
and PG synthesis is occurring in the control incubates in normal conditions ie. without
the presence of either E1MB, THM or ARA, and where arachidonic acid is not limiting
since free arachidonic acid is released due to cellular disruption during
homogenisation and free exogenous arachidonic acid was also added, we would
expect to observe maximum PG synthesis in these incubates. Therefore, since ARA
treatment further increased PG synthesis, ARA treatment must have some other effect
such as increasing PGHS activity. PGHS exhibits self-catalysed breakdown during the
synthesis of PGs (Lands, 1979). Consequently, the total amount of PGs synthesized
by endometrial homogenates is indicative of the concentration of PGHS, especially
since the metabolism of PGs in the absence of NAD+ by the guinea-pig uterus is
negligible (< 5%) (Poyser, 1979). This would suggest that ARA treatment of guinea-
pig endometrial homogenates resulted in an increase in PGHS activity. An increase in
PGHS activity and the presence of free exogenous arachidonic acid (ie. arachidonic
acid was not limiting) would explain the unexpected increase in PG synthesis
following the inhibition of PLA2 by ARA.
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CHAPTER 4 : GENERAL DISCUSSION
PGF2« has been identified as the uterine luteolytic hormone in several
mammalian species, including the guinea-pig (Horton and Poyser, 1976; Poyser,
1981) During the oestrous cycle, oestradiol secretion from the ovary increases from
day 10 (Joshi et a/., 1973) which precedes the increase in PGF2a secretion from the
uterus by 24 h (Blatchley el a!., 1972; Earthy et al., 1975; Antonini el al., 1976).
Also, the administration of oestradiol to ovariectomized guinea-pigs maintained on
progesterone stimulates uterine PGF2a output (Blatchley and Poyser, 1974; Poyser,
1983b). Therefore, oestradiol acting on a progesterone-primed uterus appears to be
the physiological stimulus for increased PGF2a production by the guinea-pig uterus
(particularly by the endometrium) towards the end of the oestrous cycle. Oxytocin is
also involved in the regulation of uterine PGF2a production in some species such as in
the sheep (Lee and Silvia, 1994) but not in the guinea-pig (Donovan, 1961; Poyser
and Brydon, 1983; Riley and Poyser, 1987b).
In the guinea-pig, it has been demonstrated that towards the end of the cycle,
oestradiol stimulates an increase in the concentration of PGH synthase in the
endometrium by inducing increased protein synthesis (Poyser, 1979). However, little
is known about how oestradiol and progesterone control endometrial PG synthesis
and, in particular, how they control the supply of free arachidonic acid for increased
PGF2re synthesis at the end of the oestrous cycle.
The rate-limiting step in PG synthesis is generally considered to be the release
of free arachidonic acid from lipid stores. In the guinea-pig uterus, 90 % of
arachidonic acid is bound to phospholipid, of which 80 % is bound to PC and PE.
There is a decrease in the amount of arachidonic acid bound as PC and PE between
days 7 and 15 of the cycle (Leaver and Poyser, 1981), suggesting that PC and PE may
be the source of arachidonic acid for PG synthesis in the guinea-pig uterus. Further
studies demonstrated a specific stimulation of the mechanisms involved in the uptake
of arachidonic acid into guinea-pig endometrium (particularly into the phospholipids)
at the end of the oestrous cycle (Ning et a/., 1983). No significant differences in the
amounts of any phospholipid in the guinea-pig endometrium between days 7 and 15 of
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the cycle were found, indicating that the increased incorporation of arachidonic acid
into endometrial phospholipids on day 15 compared to day 7 was not due to a change
in phospholipid content (Ning and Poyser, 1984). The fact that there are no increases
in either the de novo synthesis of PC, the synthesis of PC by methylation of PE or in
the synthesis of PI, indicates that the increased incorporation of arachidonic acid into
phospholipids between days 7 and 15 of the cycle cannot be due to an increase in
phospholipid synthesis. The lack of changes in both PI content and PI synthesis
between days 7 and 15 of the cycle, indicate that the stimulation of the PI cycle is not
involved in the biochemical mechanisms that lead to increased PGF2a synthesis by the
guinea-pig endometrium (Ning and Poyser, 1984). Therefore, the increased
incorporation of arachidonic acid on day 15 probably occurs by acylation of
lysophospholipids by the enzyme acyl-CoA:lysophospholipid acyltransferase (ACLS),
as previously proposed (Ning et a/., 1983). This is in agreement with the findings of
Trotter and Ferber (1981) who proposed that "the rapid incorporation of fatty acids
into membrane phospholipids appears to be due to a turnover of fatty acyl chains
rather than the de novo synthesis of phospholipids". The findings of other studies
suggest that arachidonic acid is incorporated exclusively by this mechanism (Hill and
Lands, 1968; Yamashita et al., 1973). The increase in arachidonic acid uptake into
endometrial phospholipids observed on day 15 of the guinea-pig oestrous cycle could
therefore be due to an increase in ACLS activity, and/or changes in the amounts of
lysophospholipid present and/or an increase in the activity of acyl-CoA synthetase
(ACS). In comparison to arachidonic acid, the uptake of oleic acid into phospholipids
was found to be unchanged between days 7 and 15, indicating a specific uptake for
arachidonic acid. The ACLS present in rat liver has been shown to be relatively
specific for arachidonyl-CoA; it is eight times more active with arachidonyl-CoA than
with oleoyl-CoA as substrate (Yamashita et a/., 1973). Also, a study by Okuyama el
a/. (1975) demonstrated that different enzymes or different sites on a single enzyme
exist for the transfer of different acyl-CoAs to lysophospholipids in rat liver. Platelets
have also been shown to contain an ACS specific for arachidonic acid (Wilson et a/.,
1982). Thus, if a specific increase in the enzymes ACLS and ACS specific for
arachidonyl-CoA and arachidonic acid, respectively were to occur toward the end of
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the oestrous cycle in the guinea-pig endometrium, this could explain the specific
increase in the incorporation of arachidonic acid into endometrial phospholipids
observed on day 15 of the cycle.
Although an increase in the rate of arachidonic acid uptake (i.e. reacylation
into phospholipids) may be beneficial in providing a faster turnover of arachidonic
acid for PG synthesis, such an increase may actually limit PG synthesis. Following its
release by PLA2, the amount of free arachidonic acid would be reacylated at a faster
rate if the uptake processes for arachidonic acid were stimulated. Indeed, this could be
of benefit during early pregnancy, when PG output, particularly of PGF2„, from the
uterus must be kept low so that luteal function is maintained. Studies on macrophages
and lung fibroblasts demonstrated that inhibition of ACS and ACLS activities
increased the concentration of free arachidonic acid and the amounts of PGs
synthesized (Kroener et a/., 1981; Hunter et a/., 1984; Goppelt-Streube, 1986). In a
more recent study (Preuss and Patscheke, 1992), the activities of PLA2, ACS and
ACLS (lysophosphatidyl acyltransferase) were shown to be simultaneously active,
resulting in a steady turnover of arachidonic acid in homogenates of human platelets.
EGTA (a calcium chelator) suppressed the deacylating activity of PLA2 on
endogenous membrane phospholipids and prevented the formation of eicosanoids
from previously esterified exogenous arachidonyl-CoA. Inhibition of reacylation of
arachidonic acid by apyrase resulted in an increase in eicosanoid release (Preuss and
Patscheke, 1992). These studies support the concept that eicosanoid release is not
only controlled by an activation of PLA2 but also by an inhibition of the reacylating
enzymes ACS and ACLS in stimulated tissues.
Experiment 3:1 demonstrated that ACS, ACLS and PLA2 activities were
present in the guinea-pig endometrium on days 7 and 15 of the oestrous cycle. It may
be possible that these ACS and ACLS activities have a role in the control of
arachidonic acid turnover in the guinea-pig endometrium. If endometrial ACS and
ACLS activities were to increase between days 7 and 15 of the cycle this could
explain the previously observed increase in arachidonic acid uptake (into
phospholipids) on day 15 of the cycle (Ning et a/., 1983). ACS and ACLS activities
may be present due to a specific stimulation of their activities, or occur as a
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consequence of the large quantity of free arachidonic acid being released by PLA2
which requires reacylation, since free arachidonic acid is usually maintained at low
concentrations (Bills, Smith and Silver, 1977).
Treatment with a PLA2 inhibitor (i.e. ARA) of day 7 and day 15 non-pregnant
guinea-pig endometrium cultured for 24 h (experiment 3:4) reduced the outputs of
PGF2a, PGE2 and 6-keto-PGF)a, providing further evidence for the crucial role PLA2
plays in the control of PG, particularly PGF2a, synthesis in the guinea-pig
endometrium towards the end of the oestrous cycle. The decrease in the output of 6-
keto-PGFia was much less marked than the decrease in the output of PGF2a following
PLA2 inhibition. These findings would suggest that the syntheses of PGF2a and PGI2
(as detected by 6-keto-PGFia) are controlled differently. These findings are in
agreement with previous studies (Riley and Poyser, 1987; 1990; Poyser, 1991).
The increase in 6-keto-PGFia output from guinea-pig endometrium following
treatment with HMB and THM during 24 h of culture indicates that the control of
endometrial 6-keto-PGFia synthesis in the non-pregnant guinea-pig is under the
influence of arachidonic acid reacylation (results from 3:4). This is because, following
inhibition of ACS and ACLS, the rate of arachidonic acid uptake into
lysophospholipids will be reduced, thus increasing the amount of free arachidonic acid
available for PG synthesis. In contrast, inhibition of ACS and ACLS did not increase,
but actually decreased the outputs of PGF2a and PGE2. This would imply that the
synthesis of these two PGs is not influenced by the activities of ACS and ACLS in the
same way as that of the synthesis of 6-keto-PGFla. However, during long term
inhibition of ACS and ACLS, since the rate of arachidonic acid uptake into
lysophospholipids will be reduced, the amount of arachidonic acid appropriately
placed in the sn-2 position of appropriate phospholipids (PC and PE) for PLA2 will
also be eventually reduced. Therefore, PLA2 may be indirectly inhibited by a lack of
appropriate substrate. Since the syntheses of PGF2a and PGE2 and that of 6-keto-
PGFia are different, this would explain the difference in the results of this study.
Experiment 3:2 demonstrated that ACS, ACLS and PLA2 activities were also
present in the endometrium of ovariectomized and ovarian steroid-treated
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ovariectomized guinea-pigs. It would be of interest to know whether oestradiol acting
on a progesterone-primed uterus (the physiological stimulus for increased secretion of
uterine PGF2a towards the end of the oestrous cycle) could influence the activities of
ACS, ACLS and PLA2. If a decrease in ACS and ACLS activities were to occur
towards the end of the cycle, this could be a possible mechanism for maintaining
elevated concentrations of free arachidonic acid (since arachidonic acid would be
reacylated at a slower rate) available for increased PGF2a synthesis at this time. Since
oestradiol acting on a progesterone-primed uterus is believed to be the stimulus for
increasing intracellular Ca2 concentrations in guinea-pig endometrial cells which is
then responsible for activating PLA2 (Downing and Poyser, 1983), it would be
interesting to study whether oestradiol treatment of progesterone-primed
ovariectomized guinea-pigs results in an increase in endometrial PLA2 activity. PLA2
activity in the guinea-pig endometrium increases 1.8-fold between days 7 and 16 of
the oestrous cycle (Downing and Poyser, 1983). It is not clear whether such an
increase occurs in the sheep, however, there is no change in endometrial PLA2 activity
in the ewe between days 12, 14 and 16 of the cycle (Tamby, Charpigny, Reinaud and
Martal, 1993). The administration of oestradiol to hypophysectomized rats resulted in
a large stimulation of uterine PLA2 activity. Progesterone pre-treatment substantially
reduced this stimulatory effect of oestradiol, but did not abolish it (Dey, Hoversland
and Johnson, 1982). Thus, oestradiol acting on a progesterone-primed uterus may be
the stimulus for increased endometrial PLA2 activity in the guinea-pig and other
species.
A PLA2-stimulating protein (PLAP) which is antigenically and functionally
related to the PLA2-stimulating protein melittin, has been isolated from a variety of
cell lines and is an intracellular messenger in the stimulation of PG synthesis (Clark et
a/., 1987; Clark et a/., 1988). Indeed, melittin does stimulate PGF2a output from the
guinea-pig uterus, suggesting that a protein that stimulates PLA2 could be present in
guinea-pig endometrium (Johnson and Poyser, 1991). PLAP has a molecular weight
of 28 kDa and is detectable in human rheumatoid arthritis synovial fluid (Bomalaski et
al., 1990). It is unclear what the stimulus for PLAP is and how exactly PLAP acts to
activate PLA2. It has been suggested that PLAP may affect the genome and thus
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regulate the formation of both lipocortins and phospholipases (Dennis, 1983). The
guinea-pig endometrium does not secrete a protein of 28 kDa size during 24 h culture
(Leckie and Poyser, 1993), however, even if PLAP were produced by the guinea-pig
endometrium in vivo, it may not be a secreted protein and would thus be undetected
under such experimental conditions. Thus, at the present time, it is unknown whether
PLAP is present in the guinea-pig endometrium, and if it were, whether it could be
involved in the stimulation of endometrial PGF2a synthesis towards the end of the
oestrous cycle.
In the pregnant guinea-pig, the increase in uterine PGF2a production which
normally occurs after day 11 of the cycle, must be prevented since continued
progesterone is necessary for the first one third of gestation in the guinea-pig (Bland
and Donovan, 1969b). The presence of the conceptuses has been shown to prevent
uterine PGF2(X output (Blatchley et a/., 1975b). The conceptuses apparently secrete an
anti-luteolytic factor which acts to suppress uterine PGF2(X output by preventing the
stimulatory action of oestradiol on endometrial PGF2a synthesis and release (Poyser,
1984a). This anti-luteolytic factor acts predominantly in a local manner, since in
unilaterally pregnant guinea-pigs with the sterile horn transected at the cervical end,
uterine PGF2a synthesizing capacity is 3-fold higher and the corpora lutea half the size
on the sterile side compared to the pregnant side (Maule Walker and Poyser, 1974).
The identity of the anti-luteolytic factor in the guinea-pig is not known, but it is
probably different from oTP-1 and bTP-1 which are proteins produced by ovine and
bovine embryos, respectively, that inhibit endometrial PGF2c( synthesis (Bazer, Vallet,
Roberts and Sharp, 1986). These trophoblast proteins are structurally related and
have similar activity to a-interferon (Imakawa el a/., 1987; Stewart ei a/.. 1987;
Charpigny et a/., 1988) but are now classed separately as interferon-x. However, the
anti-luteolytic factor secreted by the guinea-pig conceptus is not an interferon and is
most probably different from oTP-1 (Leckie and Poyser, 1990a). Interestingly, those
species whose embryos secrete a trophoblast protein-1 are the same species in which
ovarian oxytocin forms part of the physiological stimulus for the increase in
endometrial PGF2a synthesis towards the end of the oestrous cycle.
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It is not known whether the presence of the conceptuses in the guinea-pig
alters the control of arachidonic acid turnover during pregnancy. An increase in the
rate of arachidonic acid uptake may limit the amount of free arachidonic acid available
for PG synthesis and therefore reduce uterine PG output. Experiment 3:3
demonstrated that ACS, ACLS and PLA2 activities were also present in the
endometrial and conceptal tissues of day 15, 29 and 36 pregnant guinea-pigs. Whether
an increase or decrease in the activities of ACS, ACLS and PLA2 in endometrial or
conceptal tissues may be a mechanism by which PG production is controlled during
pregnancy is unknown. Experiment 3:5 was carried out in order to investigate the
effects of inhibitors of the enzymes that control arachidonic acid turnover and the
actual quantities of PGs that are produced by the endometrial and conceptal tissues
during pregnancy in the guinea-pig.
Similarly to the results from experiment 3:4 in which non-pregnant
endometrium was used, inhibitors of ACS and ACLS decreased PGF2a and PGE2
outputs, and increased the output of 6-keto-PGFia from the endometrium of day 22,
29 and 36 pregnant guinea-pigs maintained in culture for 24 h. The inhibitor of PLA2
also reduced all three endometrial PG outputs on all days of pregnancy. Therefore, the
control of arachidonic acid turnover appears to be similar in the non-pregnant and
pregnant guinea-pig endometrium.
In contrast to the endometrium, in the subplacenta, inhibitors of arachidonic
acid reacylation increased PGF2a output and, to a lesser extent, PGE2 output. The
output of 6-keto-PGFia was unaffected in early-pregnant (day 22) animals, but
slightly increased on day 36 of pregnancy. ACS and ACLS appear to be involved in
the control of PG synthesis from this tissue. The inhibitor of PLA2 had no effect on
PGF2a output (apart from a slight decrease in day 29 pregnant animals) from the
subplacenta. Therefore, PLA2 does not appear to be involved in the release of free
arachidonic acid for PGF2„ synthesis in the pregnant guinea-pig subplacenta.
Treatment with a PLA2 inhibitor actually resulted in an unexpected increase in the
outputs of PGE2 and 6-keto-PGF]a. The reason for this is not clear, but could may be
due to other effects of the inhibitor on PG synthesis and metabolism.
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In the chorioallantoic placenta from pregnant guinea-pigs maintained in
culture for 24 h, the inhibitors of arachidonic acid uptake slightly increased PGF2a
output, but only in day 29 and 36 pregnant animals and only after 24 h of culture. The
output of PGE2 and 6-keto-PGFla were also increased, but only after 18 and 24 h of
culture and on days 22 and 29, not day 36, of pregnancy. Therefore, ACS and ACLS
do appear to be involved in the control of PG synthesis by the chorio-allantoic
placenta, but not to such an extent as that observed in the subplacenta. The inhibitor
of PLA2 in the chorio-allantoic placenta inhibited PGF2a and PGE2 outputs slightly on
day 22 of pregnancy, but had very little effect on PG output in later pregnant animals.
Similarly to the subplacenta, inhibition of PLA2 in day 29 and 36 pregnant guinea-pigs
actually tended to increase PG output slightly. Therefore, in the guinea-pig
subplacenta and chorio-allantoic placenta, the control of arachidonic acid uptake does
appear to be involved in the control of PG output from these tissues during
pregnancy. In contrast, PLA2 does not appear to have a role in the regulation of
arachidonic acid for PG synthesis in these tissues.
In the fetal membranes, inhibition of ACS and ACLS increased PGF2a (both
day 29 and 36 pregnant animals) and PGE2 (only day 29 pregnant animals) outputs,
but only after 24 h of culture. The output of 6-keto-PGFia was slightly decreased on
day 29, but greatly increased by THM treatment on day 36 of pregnancy, suggesting a
role for the control of arachidonic acid uptake in the regulation of PG, particularly 6-
keto-PGFla, output from the fetal membranes of pregnant guinea-pigs. The inhibition
of PLA2 tended to inhibit all PG outputs from the fetal membranes.
In section 3:5, the basal PG outputs from the endometrium, subplacenta,
chorio-allantoic placenta and fetal membranes of day 22, 29 and 36 pregnant guinea-
pigs during 24 h culture were also measured. These results indicated that PGF2a and
6-keto-PGFia outputs were generally greatest from the endometrium, with much
lesser amounts produced by the subplacenta, chorio-allantoic placenta and fetal
membranes. PGE2 output was similar from all tissues. However, there was a striking
14-fold increase in PGF2rx output from the chorio-allantoic placenta between days 22
and 36 of pregnancy. Therefore, the chorio-allantoic placenta may be an important
source of PGF2a later in pregnancy.
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It may be possible that the low amounts of PGs synthesized by the fetal
membranes are due to a stimulation of the mechanisms that control arachidonic acid
uptake. Such a stimulation may limit the amount of free arachidonic acid available for
PG synthesis, resulting in the low outputs observed in section 3:5. In contrast, in the
chorio-allantoic placenta, where greater amounts of all PGs, particularly PGF2«, are
produced later in pregnancy, low ACS and ACLS activities could reduce the rate of
arachidonic acid uptake thus increasing the amount of free arachidonic acid available
for PG synthesis.
The control of arachidonic acid turnover may play an important role in the
regulation of PG synthesis in the guinea-pig uterus. Perhaps oestradiol acting on a
progesterone-primed uterus, the physiological stimulus for increased PGF2a output
from the endometrium towards the end of the cycle for the purpose of luteal
regression, could inhibit the rate of arachidonic acid reacylation on day 15 of the cycle
which could, in turn, be of benefit in maintaining elevated concentrations of free
arachidonic acid available for increased PG synthesis at that time. Further studies are
needed to investigate these possibilities.
PGs have an important role during pregnancy. They subserve the
establishment, maintenance and conclusion of pregnancy (Boone, Currie and Leung,
1993). In the human, successful implantation and maintenance of pregnancy involves
trophoblast invasion of the decidualized endometrial stroma and dilatation of maternal
spiral arteries that terminate in intervillous spaces. These events depend on increased
blood flow to the feto-placental unit, inhibition of clotting at the maternal-placental
interface and suppression of the maternal immune response (North, Whitehead and
Larkins, 1991).
Maintenance of a PG balance may be critical to fetal and placental blood
perfusion. Placental insufficiency could lead to hypoxic / ischemic conditions
damaging fetal development. PGI2 from fetal vessels of the placenta has been shown
to be involved in the maintenance of the low pressure, high velocity state of the
human fetal placental circulation. The fetal vasculature preferentially produces PGI2
rather than any other PG, and at higher concentrations than maternal vessels (Gude,
Rice, King, Boura and Brennecke, 1990). Arachidonic acid or PGI2 infusion results in
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vasodilation of fetal vessels of human perfused placental lobules while arachidonic
acid results in vasoconstriction of umbilical veins (Gude el al., 1990). PGI2 is a major
product of cultured human umbilical vein endothelial cells (Patel, Sullivan and Elder,
1989).
PGs originating from the conceptus appear to have numerous roles, including,
intrauterine migration of embryos, blastocyst hatching from the zona pellucida, ion
transport across trophectoderm, fluid accumulation in the blastocoele, increased
endometrial capillary permeability and blastocystic glucose metabolism (see Lewis.
1989). Between days 7 and 12 of pregnancy, pig embryos migrate and become spaced
in the uterus. Local myometrial contractions appear to be involved in controlling this
migration, and blastocystic PGs may stimulate these contractions (Pope, Maurer and
Stormshak, 1982). Before blastocyst implantation, its protective covering, the "zona
pellucida" must be shed. It has been demonstrated that inhibitors of PG synthesis and
PG antagonists reduce the rate of hatching of mouse embryos from the zona pellucida
(Biggers, Leonov, Baskar and Fried, 1978). Since PGE2 is able to promote water
movement across epithelia, it was proposed that PGE2 produced by the blastocyst
promotes water passage across the trophectoderm resulting in the accumulation of
blastocoelic fluid, and the eventual "hatching" of the blastocyst from the zona
pellucida (Biggers et a/., 1978). Later studies supported this hypothesis (Hurst and
Farlane, 1981; Chida, Uehara, Hoshiai and Yajima, 1986). In a study by Lewis
(1986b) it was demonstrated that indomethacin decreased PG synthesis by, and
transport of 22Na across, day 16 sheep trophoblast and also prevented the formation
of trophoblastic vesicles hi vitro. This study suggested that PGs may be involved in
the control of fluid accumulation during the period of rapid blastocystic elongation
(prior to implantation) in sheep. Localized increases in endometrial capillars'
permeability precede implantation in numerous mammals, and PGs appear to be
involved in initiating these increases (see Lewis, 1989). Other studies have also
suggested a role for PGs (possibly of blastocystic origin) in the control of energy
metabolism in blastocysts (see Lewis, 1989).
During pregnancy, a balance must exist between immune tolerance of fetal
tissue and a local suppression of inflammatory responses It has been suggested that
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progesterone, with its immunosuppressive and anti-inflammatory properties, plays a
role in maintaining this balance. Evidence for this theory is provided by studies using
antiprogesterone steroids, such as RU486, that can disrupt pregnancy in women at
any stage and, used together with PGs, provide an effective method of inducing
abortion (Kelly, 1994). A possible mechanism of controlling PG concentrations may
be through prostaglandin dehydrogenase (PGDH), the enzyme reponsible for the
conversion of PGs to their 15-keto metabolites, and thus inactivating them. This
enzyme is abundant in the pregnant uterus, and could provide a mechanism of control
in maintaining low concentrations of PGs during pregnancy, and increased PG
concentrations during the process of parturition. Indeed, PGDH rises in early
pregnancy, and some of the highest concentrations of this enzyme are seen in chorion,
decidua and placenta (Kelly, 1994). In women at term elective cesarean section or
after term spontaneous labor immunoreactive PGDH was demonstrated to be
predominant in chorion, present at low activities in decidua and absent in amnion.
PGDH in the placenta was localized in intermediate trophoblast cells and
synctiotrophoblast, but not in cytotrophoblast or villous stromal tissue. (Cheung,
Walton, Tai, Riley and Challis, 1990). There was no change in the localization of
PGDH in any of the tissues in association with labor, suggesting that changes in
PGDH activity or distribution are unlikely to contribute to the increase in PG
concentration at parturition. However, it may be possible that placental PGDH could
influence the concentration of PGs produced within the placenta which reach the
underlying decidua and/or myometrium. During late human pregnancy, the amnion is
believed to be a major site of PGE2 production, which may cross the fetal membranes
to exert biological effects on decidua and/or myometrium. A high PGDH activity in
the chorion would suggest a possible role in the maintenance of pregnancy, protecting
the decidua from fetal-derived PGs. However, PGDH is present heterogeneously in
chorion and thus may not present the uniform PG metabolic barrier previously
assumed, since some PG may cross and escape metabolism (Cheung el al., 1990).
Other studies have demonstrated PG production by sheep trophoblast (Ellwood,
Mitchell, Anderson and Turnbull, 1979) and studies in placental tissue at term showed
PGDH at high concentrations in intermediate trophoblast and synctiotrophoblast, but
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synctiotrophoblast, but not in cytotrophoblast (Challis, Jacobs, Riley, Boshier, Han,
Smith, Cheung, Langlois and Fraher, 1990; Cheung, Walton, Tai, Riley and Challis,
1990). However, in first trimester human villous trophoblast, the PG synthetic
capacity of the synctiotrophoblast is associated with extensive PGDH localized in the
cytotrophoblast (Cheng et al., 1993a). This combination results in the expression of
PGE in the synctiotrophoblast (Cheng et al., 1993b) with a presumed outward
secretion and would provide a mechanism by which vessels of the fetal circulation
lying within the trophoblastic villi are protected against PGs (Kelly, 1994). A high
concentration of PGE in the synctiotrophoblast layer could act as an
immunosuppressive defence against maternal blood cells (Tawfik, Hunt and Wood,
1986). The trophoblastic villi show only weak staining for progesterone receptors
(Shi, Wang, Fu, Xu and Zhu, 1993) and thus this source of PGE is unlikely to be
under the influence of progesterone.
PGDH levels dropped markedly in guinea-pigs treated with RU486, especially
in tissue with a high metabolizing capacity such as chorio/decidual tissue (Kelly and
Bukman, 1990). Enzyme measurements in tissue from women given RU486 showed a
similar drop in PGDH activity, with significant decreases following 12 h exposure to
RU486. (Cheng, Kelly, Thong, Hume and Baird, 1993a). Immunohistochemistry
studies demonstrated that the drop in PGDH was seen in all cells, but particularly in
those that were perivascular (Cheng, Kelly, Thong, Hume and Baird, 1993b). When
PGE was examined in decidua from these women, the elevation in PGE in small blood
vessels was striking. This increase was significant following 12 h RU486 treatment />/
vivo, and was accompanied by a decrease in observable PGE metabolite. Small blood
vessels that were PGE negative and 13,14-dihydro-15-keto-PGE2 (PGEM) positive in
untreated women, were PGE positive and 13,14-dihydro-15-keto-PGE2 (PGEM)
negative in RU486-treated women. These results would suggest that PG stimulation
by the antiprogestin RU486, is by means of a direct effect on PGDH, and that the
prominent increase in PGE in blood vessels may be a major mode of action in causing
abortion, and that one of the major mechanisms by which progesterone ensures a
successful pregnancy is by maintenance of low PG levels in the vasculature. The PGs
may also synergize with leukocyte chemotactic agents stimulating neutrophil ingress
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and tissue destruction (Cheng et a/., 1993). A significant signal for immigration of
neutrophils into tissues, from a chemokine such as interleukin (IL)-8, which also has
activating potential itself, will stimulate the release of their specific granules,
containing collagenase, which can dissolve and disrupt extracellular matrix and
ground substance. Further activation can result in the release of proteases,
leukotrienes, PGs and a wide range of effector cytokines, such as IL-8 (see Kelly,
1994). This may be of importance during the process of parturition.
The conceptus must be able to modulate the maternal humoral (antibody-
mediated) and cellular (killer-cell mediated) immune responses. Several mechanisms
that have been demonstrated appear to utilize PGE2. An immunosuppressive agent
produced by cultured human decidual cells has been identified as PGE (Parhar,
Kennedy and Lala, 1988). PGE2 inhibits the function of many cells of the immune
system, and in human semen (with the highest concentrations of PGE found so far),
PGE is believed to suppress the immune responses of the female reproductive tract to
maximize the chances of reproductive success (Kelly, .1994). The mechanism of action
of PGE on leukocytes involves an increase in intracellular cAMP concentrations. The
major PGs in human semen, the 19-hydroxy PGEs, are selective EP2 receptor
agonists which are associated with a rise in intracellular cAMP, thus providing further
evidence for the immunosuppressive role of the seminal PGs (Kelly, 1994). Although
the majority of effects of PGE on leukocytes are suppressive, there is new evidence
that PGE may act synergistically with IL-2 to stimulate granulocyte macrophage
colony stimulating factor (GMCSF) production (Quill, Gaur and Phipps, 1989), which
has also been demonstrated to stimulate placental cell growth (Athanasakis,
Bleackley, Paetkan, Guilbert, Barr and Wegmann, 1987; Armstrong and Chaouat,
1989).
A feature of first trimester decidua is the increased quantity of large granular
lymphocytes (LGL) attributed to the Natural Killer (NK) cell lineage that display an
abundance of a characteristic marker (CD56) (Ritson and Bulmer, 1987). These cells
differ from the majority of circulating NK cells in their morphology, cell surface
markers and cytotoxicity. LGLs in decidua have been demonstrated to have low
cytotoxicity and not to kill trophoblast cells (King and Loke, 1990), but this situation
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can be reversed by IL-2 treatment. The specific mechanism responsible for
maintaining or inducing the phenotype and morphology of these regulatory cells is
unclear, but recent experiments have implicated a role for PGE2. Cytotoxicity in NK
cells can be reduced by PGE2 (Goto, Herberman and Holden, 1983). The cells found
in murine decidua basalis in close proximity to the trophoblast are, similarly to their
human counterparts, of the NK lineage (Linnemeyer and Pollack, 1991a); large and
granular with poor cytotoxicity, but killing can be induced by IL-2. Mouse LGLs
exhibit a particular marker (4H12) of large granular phenotype (Linnemeyer and
Pollack, 1991b). In a study where murine spleen-derived adherent NK cells were
treated with PGE in culture, the cells underwent transition to terminally differentiated
NK cells exhibiting the large granular morphology and 4H12 marker. The cells
gaining the 4H12 marker demonstrated a greatly reduced cytotoxicity (Linnemeyer
and Pollack, 1993). Thus, PGE2 appears to play a role in the transformation of the
function, morphology and markers of NK cells in the mouse. Evidence for such a role
of PGs is further strengthened by a study in which chronic indomethacin treatment to
pregnant mice resulted in NK cell activation within the uterus and subsequent embryo
death (Lala, Scodras, Graham, Lysiak and Parhar, 1990). It is presently unknown
whether a similar mechanism may occur in the human and other species. Another
action of PGE in reducing the effect of the maternal immune response is its ability to
induce "class switching"of globulins, so that the production of immunoglobulin (Ig)
G-l and IgE are favored with a subsequent reduction in the ability to activate the
complement system (Phipps, Stein and Roper, 1991). Also, paternal antigens are
produced in several species, including man, and can be induced in mice. In mice,
paternal antigens are almost exclusively of the IgG-1 isotype, which because it is
unable to fix complement, is not very cytotoxic, with no cytotoxicity having been
detected in maternal sera (Bell and Billington, 1980). A recent hypothesis based on
studies of decidual cytokine ratios in mice, suggests that pregnancy is characterized by
a strengthened maternal humoral immune response and a diminished cellular response
This is characterized by an increase in T helper (Th) -2 cells (which produce cytokines
that stimulate antibody generation) and a decrease in Th-1 cell activity (which
generate cytokines required for cellular responses) (Wegmann, Lin, Guilbert and
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Mosmann, 1993). In an inflammatory response, Th-l/Th-2 responses are determined
by antibody presenting cells, and the mediator is believed to be PGE2. PGE stimulates
cAMP in both Th-1 and Th-2 cells, however, such a change only results in the
inhibition of Th-1 cells (Betz and Fox, 1991). Therefore, a physiological control
mechanism that is observed in inflammation, may be used within the decidua, where
PGE could be produced by either decidual cells or synctiotrophoblast.
The present studies have demonstrated that the control of arachidonic acid
turnover may have a role in the regulation of PG synthesis during pregnancy in the
guinea-pig. In particular, the control of arachidonic acid uptake may be important in
the placentae and fetal membranes, but not in the endometrium, of pregnant guinea-
pigs. Also, PLA2 may have a role in the endometrium and fetal membranes, but not in
the placentae, in the regulation of PG synthesis from the pregnant guinea-pig.
In a study by Riley and Poyser (1987), it was proposed that in the non¬
pregnant guinea-pig, oestradiol induces the synthesis of a protein ("lipostimulin") by
the endometrium which acts on a progesterone-primed uterus to raise the endometrial
intracellular Ca2 concentration. This calcium then associates with calmodulin (Poyser,
1985a, b) which then activates PLA2 (Moskowitz et a/., 1985). Thus, PLA2 will
release arachidonic acid from endometrial phospholipids, mainly PC and PE (Leaver
and Poyser, 1981; Ning and Poyser, 1984) resulting in increased PG synthesis. The
calcium ionophore, A23187 stimulates uterine PG synthesis by a mechanism
dependent upon the presence of calcium (Poyser, 1984b). The effect of A23187 on
arachidonic acid turnover inhibited- PG synthesis from the day 7 superfused guinea-
pig uterus in vitro, was investigated in experiment 3:6. Inhibitors of ACS, ACLS and,
surprisingly, PLA2 all increased PGF2a, PGE2 and 6-keto-PGFia outputs. The
inhibition of ACS and ACLS presumably slowed the rate of arachidonic acid uptake
thus, increasing free arachidonic acid available for PG synthesis. The reason for the
increase in PG output following PLA2 inhibition is unclear, but may be due to other
effects of the inhibitor on PG synthesis and metabolism. The increase in PG synthesis
following PLA2 inhibition and A23187 treatment may be due to A23187 stimulating
PLC activity.
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Inhibition of ACS and ACLS with THM prevented the A23 187-stimulated
increase in PG output. The reason for this is unclear. The inhibition of arachidonic
acid uptake may lead to a reduction in an appropriate phospholipid pool for the action
of PLA2, since arachidonic acid is not taken up into lysophospholipids if ACS and
ACLS are inhibited. This would explain the increase in PG output during the first 20
min of THM treatment, and the lack of effect of A23187 during the following 20 min
when the uterus was still treated with THM. This would also explain why inhibitors of
arachidonic acid turnover decreased endometrial PGF2(X and PGE2 outputs during 24 h
of culture i.e. over a long period of inhibition of arachidonic acid uptake, appropriate
phospholipids (PC and PE containing sti-2 arachidonic acid) will become limited, thus
reducing PG synthesis. The syntheses of PGF2a and PGE2 and the synthesis of 6-keto-
PGFitx are different, explaining why the output of endometrial 6-keto-PGFi„ is
increased by the inhibition of ACS and ACLS during 24 h culture It has been
previously suggested that a different pool of arachidonic acid is used in the production
of 6-keto-PGFia by the guinea-pig endometrium (Poyser, 1991).
In experiment 3:7, arachidonic acid was not limiting during the 1 h incubation
of day 7 guinea-pig homogenates together with arachidonic acid turnover inhibitors,
since exogenous arachidonic acid was added to the Krebs solution in which the tissue
was homogenised and incubated. Therefore, since free arachidonic acid was not
limiting, it was expected that treatment with THM and HMB would have no effect on
PG release by guinea-pig uterine homogenates. Perhaps the decrease in PGF2rt output
following THM treatment was due to inhibition of arachidonic acid uptake indirectly
decreasing the appropriate phospholipid pool available for the action of PLA2 i.e. in
the guinea-pig uterus, the synthesis of PGF2a appears to depend upon the availability
of phospholipids, predominately PC and PE, containing arachidonic acid at the sn-2
position. This does not appear to be the case for 6-keto-PGFia, and to a lesser extent
PGE2, output from the guinea-pig uterus since these PG outputs were unaffected by
THM treatment of guinea-pig uterine homogenates. HMB was found to be much less
potent than THM in other experiments, so that during this experiment, arachidonic
acid probably continued to be reacylated, thus resulting in reduced PG synthesis. The
increase in the output of all three PGs following treatment with a PLA2 inhibitor
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(ARA) is somewhat surprising. Perhaps the inhibition of PLA2 "switches on" PLC
activity since the guinea-pig uterus has a large source of a PLC enzyme specific for PI
(Bennett and Crooke, 1987). Also, PGHS exhibits self-catalysed breakdown during
the synthesis of PGs (Lands, 1979). Consequently, the total amount of PGs
synthesized by endometrial homogenates is indicative of the concentration of PGHS,
especially since the metabolism of PGs in the absence of NAD by the guinea-pig
uterus is negligible (< 5%) (Poyser, 1979). Thus, ARA treatment may have induced
an increase in PGHS activity resulting in increased PG production in the homogenate
experiments.
The four principle techniques used in these investigations, namely superfusion,
culture, homogenate and microsome, have produced results with the aim of further
understanding the control of arachidonic acid turnover in relation to PG production in
the guinea-pig uterus. Results between different techniques cannot be directly related
since all have different experimental conditions and used uterine tissues in different
preparations. This is highlighted in the findings that short-term inhibition (as in
superfusion experiments) of arachidonic acid reacylation resulted in generally
increased PG production, possibly due to an increase in free arachidonic acid available
for PG synthesis. However, during long term inhibition of arachidonic acid reacylation
(as in 24 h tissue culture experiments) a general decrease in PG production was
observed suggesting a decrease in PG synthesis. This may have been due to the
indirect inhibition of PLA2, since during long term inhibition of arachidonic acid
reacylation, appropriate esterified arachidonic acid in phospholipids will also be
eventually reduced.
All the techniques used were not only carried out on different time scales
(superfusion: 160 min, culture: 24 h, homogenate: 1 h, microsome: 10 min) but also
utilized different tissue preparations. Superfusion utilized whole uterine tissue, so that
the presence of the myometrium should not be disregarded. The short duration of
drug treatments (40 min), immediate collection of PGs, together with simultaneously
run controls, achieved clear observations of PG production, and the influence of
different treatments on PG production, by the superfused guinea-pig uterus in vitro.
The tissue culture experiments utilized endometrial and fetal tissues cultured for 24 h,
2.14
with or without drug treatments, and were sampled for PG production every 6 h. The
influence of inhibitors of arachidonic acid turnover as seen in the resulting PG
production was compared to PG production in untreated tissue. The possibility of
toxic effects due to the inhibitors on the tissues during such long term experiments,
and particularly at high inhibitor concentrations, should be considered. Cell-viability
tests at the end of such experiments should ideally be carried out. In the experiments
carried out using 1 h endometrial homogenate incubations, tissue was homogenized.
Since the tissue was homogenized, the PG production measured represents that from
disrupted cellular tissue. This may have specific effects on PG synthesis, such as
inducing the activity of PGHS or influencing the metabolism of PGs. PGHS exhibits
self-catalysed breakdown during the synthesis of PGs (Lands, 1979). Consequently,
the total amount of PGs synthesized by endometrial homogenates is indicative of the
concentration of PGHS, especially since the metabolism of PGs in the absence of
NAD' by the guinea-pig uterus is negligible (< 5%) (Poyser, 1979). Thus, this
technique is useful for investigating the influence of drug treatments, not only on the
resulting PG production, but also as a possible method for observing changes in
PGHS activity in the guinea-pig uterus. In the experiments investigating the presence
of the enzyme activities that control arachidonic acid turnover in the guinea-pig uterus
microsome preparations were utilized. This achieves a specific investigation of the
enzymes in their cellular compartments. However, the position of the enzymes is of
importance, and this may vary for different enzymes, making comparison of results for
different enzymes difficult. For instance, one enzyme on the inside of the endoplasmic
reticulum will have more difficulty in reacting with exogenous substrates, than another
enzyme positioned on the exterior of the endoplasmic reticulum. Using phospholipid
mixtures in the reactions (as in these experiments) also raises the possibility of micelle
formation, and thus difficulty for the enzyme-substrate complexes to form.
Other methods that could have been used to detect the presence of enzyme
include Western blotting and using probes for mRNA of the enzymes. For example,
by using quantitative Western blotting, the protein (enzyme) concentrations could
have been investigated at different times, during the oestrous cycle and pregnancy,
illustrating whether any changes in the concentrations of the enzymes occurs during
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these times. If an antibody were available, the cellular site of the enzymes could also
be shown using immunohistochemistry techniques. If cDNA sequences to these
enzymes were known and available, expression of mRNA during the oestrous cycle
and pregnancy could be examined by Northern blotting, and this mRNA localised
using in situ hybridisation techniques.
The term "electrophoresis" describes the migration of a charged particle under
the influence of an electric field. Many biological molecules, including proteins,
possess ionisable groups, and thus, at any given pH, exist in solution as electrically
charged species either as cations (+) or anions (-). By applying a potential difference,
different proteins can be separated due to their different electophoretic mobilities. The
protein mixture is applied to some form of support media, commonly polyacrylamide
gels. Hence polyacrylamide gel electrophoresis (PAGE). Separated samples can be
located by staining with an appropriate dye or by autoradiography if the sample is
radiolabeled. SDS-PAGE (using the detergent SDS) is frequently used for studying
proteins. However, this method is of no use to detect one protein (such as an enzyme)
since the SDS denatures the enzyme. Therefore in this case, it is necessary to use non-
denaturing conditions. In native or buffer gels, polyacrylamide gels are used without
SDS so that the proteins are not denatured prior to loading. Since all the proteins
carry their native charge at the pH of the gel, proteins separate according to their
different electrophoretic mobilities and the sieving effects of the gel. The enzyme of
interest can be identified by incubating the gel in an appropriate substrate solution
such that a coloured product is produced at the site of the enzyme. An alternative
method for enzyme detection is to include the substrate in an agarose gel that is
poured over the acrylamide gel and allowed to set. Diffusion and interaction of
enzyme and substrate between the two gels results in colour formation at the site of
the enzyme (Wilson and Walker, 1994). Although essentially an analytical technique,
PAGE does achieve fractionation of a protein mixture during the electrophoresis
process. It is possible to make use of this fractionation to examine further individual
separated proteins. The first step is to transfer or "blot" the pattern of separated
proteins from the gel onto a sheet of nitrocellulose paper. This method is known as
"Western blotting", by analogy with "Southern blotting", the equivalent method used
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to recover DNA samples from an agarose gel. Transfer of the proteins from the gel to
the nitrocellulose can be achieved in one of two ways. In "capillary blotting" the gel is
placed on a wet pad of buffer-soaked filter paper and a sheet of nitrocellulose placed
on the gel. Buffer is then drawn through the gel by placing a pad of dry absorbent
material (such as filter paper) followed by a heavy weight on top of the nitrocellulose
sheet. The passage of buffer by capillary action through the gel carries the separated
proteins onto the nitrocellulose sheet, to which they bind irreversibly by hydrophobic
interaction. The process is carried out overnight, but due to the small pore size of the
acrylamide gel, only a limited amount of buffer travels through the gel in this time, so
that only between 10-20 % of the protein in the gel is transferred. A quicker and more
efficient method of transfer is achieved by "electroblotting" where a sandwich of gel
and nitrocellulose is compressed in a cassette and immersed, in buffer, between two
parallel electrodes. A current is passed at right angles to the gel, which causes the
separated proteins to electrophorese out of the gel and onto the nitrocellulose sheet.
The nitrocellulose with its transferred protein is referred to as the "blot". Once
transferred onto the nitrocellulose, the separated proteins can be examined further.
This involves "probing" the blot, often using an antibody to detect a specific protein.
The blot is firstly incubated in a protein solution (eg. BSA) which will block all
remaining hydrophobic binding sites on the nitrocellulose sheet (referred to as "blotto
technique". The blot is then incubated in a dilution of an antiserum (primary antibody,
eg. rabbit IgG) directed against the protein of interest. The blot is then incubated
further with a second antibody directed against the IgG of the species that provided
the primary antibody (eg. anti-rabbit IgG). This second antibody is appropriately
labelled so that the interaction of the secondary antibody to the primary antibody can
be visualised. A common detection method is to use an enzyme-linked second
antibody, so that following incubation of the blot with second antibody, the blot is
further incubated in enzyme-substrate solution. The enzyme converts the substrate
into an insoluble coloured product that is precipitated onto the nitrocellulose. The
presence of the coloured band indicates the position of the protein of interest.
Although enzymes are commonly used as markers for second antibodies, other
markers are also used including, '"T-labelled second antibody (binding to the blot is
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detected by autoradiography), fluorescein isothiocyanate-labelled second antibody
(fluorescent label detected by exposure of blot to ultra-violet light), 12:,I-labelled
Protein A (Protein A binds to IgG, thus 125I-labelled Protein A is used instead of
second antibody, and binding to blot is detected by autoradiography) and gold-
labelled second antibody (directly visible as red colour when gold particles bind to
primary antibody on the blot) (Wilson and Walker 1994; Burnette, 1981).
Hybridization of a nucleic acid probe to endogenous mRNA present in cytological or
histological preparations is one of the most precise methods available for detecting
target mRNA (Decimo, Labouesse and Dolle, 1995). mRNA contains sequences of
ribonucleotides which code for amino acid sequences of proteins. A single mRNA
molecule codes for a single polypeptide chain in eukaryotes (Wilson and Walker,
1994). Thus, the in situ hybridization of a nucleic acid probe to a particular cellular
mRNA allows the detection of the particular protein (eg. enzyme) coded by that
mRNA. At present, complementary RNA (cRNA) probes (riboprobes) labelled with a
low-energy (3 emitter are commonly used as they are believed to offer the greatest
sensitivity (Decimo et a/., 1995).
In summary, these studies have investigated the role that the control of
arachidonic acid turnover plays in the control of PG synthesis in the non-pregnant and
pregnant guinea-pig uterus. The important roles of PGs, both in the non-pregnant and
pregnant guinea-pig uterus, have been discussed. ACS, ACLS and PLA2 activities
have been demonstrated to be present in both non-pregnant and pregnant
endometrium, and in the conceptal tissues of pregnant guinea-pigs. Thus, these
enzymes may play a part in the control of arachidonic acid turnover and therefore, PG
synthesis, in these tissues. The use of inhibitors has also demonstrated that these
enzymes may be involved in the tightly regulated control of PG production during the
oestrous cycle and early pregnancy in the guinea-pig.
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